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ABSTRACT 
Chemical biology is a multidisciplinary field, combining perspectives and techniques from 
biology and chemistry to study biological systems. Often, these multidisciplinary endeavors 
hinge on the application of the powerful tools of synthetic and analytical chemistry to solve 
problems or test an interesting hypothesis in a biological system. The viewpoint of biology 
offers a larger scope with the potential for more immediately applicable results. Application 
of organic synthesis and analytical techniques identify biological signals or signal disrupters. 
Following, perturbation of a signaling pathway via a synthetic signaling molecule modulates 
the transcription of a desired gene produced correlated to a phenotype of interest or aids in 
the identification of an unknown component in the biological degradation of a chemical 
signal. Finally, implementation of nuclear magnetic resonance (NMR) and/or high 
performance liquid chromatography- mass spectrometry (HPLC-MS) contributes to 
elucidating the structure, annotating the identity, or quantitating biological signals or signal 
disrupters. In the first study, a library of 1-(4-substitutedphenyl)pyrazole-based 
glucocorticoid (GC) analogues were synthesized and evaluated for their ability to reduce 
inflammation with a reduced impact on insulin production. Compounds 11aa and 11ab at 1 
µM [micromolar] reduced inflammation to a similar extent to dexamethasone 10 nM with 
improved transactivation and reduced impact on insulin production. In the process of 
screening, structure-activity relationships were also shown to be correlated to the desired 
biological activity. In the second series of studies, 4-methylphenol (4MP), a putative anoxic, 
abiotic, mineral-mediated degradation product of bisphenol A (BPA), was shown to not be a 
BPA degradation product. Additionally, it was shown that BPA is not inert under anoxic 
conditions and that MnO2 [magnesium oxide]-mediated coupled abiotic−biotic processes 
may be relevant for controlling the fate and longevity of BPA in sediments and aquifers. In 
the third study, the N-acyl homoserine lactone (AHL) production, gene transcription, and 
phenotype expression of Phaeobacter sp. strain Y4I was quantitated to ultimately describe 
the regulation of indigoidine biosynthesis by two quorum sensing gene sequences. In the 
fourth study, AHLs are shown to be present in coral black band disease (BBD) and their 
production, enhanced by temperature, may control the structuring of infected and healthy 
coral microbial communities.  
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INTRODUCTION  
The four chapters of this dissertation each represent a study or pair of sequential studies 
focusing on the study of biological signaling molecules or signaling disruptors. The first 
chapter features non-steroidal glucocorticoid (GC) analogues. GCs, are steroids, 
possessing both anti-inflammatory and metabolic effects, synthesized endogenously in 
the adrenal glands.1 Their potential for being a possible type 1 diabetes mellites therapy 
was explored. The second study features Bisphenol A (BPA) and studies its degradation 
in abiotic, anoxic freshwater sediment. BPA is a high production volume chemical used to 
manufacture polycarbonate, epoxy resins, flame retardants, and lacquer coatings on food 
cans, as well as other products.2  The third and fourth chapters feature N-acyl homoserine 
lactones (AHL), a bacterial cell-to-cell signaling molecules used to coordinate population 
size, colonization, virulence, and antibiotic production s3. The third chapter describes the 
regulation of the antimicrobial indigoidine by two AHL cell-to-cell communication systems. 
The fourth chapter showed how AHLs and autoinducer 2 (AI-2), another bacterial cell-to-
cell signaling molecule, may pay a role in structuring the microbial communities of both a 
polymicrobial infection and the healthy coral microbiome as well as the pathobiology of 
coral black band disease (BBD). 
 
The focus of this dissertation is an overview of studies in the field of chemical biology, 
which often applies the tools of chemistry to test biological hypothesis. Each chapter 
focuses on the chemist’s contribution to each study in the areas of discovery, synthesis, 
and characterization. These contributions are made possible by the tools of chemistry, 
generally in these studies, organic synthesis, high performance liquid chromatography-
mass spectrometry (HPLC-MS), and nuclear magnetic resonance spectroscopy (NMR). 
Synthesis of biological signaling molecules, signaling disruptors, and analogues allow 
perturbation of biological systems, confirmation of structures during the process of 
structural elucidation, and ability to afford internal calibration and quantitation during 
HPLC-MS experiments. HPLC-MS and its variants employed in these studies allow aids 
in discovery and characterization via determining molecular formula and some structural 
information, as well as quantitative measurements. NMR aids in discovery and 
characterization provides very detailed information about the structure of a molecule as 
well as its chemical environment.  
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CHAPTER I. EVALUATION OF THE STRUCTURAL VARIATIONS OF A 
SERIES OF NON-STEROIDAL 1-(4-SUBSTITUTEDPHENYL)PYRAZOLE-
BASED GLUCOCORTICOID ANALOGUES THAT LEAD TO ANTI-
INFLAMMATORY ACTIVITY WITH REDUCED SIDE-EFFECTS ON BETA 
CELL FUNCTION 
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The work outlined in this chapter is currently in the final stages of preparation for 
publication. The work was accomplished by Carson W. Prevatte1, Susan J. Burke2,3, 
Brandon J. Kennedy1, Alex R. Fisch1, Russel T. Smith1, Lee E. Dunlap1, Jason J. Collier2,3, 
and Shawn R. Campagna1. This chapter represents the major work of CWP in this 
dissertation. This chapter was written by CWP under the supervision of SRC and he is the 
primary contributor in terms of the work performed and intellectual input in each section 
apart from the generation of experimental bioassay data by SJB. 
 
Affiliations: Departments of 1Chemistry and 2Nutrition University of Tennessee, Knoxville, 
Tennessee 37996; 3Adipocyte Biology Laboratory, Pennington Biomedical Research 
Center, Baton Rouge, Louisiana 70808 
 
JJC and SRC conceived the study. The synthesis of all 36 glucocorticoid (GC) analogs 
evaluated were synthesized by CWP with assistance from RTS and LED. Modifications 
and optimizations to the previously reported synthesis were performed by CWP.4 
Characterization was performed by CWP, BJK and ARF. This includes synthesis of some 
analogues that were in insufficient quantities to characterize after being subjected to 
bioassay evaluation. Bioassay evaluation of the GC analogues was performed by SJB, 
and the generation of the experimental data was accomplished by SJB and JJC. The 
modifications and optimizations of the previously reported synthesis are discussed by 
CWP. CWP and BJK contributed to the discussion of the structure-activity relationships 
determined from the bioassay results.  
 
CWP contribution  
 
Technical skill, fundamental knowledge of organic chemistry, and the ability to combine 
chemical and biological results came together in a discussion of new structure-activity 
relationships and reevaluation of previously reported glucocorticoid (GC) analogues. 
Previously reported by Merck (2004), 1-(4-fluorophenyl)pyrazole-based GC analogues were 
shown to act as ligands for the glucocorticoid receptor (GR). Their ability to reduce 
inflammation without accompanying side effects was measured using general bioassays. 
Our study took it a step further, by synthesizing a larger, more structurally diverse library of 
GC analogues with the Merck scaffold and evaluating them with specific bioassays relevant 
to determine their preliminary potential for treating type 1 diabetes mellitus (T1DM). First, 
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The previously reported4 library which possessed analogues with a single, electron-
withdrawing 1-(4-fluorophenyl)pyrazole. In contrast, this study reports three series of 1-(4-
substitutedphenyl)pyrazoles each possessing an electron-withdrawing, electron donating, 
and neutral substituent at the 4-position. Second, the previously reported bioassays 
produced structure activity relationships correlating structure to general anti-inflammatory 
and transactivation activity while this study correlates its wider scope of structures to anti-
inflammatory, transactivation, and insulin production in vivo using rat beta cells containing 
luciferase gene reporter assays and the glucose stimulated insulin secretion assay (GSIS).  
 
Despite the synthesis of 1-(4-fluorophenyl)pyrazole-based analogues being previously 
reported, the two most significant steps in the synthetic scheme did not generate the desired 
products in high purity and yield using the reported conditions. The optimizations for these 
two reactions made up the most significant contribution in terms of effort and allowed 
efficient synthesis of the aldehyde point of differentiation and secondary (2°) alcohol 
analogues. Additionally, the synthesis of two additional, novel analogue series with different 
4-substituted headgroups expanded the previously reported study by Merck. Precedence 
for the headgroups exists in their application in other analogue scaffolds containing a 1-(4-
substitutedphenyl)pyrazole and allows modulation of the electronics that can generate new 
structure-activity relationships. Finally, for this chapter, the discussion consists of two 
sections. First, a discussion of the optimization of a Wittig reaction and two organolithium 
additions to carbonyl compounds is discussed. Generally, discussion of the optimization of 
these reactions serves to educate the reader in regards to the general process of reaction 
optimization driven by a decision-making process based on the fundamental principles of 
organic chemistry. More specifically, the measures taken, and the reasoning behind them, 
can be applied to the same or similar reaction types. Second, the discussion for the 
dissertation, as opposed to the publication for this project, is written solely by CWP and 
focuses on identifying trends in structure-activity relationships. From this, reevaluating the 
potential of the GC analogues with the Merck scaffold in application to treating T1DM will 
also be discussed.  
 
1.1 Abstract 
 
Glucocorticoids (GCs), acting via the glucocorticoid receptor (GR) ubiquitously expressed 
in mammalian tissues, are commonly implemented in managing inflammatory, 
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autoimmune, and allergic disorders, certain cancers, and transplantation of organs and 
tissues. Previously reported 1-(4-fluorophenyl)pyrazole-based GC analogues acting as 
GR agonists have been shown to reduce interleukin 6 (IL-6)-induced inflammation 
(transrepression), but were often accompanied by an unwanted increase in transcription 
of genes associated with type 1 diabetes mellitus (T1DM), muscle wasting, and 
osteoporosis (transactivation). Development of an anti-inflammatory GC-based molecule 
with a biological activity that minimizes transactivation could greatly contribute to the 
prevention and treatment of T1DM, which is characterized as an autoimmune disorder 
caused by inflammation and subsequent autoimmune-mediated destruction of the insulin-
producing beta cells. In this study, a series of diverse 1-(4-substitutedphenyl)pyrazole-
based GC analogues were synthesized and screened to determine the structure-activity 
relationships that lead to the desired biological activity. Luciferase bioreporter assays, 
including chemokine ligand 2 (CCL2) promoter-luciferase promoter, glucocorticoid 
response element (GRE) promoter-luciferase promoter, and glucose stimulated insulin 
secretion (GSIS), were used to measure repression of interleukin 1 beta (IL-1β)-induced 
inflammation, activation of pro-inflammatory genes, and the effect on insulin production, 
respectively. Repression of IL-1β-induced inflammation by compounds 11aa and 11ab at 
1 µM were comparable to dexamethasone at 10 nM with significantly reduced GRE 
activation. Compounds 11aa and 11ab also exhibited a reduced impact on insulin 
production relative while dexamethasone lowered insulin production about 40%. 
 
1.2 Introduction 
 
Glucocorticoids (GCs) are steroids, possessing both anti-inflammatory and metabolic 
effects, synthesized endogenously in the adrenal glands. GCs operate by acting as the 
ligand for the glucocorticoid receptor (GR), which resides in the cytoplasm bound to 
chaperone proteins such as heat shock protein 90 (hsp90). The GR is expressed by nearly 
all cell types, including  beta cells, and is the product of a single gene, NR3C1, that is post-
translationally modified to produce functionally distinct subtypes of the GR.1 The GR has 
six modes of activation at the cellular level. The ligand-bound GR (GR-GC) can translocate 
to the nucleus whereby it can bind a glucocorticoid response element (GRE), a 
palindromic gene sequence within the promotor, as a dimer to (1) induce or (2) suppress 
gene expression5. Additionally, while in the nucleus, GR-GC can (3) facilitate or (4) hinder 
the actions of other transcription factors. Alternatively, the GR-GC can remain in the 
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cytoplasm and (5) increase or (6) decrease the activity of a protein in the cytoplasm.6 Due 
to the anti-inflammatory and metabolic-altering effects of GCs, along with the ubiquity of 
the GR, GC-based therapies have been successfully applied to treating a wide range of 
inflammatory, auto-immune disorders and cancers as well aiding in organ and tissue 
transplants. 
 
T1DM is characterized as an autoimmune disorder characterized by inflammation and 
subsequent autoimmune-mediated destruction of the insulin-producing beta cells.7 One 
manner of autoimmune beta cell death commonly associated with T1DM occurs through 
insulitis, which is the process by which beta cell damage and death occur via infiltration 
by macrophages and T cells along with accumulation of pro-inflammatory cytokines such 
as IL-1β, interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α).8-10 Cytokine-
mediated inflammation of beta cells causes the expression of chemokine ligands 9 and 10 
(CXCL9 and CXCL10), which signal the recruitment of T cells chemokine receptor 3 
(CXCR3).8, 11-12 Two of the six modes of activation for the GR are often attributed to 
contributing to the deleterious and salutary effects. The deleterious mode of activation is 
termed transactivation which describes the translocation of the GR-GC to the nucleus to 
increase transcription of pro-inflammatory genes via binding GRE. The metabolic 
deregulation caused by the direct binding of the GR-GC to GREs is thought to result in 
the multitude of side effects previously mentioned, as well as hypertension and 
hyperglycemia. The salutary mode of activation is termed transrepression which describes 
the translocation of the GR-GC to the nucleus to inhibit the action of pro-inflammatory 
cytokines, such as IL-1 β, AP-1, and the nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB). These cytokines serve as transcription factors that can generally 
influence immune system regulation and response. The repression of various pro-
inflammatory genes via binding directly to transcription factors is attributed to conferring 
the sought-after anti-inflammatory effects.13-27 More recently, however, the GR-GC has 
been shown to suppress transcription of pro-inflammatory genes by binding to GRE. 
Additionally, it has been determined that GR-GC binding conformation is effected by the 
type of GRE, which suggests that one a GR-GC subtype that cannot bind one GRE may 
be able to bind another based on the specific target gene.28-29 Furthermore, since the types 
and ratios of transcriptional cofactors vary among cell or tissue types, the interaction 
between the GR-GC and transcription factors is dependent upon the activity and 
dissociative properties of the GR-GC in terms of tissue type.29-34 
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Application of synthetic GCs as a possible anti-inflammatory therapeutic for T1DM and 
immunosuppressive agent for organ transplants is a significant field of research. In the 
US, diabetes is the 7th leading  cause of death, affecting 29.1 million people or 9.3% of the 
U.S. population in 2016, 86 million US adults have prediabetes35. Diabetes is the leading 
cause of kidney failure, non-traumatic lower-limb amputations, and new cases of blindness 
in adults and significantly contributes to heart disease and stroke35. Estimated cost of 
diabetes in the US in 2014 was $176 billion in direct and $69 billon indirect36. The ideal 
GC-based T1DM therapeutic would aim to address the inflammation that initiates the 
autoimmune response that ultimately destroys the  beta cells. Moreover, synthetic GCs 
are designed to exhibit a therapeutic profile possessing enhanced anti-inflammatory 
activity with reduced side effects. Despite incredible beneficial properties of GCs, they 
pose a long list of serious side effects including Cushing's disease, Metabolic Syndrome, 
osteoporosis, and diabetes. In fact, the most common cause of drug-induced diabetes is 
clinical administration of GCs, and the incidence of GC-induced diabetes continues to rise. 
 
Synthetic GCs have been shown to improve beta cell development by reducing 
inflammation at the transcription-level by reducing the expression of interleukin 1 (IL-1) 
and TNF-α-induced expression of IL-6.37-38,39 However, they have also been shown to 
reduce adult  beta cell mass.40,41 A study published by Merck Research Laboratories in 
2004 reported the synthesis of  non-steroidal 1-(4-fluorophenyl)pyrazole-based GC 
analogues and biological evaluation of bioassays measuring general transactivation and 
transrepression.4 The study showed that two tertiary (3°)  alcohol derivatives of 1-(4-
fluorophenyl)pyrazole-based GC analogues possessing 3-thiophenyl- or 4-fluorophenyl- 
modifications resulted in potent IL-6 inhibitors relative to dexamethasone as evaluated by 
the IL-6-release assays using the human A549 lung epithelial cell line and isolated mouse 
thioglycolate-elicited peritoneal exudate cells. Ultimately, the 3-thiophenyl 3° alcohol 
analogue was evaluated in vivo in the mouse LPS challenge model producing an ED50 of 
4.0 mg/kg relative to 0.5 mg/kg for prednisolone in the same assay.  
First, the library of previously reported analogues possessed structurally diverse side 
chains 1-(4-fluorophenyl)pyrazole-based scaffold. Our study reports a three-analogue 
series of the same scaffold possessing an electron-withdrawing, electron donating, and 
neutral substituent in the 4-position. Second, the previous reported bioassays producing 
general structure activity relationships correlating structure to general anti-
inflammatory/transactivation activity while this study correlates its wider scope of 
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structures to anti-inflammatory, transactivation, and insulin production. Testing the 
transactivation and anti-inflammatory (transrepression) properties of GC was 
accomplished in vivo using rat beta cells containing luciferase gene reporter assays and 
the glucose stimulated insulin secretion assay (GSIS). 
 
This study is an extension of the previously reported study and possess three main areas 
of innovation.4 First, whereas the Merck study screened for more general anti-
inflammatory and transactivation activity, the study presented herein uses bioassay more 
specific to determining the potential of the ability of these non-steroidal GR ligands to treat 
T1DM. A compound library possessing 36 1-(4-substitutedphenyl)pyrazole-based GC 
analogues were synthesized and subjected biological evaluation (Table 1.1). Of these 36, 
the 21 possessing methyl or methoxy headgroups are previously unreported. This study 
measured the anti-inflammatory, transactivation, and insulin suppression actives in vivo 
using rat beta cells, the cells possessing the chemokine ligand 2 (CCL2) promoter-
luciferase promoter, measuring IL-1β-mediated transrepression, and the GRE promoter-
luciferase promoter, measuring the transactivation of pro-inflammatory genes. The best 
top performing analogues for the luciferase gene reporter assays were subjected to the 
glucose-stimulated insulin secretion assay (GSIS) to determine the impact on insulin 
production. Second, the scope of analogues screened is expanded, including the 
previously reported 1-(4-fluorophenyl)pyrazole-based GC analogues as well as 4-methyl 
and 4-methoxy analogues. This will provide three series of analogues possessing a 1-(4-
substitutedphenyl)pyrazole with a fluoro, methoxy, and methyl group that provide a series 
with an electron-withdrawing, electron-donating, and relatively neutral substituent. 
Ultimately, this will generate new structure-activity relationships among a relatively larger 
scope of 1-(4-substitutedphenyl)pyrazole-based GC analogues by comparing structure to 
a very specific selection of bioassays relevant to testing the potential for acting as a T1DM 
therapeutic.   
 
1.3 Materials and Methods 
 
Chemistry materials and instrumentation. Chemical reagents were purchased 
commercially and used without further purification. Dry ethereal solvents were obtained 
by distillation from a potassium benzophenone ketyl still. All other dry solvents were 
distilled from CaH2(s). Thin-layer chromatography (TLC) was performed using Sorbent  
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Table 1.1. All 2° and 3° alcohol 1-(4-substitued-substituted phenyl)pyrazole-based GC analogues 
synthesized.  
A total of 31 2° and 3° alcohols were subjected to biological evaluation. Compounds highlighted in 
green were previously reported and were synthesized by a previously reported addition to an 
aldehyde or ketone. Compounds highlighted in yellow were previously unreported and were 
synthesized in the same manner as those in green. Compounds highlighted in orange were 
previously reported 2° alcohols generated using significantly modified versions of a previously 
reported organolithium addition. Compounds highlighted in red were previously unreported 2° 
alcohols generated using significantly modified versions of a previously reported organolithium 
addition. Compounds in purple were an undesired t-Bu adduct sometimes obtained during the 
generation of 1-(3,4-difluoro-5-methoxyphenyl)-modified 2° alcohols. 
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Technologies silica G F254 TLC plates. All compounds of interest were visualized as single 
spots using short-wave UV light; more permanent staining of TLC spots was achieved 
using p-anisaldehyde, vanillin, or ceric ammonium molybdate (Hannesian’s stain) TLC 
staining solutions. Silica gel with a 60 Å pore size and a particle diameter of 40-63 µm was  
used for flash chromatography. 
 
1H-NMR spectra were obtained on either an Oxford 300 MHz or Varian InNova 500 MHz 
NMR spectrometer in solutions of CDCl3. All 13C-NMR spectra were recorded on a Varian 
InNova 500 MHz NMR spectrometer in solutions of CDCl3. High resolution mass 
spectrometry (HRMS) for characterization of previously unreported compounds was 
performed using a JEOL DART source in positive ion mode coupled to a JEOL AccuTOF 
JMS-T100LC mass spectrometer. HRMS for characterization of crude mixtures was 
performed using the JEOL DART source in positive ion mode coupled to a JEOL AccuTOF 
JMS-T100LC mass spectrometer or a Sciex Turboionspray electrospray ionization source 
in positive mode coupled to an Applied Biosystems QStar Elite mass spectrometer. Optical 
rotation was measured using a Perkin-Elmer 241 polarimeter equipped with a sodium 
source lamp. IR spectra were collected using a Nicolet iS5 spectrophotometer.  
 
Synthesis of 1-(4-substituedphenyl)pyrazole-based GC analogues. The total 
synthesis of all 1-(4-substitutedphenyl)pyrazole-based GC analogues tested in this study 
were prepared as previously described or by a slightly modified version of a published 
synthesis for 1-(4-fluorophenyl)pyrazole-based GC analogues (Scheme 1.1, Table 1.1).4  
First, the previously described one-pot Wittig-hydrolysis reaction employed to obtain the 
homologous aldehyde 10 from ketone 8 was performed in two steps via isolation and 
purification of the intermediate enol ether 9. Following, reaction conditions were 
significantly modified for reactions of aldehyde 10 to secondary (2°) alcohol 11 requiring 
in situ generation and addition of organolithium compounds. Next, an entirely different 
method for the oxidation of secondary alcohol 11 to ketone 12 was employed using a PCC 
oxidation rather than the previously described method using N-Methylmorpholine-N-Oxide 
(NMO) with TPAP (tetrapropylammonium perruthenate). Additionally, the synthetic 
scheme also differs from the previously described synthesis by exchanging 4-fluorophenyl 
hydrazine for the appropriate 4-substituted phenylhydrazine used to generate previously 
unreported intermediates and GC analogues containing a 4-methyl- or 4-methoxy-
substituents. This creates three different analogue series with different “headgroups.” 
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Scheme 1.1. Synthetic route to 1-(4-substitutedphenyl)pyrazole-based GC analogues. 
 
12 
 
urthermore, chiral HPLC was not employed in the purification of the GC analogues as 
previously reported, but rather standard bench-top flash chromatography and trituration 
techniques were employed. Consequently, purification of some crude mixtures was not 
feasible. Thus, the synthetic methodology was ultimately modified to prevent generating 
crude mixtures containing components bearing identical Rf values by TLC analysis. 
 
The total synthesis of the steroid core begins with a Robinson annulation conducted over 
two steps. A Michael addition between methyl vinyl ketone and 2-methylcyclohexane-1,3-
dione, 1 and 2, using acetic acid and water heated to 75° for one hour to forms 
intermediate trione 3. Intramolecular cyclization is accomplished by stirring 3 with L-proline 
in DMF for 120 h at room temperature to generate primarily the (S)-isomer of Wieland-
Miescher ketone 4 (WMK)4. Further resolution of 4 was not performed. Next, selective 
protection of 4 with ethylene glycol performed neat with catalytic p-toluenesulfonic acid 
and 4 Å molecular sieves for 30 min or until complete via TLC monitoring generates 
intermediate 5 which possesses an α-β-unsaturated ketone available for enolate 
formation. Subsequent addition to ethyl formate in toluene over 3 h to generates β-
ketoaldehyde 6. Addition of the appropriate 4-substituted phenylhydrazine to 6 in acetic 
acid for 2 h or until complete via TLC monitoring completes the core structure of the 1-(4-
substitutedphenyl)pyrazole-based GCs, 7. The acid-catalyzed deprotection of acetal 7 
using 6 N HCl in THF for 3 h under reflux provides intermediate ketone 8. A Wittig-
hydrolysis-type homologation of ketone 8, conducted over two steps via intermediate enol 
ether 9, affords aldehyde 10, the essential intermediate for the divergent synthesis of all 
analogues presented in this study. To obtain aldehyde 10 in high purity, the intermediate 
enol-ether 9 was isolated from the Wittig reaction, purified via flash chromatography, and 
subsequently subjected to hydrolysis conditions. A series of 2˚ alcohols 11 was achieved 
by adding aldehyde 10 to a solution of the appropriate organolithium or Grignard reagent 
in THF at -78° C with various conditions depending on reaction partners. Intermediate 
ketone 12 was obtained through a PCC oxidation of 11 in dichloromethane for 2 h or 
complete via TLC monitoring, and after purification via flash chromatography, was treated 
with MeLi in ether at -40° C to afford 3˚ alcohols 13. 
 
Purification Methods. Throughout the synthetic procedure are purification steps 
requiring silica-based flash chromatography. Difficulty was encountered during the 
purification of most 2° alcohol GC analogues. TLC analysis typically done using a 25% 
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solution of EtOAc in hexanes resulted in visualization of resolved compounds using short-
wave UV light revealed separations that do not seem particularly challenging, but the 
same solvent system applied to a flash chromatography by routine methods resulted in 
poor separation. Dissolution of the compounds in halogenated solvents such as 
dichloromethane allow for wet-loading very concentrated solutions to the top of the column 
as is typically employed in standard benchtop flash chromatography. However, the 
intermediate polarity of these polar aprotic solvents contributes to increasing unwanted 
band-broadening and poor separation, especially during equilibration after loading 
between the loading solvent and solvent system. Unfortunately, all the compounds purified 
in this synthesis would only dissolve in mostly polar solvents that would obscure the 
chromatography and result in poor separation. It was found that the best chromatographic 
resolution can be obtained by loading compounds onto silica, wet-packing the silica 
column, carefully placing a thin layer of sand to maintain column integrity during compound 
loading, and finally loading the vacuum-dried compound-adsorbed silica on top of the sand 
layer. This procedure mimics that of a typical TLC analysis where the compound is loaded 
onto a small section of silica, solvent is allowed to evaporate, and then the whole 
chromatographic system is subjected to the desired mobile phase composition. Despite 
careful solvent system design and column technique, many of the 2° alcohol GC 
analogues were subjected to column chromatography multiple times in order to obtain an 
adequate amount of high purity material to subject to bioassay evaluation as well as move 
forward in the synthesis. 
 
Trituration was employed to remove trace impurities that were not removed with flash 
chromatography as well as in specific application to separating up to 0.11 ratio mixtures 
of ketones 8 and aldehyde 10 resulting after incomplete conversion of 8 to 10 using the 
previously reported one-pot Wittig reaction4. In either application, trituration was 
accomplished by sonication of the preliminarily flash chromatography-purified, often 
colored, crude mixture in diethyl ether or THF. Removal of the colored supernatant 
containing the impurity or starting ketone, leaves the purified product as a white powder. 
In the case of the separation of ketones 8 and aldehydes 10, several triturations may be 
necessary.   
 
Cell Culture, Islet Isolation, Primary Hepatocytes, and Glucose-stimulated 
Insulin Secretion (GSIS). Insulin secretion was measured as previously described using 
14 
 
832/13 rat insulinoma cells.42-43 Isolation of rat islets was performed as previously 
reported.12 Primary hepatocytes from Prague-Dawley rats were supplied from Triangle 
Research Labs. The age of the rats was 8–10 week, and their weights were between 150 
and 200 g when the islets were harvested. The saturating concentrations of the 
commercially available steroid or GC analogue used in GSIS measurements as indicated 
in each figure.43  
 
Cell Viability Assays. 832/13 rat insulinoma cells were exposed to the commercially 
available steroid or GC analogue as indicated in each figure. Viability was assessed using both 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) and adenylate kinase (ADK) assays. These procedures have been previously validated 
using the clonal 832/13 beta cell line.12 
 
Luciferase Assays, ELISA, and Real-time PCR Analysis of mRNA. 832/13 rat 
insulinoma grown to 50% confluence in 24-well plates were transiently transfected with 25 
ng of the appropriate plasmid using TransFectin Lipid Reagent (Bio-Rad) per the 
manufacturer’s protocol. Following, the results were normalized to total protein content 
according to a reported previously method41. Rat Quantikine (CCL2) ELISA kits (R&D 
Systems, Inc., Minneapolis, MN) was used to detect the CCL2 concretions in the media. 
Total RNA  isolation, cDNA synthesis, and quantification of mRNA abundance measured 
with real-time RT- PCR was performed using a previously reported method.11,44 
 
1.4 Results and Discussion 
 
Optimization of the Wittig-hydrolysis reaction to obtain aldehyde 10. Despite the 
thorough details of the previously reported synthesis of 1-(4-fluorosubstituted 
phenyl)pyrazole-based GC analogues (Merck Research Laboratories 2004), application in 
converting ketones 8 to aldehydes 10 via the one-pot Witting-hydrolysis sequence did not 
consistently result in a complete conversion. The TLC-determined Rf value between all 
ketones 8 and aldehydes 10 was less than 0.10 in all solvent systems tested. Solvent 
systems tested included solutions of EtOAc in hexane ranging from 10-40%, MeOH in DCM 
ranging from 0.5-2%, and EtOAc in DCM ranging from 10-20%. Furthermore, the developed 
TLC plate often contained the two as overlapping spots. Thus, application of standard 
benchtop flash chromatography techniques was ill-suited for separation of these two 
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components. This posed a significant problem since the intermediate aldehyde is the point 
of differentiation from which all 1-(4-substitutedphenyl)pyrazole-based GC analogues were 
derived. Separation of the two-component aldehyde-ketone mixture, up to a 0.11 ratio by 
NMR, was accomplished by subjecting the orange-brown crude product to flash 
chromatography followed by several successive triturations in diethyl ether. It was 
discovered that ketones 8 are marginally more soluble in diethyl ether than aldehydes 10. 
This method of successive triturations was exclusively used to obtain aldehyde 10a of fair 
purity that could be used to make the product GC analogues. However, it was detrimental 
to the yield. For the synthesis of aldehyde 10b and 10c, an optimization of the previously 
reported method4 was conducted, and this new, optimized method was ultimately employed, 
as opposed to trituration, to ultimately access these aldehydes. 
 
Initially, a series of test reactions were run to determine which stage or component to 
optimize. In the first test reaction, ketone 8a was subjected to the previously reported Wittig 
reaction conditions4 with the phosphonium salt of interest, 
(methoxymethyl)triphenylphosphonium chloride (Ph3PMOMCl) (Scheme 1.2). The reaction 
was immediately quenched by the addition of 1:1 THF/MeOH, diluted with EtOAc, and 
washed with water and brine. After concentration, crude aldehyde 9a was analyzed via NMR 
to determine the extent to which the ketone was being converted to the enol ether. Though 
a spectrum of conversion for each run varied, an incomplete conversion was observed 
among all runs as evidenced by a peak at 6.27-6.28 ppm corresponding to the vinyl proton 
of ketone 8a. This suggested that the previously reported one-pot, two-step Wittig reaction 
required optimization.  The hydrolysis of enol ether 9a to generate aldehyde 10a was not 
suspected to result in incomplete conversion as the equilibrium between an enol ether and 
an aldehyde under acidic, aqueous hydrolysis conditions greatly favors the forward reaction.  
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Scheme 1.2. Previously reported one-pot Wittig hydrolysis reaction quenched after the Wittig reaction. 
An incomplete conversion of ketone 8a to enol ether 9a suggested that it was the Wittig reaction 
component of the previously reported one-pot, two step homologation reaction which required 
optimization. 
 
Scheme 1.2. Previously reported one-pot Wittig hydrolysis reaction quenched after the Wittig 
reaction. An incomplete conversion of ketone 8a to enol ether 9a suggested that it was the Wittig 
reaction component of the previously reported one-pot, two step homologation reaction which 
required optimization. 
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For the second test reaction, a Wittig reaction between benzaldehyde and Ph3PMOMCl was 
performed using previously reported conditions(Scheme 1.3)4. Complete conversion of the 
aldehyde was observed in the NMR spectrum of the crude product as evidenced by the 
absence of an aldehyde peak in the 9.5-10.5 ppm range and two sets of vinyl and methoxy 
protons for both alkene stereoisomers. Though this reaction was run for the full 24 hours, it 
was likely completed in a much shorter time because the carbonyl component of the Wittig 
reaction was a more reactive, unhindered aldehyde. The successful reaction between the 
ylide generated from Ph3PMOMCl and the more reactive model carbonyl compound, 
benzaldehyde, reduced the concern of the reactivity of the carbonyl reacting partner of the 
Wittig reaction. This suggested that the ylide was being efficiently produced from the 
phosphonium salt of interest and attention should be focused on the carbonyl component. 
  
 
 
 
 
For the third test reaction, two reactions between WMK ketone 4 and Ph3PMOMCl were 
conducted to study a Wittig reaction with a ketone sterically analogous to ketone 8 (Scheme 
1.4). The reaction conditions were the same as those previously reported, but a complete 
conversion of the starting ketone was observed by TLC after 7.5 h. Full conversion was 
observed in the NMR spectrum of the crude product as evidenced by the absence of a peak 
at 5.85 ppm corresponding to vinyl proton of WMK 4 as well as the presence of new vinyl 
and methoxy protons. The product distribution consisted of three sets of enol ether protons, 
16-18, which resulted from reactions at each or both ketones.  
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Scheme 1.3. Wittig reaction between benzaldehyde 14 and Ph3PMOMCl 15. Complete conversion 
was observed in the NMR spectrum for the Wittig reaction between the ylide generated from 
Ph3PMOMCl and a carbonyl compound more reactive relative to ketone 8.   
 
Scheme 1.3. Wittig reaction between benzaldehyde 14 and Ph3PMOMCl 15. Complete 
conversion was observed in the NMR spectrum for the Wittig reaction between the ylide generated 
from Ph3PMOMCl and a carbonyl compound more reactive relative to ketone 8.   
Scheme 1.4. Wittig reaction between WMK 4 and Ph3PMOMCl. Complete conversion was observed 
between two runs of this test reaction. These results suggested that the sterics of the ketone of interest, 
8a, were not a significant factor in the incomplete conversion observed in the reaction of interest.  
 
Scheme 1.4. Wittig reaction between WMK 4 and Ph3PMOMCl. Complete conversion was 
observed between two runs of this test reaction. These results suggested that the sterics of the 
ketone of interest, 8a, were not a significant factor in the incomplete conversion observed in the 
reaction of interest.  
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The final test Wittig reaction was conducted by way of the first step in an alternative 
sequence that was attempted to obtain the aldehyde. Successful Wittig reactions were 
conducted between ketone 8a and either methyltriphenylphosphonium bromide 
(Ph3PCH3Br) or methyltriphenylphosphonium iodide (Ph3PCH3I) using previously reported 
conditions (Scheme 1.5).45 Complete conversion of the starting ketone 8a was observed by 
TLC after 6 h. This was observed in the NMR spectrum for the crude product by the absence 
of a peak at 6.28 ppm corresponding to the vinyl proton of the starting ketone 8a. Product 
19 was subjected to flash chromatography, and its structure was confirmed by NMR. The 
percent yield for the reaction was 76.8 %. 
 
 
 
 
 
 
 
The results of the test reactions showed that the previously reported Wittig reaction 
conditions efficiently generated an ylide from two different phosphonium salts and resulted 
in complete conversion with their aldehyde or ketone reaction partner. However, since the 
same conditions resulted in incomplete conversion for the reaction of interest, attention was 
drawn to the lengthy reaction time it required, which was the most significant difference 
between the reaction of interest and the test reactions. All test reactions were all complete 
in less than 24 h except for the reaction with benzaldehyde, which would have likely been 
observed to have a shorter reaction if the reaction had been monitored by TLC. It was 
hypothesized that because the stir time was so long, the reaction  would be more likely to 
succumb to trace amounts of water that could enter either from the nitrogen line that 
provided the inert atmosphere for the reaction or from the crude needle and septum setup 
commonly employed in academic research labs. Use of a drying tube packed with 
anhydrous CaSO4 directly before the reaction flask did not result in a consistent 
improvement in conversion. Additionally, swapping out the needle and septum setup for a 
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Scheme 1.5. Wittig reaction between ketone 8a and Ph3CH3Br. Complete conversion was observed by 
TLC after 7.5 h. Complete conversion was also observed in the NMR spectrum. Product 19 was 
subjected to flash chromatography, and pure product 19 was isolated in 76.8 % yield. These results 
suggest that it is the relatively lengthy time of the reaction of interest that is correlated to its incomplete 
conversion.  
 
Scheme 1.5. Wittig reaction between ketone 8a and Ph3CH3Br. Complete conversion was 
observed by TLC after 7.5 h. Complete conversion w s also observed in the NMR spectrum. Product 
19 was subjected to flash chromatography, and pure product 19 was isolated in 76.8 % yield. These 
results suggest that it is the relatively lengthy time of the reaction of interest that is correlated to its 
incomplete conversion.  
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ground glass vacuum adapter immediately after the reaction setup was complete, which 
likely allowed air to enter during the exchange, also did not result in an improvement. 
 
Rather than optimizing the reaction conditions or purification, an intermediate workup and 
purification step between the Wittig and hydrolysis steps was envisioned to give a crude 
reaction product with a mixture of enol ether 9 and ketone 8 which could be separated using 
standard benchtop chromatography. Good separation on TLC between the two 
stereoisomers of the enol ether and the ketone was observed and provided the promise for 
successful flash chromatography. As an example, for enol ether 9c, the Rf values for the 
pair of enol ether diastereomers was 0.63 and 0.67 while the starting ketone 8c was 0.57 
when developed with 30% EtOAc in hexanes. The reaction was performed as previously 
reported and immediately quenched by the addition of 1:1 THF/MeOH, diluted with EtOAc, 
washed with water and brine, concentrated in vacuo, and subjected to a column eluted with 
15% EtOAc in hexanes. The successfully isolated enol ether stereoisomers were 
concentrated and subjected to the previously reported hydrolysis conditions4. The yield of 
9c over these two steps with intermediate purification was 71%. Though not optimizing the 
reaction or purification directly, this reliably produced aldehyde product of high purity and 
good yield while allowing the remaining starting ketone to be recovered. 
 
Optimization the synthesis of 1-(3,4-difluoro-5-methoxyphenyl)-modified 2° 
alcohols 11xd (Table 1.2). Application of the previously reported general method 
describing the generation and addition of organolithium nucleophiles to the aldehyde 
precursor of 1-(4-substitutedphenyl)pyrazole-based GC analogues did not result in efficient 
conversion when applied to the generation and addition of 5-lithio-2,3-difluoroanisole and 3-
lithiothiophene to aldehydes 10 in this study. Because of this, optimization of these two 
organolithium additions was conducted as each 1-(4-substitutedphenyl)pyrazole-based GC 
analogue was synthesized (Tables 1.2). The reactions could be optimized as analogues 
were successfully synthesized because despite most reaction conditions resulting in a low 
yield, each condition produced product in adequate quantities and purity for bioassay 
evaluation. here was no difference in reactivity expected or observed among aldehydes 10 
with a fluoro, methyl, or methoxy 4-substituted phenyl headgroup. Thus, a single condition 
may have contained runs carried about among different aldehydes. Additionally, the 
previously reported method was described on single milligram scale with the final purification 
of the 2° alcohols 11 sometimes requires purification by single milligram- 
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Condition Organolithium formation Addition to aldehyde Color change
1 20 min at -78° C 45 min at -78° C
2 5 min at -78° C 60 min at -78° C dark yellow 
warmed to 0° C for 5 min
returned to -78° C for 5 min
3 warmed to -40° C for 20 min 60 min at -78° C avoided color
4 5 min at -78° C 60 min at -78° C
-40° C to r.t. over 55 min, no dry ice 
added so allowed to warm some
yellow-green
5 5 min at -78° C 60 min at -78° C
5 min at 0° C
5 min at -78° C
N
N
R1
HO
F
F
O
N
N
R1
HO
+
11
in THF
F
F
OBr
20
F
F
OLi
21 11xd 11xg
Table 1.2. Optimization of the generation and addition of 5-lithio-1,2-difluoro-3-methoxybenzene to 
aldehyde 10 to obtain 2° alcohol 11 was performed. 
 
Table 1.2. Optimization of the generation and addition of 5-lithio-1,2-difluoro-3-methoxybenzene to 
aldehyde 10 to obtain 2° alcohol 11 was performed. 
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scale chiral HPLC. The optimizations of 2° alcohol analogues reported herein is a method 
for generating alcohols 11xd  and 11xe, discussed in the following section, in gram 
quantities and purification was accomplished exclusively by standard benchtop 
chromatography with occasional post work-up via trituration. With a larger amount of 
molecule in hand, a larger scale studies subjecting the molecules to more bioassays or 
perhaps larger numbers of organisms for in vivo evaluation can be accomplished.  
 
In application to the synthesis of 1-(3,4-difluoro-5-methoxyphenyl)-modified analogues, the 
previously reported method for organolithium addition conditions called for a large excess 
of 5-Bromo-2,3-difluoroanisole and t-BuLi, 10 and 20 equiv. respectively. Because this 
equivalency was initially thought to be excessive, more mild conditions were initially used in 
conditions 1 and 2. Condition 1 used 2.0 equiv. n-BuLi and 5.0 equiv. of aryl bromide (ArBr) 
and resulted in a low yield, 21.3%. The results of condition 1 were not thoroughly 
investigated. Condition 2 used 3.0 equiv. n-BuLi and 1.5 equiv. 5-Bromo-2,3-difluoroanisole 
and resulted in a 13.1% of the adduct between n-BuLi and aldehyde 10a. It should be noted 
that at the time conditions 1 and 2 were performed, the optimization of the Wittig reaction 
was not complete. Thus, these reactions were conducted with starting material containing 
5-10% of the ketone 8a. Despite this, the NMR and mass spectra of the crude product 
generated from condition 2 provided data constructive to the end of determining the point of 
inefficiency for this organolithium addition. Beginning with WMK 4, all intermediate products, 
and the 1-(4-substitutedphenyl)pyrazole-based GC analogue products all contained a vinyl 
proton with a signature chemical shift. The vinyl proton peak indicated of the number and 
identity of components in the crude mixture which included the product of interest, undesired 
products, or the unreacted starting material. The NMR spectra for the crude product 
obtained from condition 2 contained a complex mixture of components of interest as 
evidenced by the four peaks in the alkene region. The vinyl proton corresponding to enol 
ether 9a (6.12 ppm, 1.05 H) was accompanied by three other vinyl protons corresponding 
to ketone 8a unreacted from the previous Witting reaction (6.28 ppm, 1.71 H), the adduct 
between n-BuLi and ketone 8a (6.15 ppm, 2.80 H), and the adduct between n-Bu and the 
aldehyde 10a (6.10 ppm, 2.00 H). High resolution mass spectrometry analysis of the crude 
product showed four peaks corresponding to the four components identified in the NMR 
spectrum. Peaks with mass-to-charge ratios (m/z) of 454.72186, 369.23278, 355.29356, 
and 297.53081 correspond to the [M+H]+ ions for the product of interest, the adduct between 
n-BuLi and aldehyde 10a, the adduct between n-BuLi and ketone 8a, and ketone 8a. 
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The presence of the n-BuLi adducts in the NMR and mass spectra of the crude product 
generated from condition 2 suggests that the conversion of 5-Bromo-2,3-difluoroanisole to 
5-lithio-2,3-difluoroanisole was incomplete. Rather than reacting with 5-Bromo-2,3-
difluoroanisole, the excess n-BuLi was available to add to the aldehyde 10a. This was 
unexpected because 2 equiv. of n-Bu relative to 5-Bromo-2,3-difluoroanisole was employed. 
This is the standard equivalency required since one equivalent is responsible for the 
halogen-lithium exchange while the other is necessary to quench the alkyl halide byproduct 
(Scheme 1.6). Elimination of the alkyl halide by-product ensures the reverse halogen-lithium 
exchange does not occur. Comparing the mass and NMR spectra of the crude product 
generated from condition 2, the ratio between the product of interest, unreacted ketone, the 
adduct between n-BuLi and the 8a, and the adduct between n-BuLi and the 10a was 
1.05:1.71:2.80:2.00 per the integration values for the vinyl protons obtained from the NMR 
spectrum for the crude product and about 11:35:38:4 per the intensities in the mass 
spectrum for the crude product, respectively. This provided difficulty at the time of analysis 
because the four components in the NMR spectrum of the crude product could not be easily 
correlated to the components of the crude mass spectrum by matching the relative 
integrations to the relative intensities of each component. The lower intensity of the product 
of interest in the mass spectrum made it seem like a more minor component than it was. 
This was likely due to a difference in the ionization potential between the n-Bu adducts and 
1-(3,4-difluoro-5-methoxyphenyl) adducts. The crude mixture was subjected to flash 
chromatography, and the main product generated by condition 2 was determined to be the 
adduct between n-BuLi and aldehyde 10a by the presence of a single peak with a m/z of 
369.23370 for the corresponding [M+H]+ ion from an accurate mass measurement taken of 
the main component eluted from the column. 
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Scheme 1.6. Halogen-lithium exchange requires two equivalents of RLi. One equivalent is responsible 
for the generation of 15 from 14 while the other is necessary to eliminate the 19 by generation of 20 via 
E2 elimination so that the reverse halogen-lithium exchange does not occur.  
 
Scheme 1.6. Halogen-lithium exchange requires two equivalents of RLi. One equivalent is 
responsible for the generation of 15 from 14 while the other is necessary to eliminate the 19 by 
generation of 20 via E2 elimination so that the reverse halogen-lithium exchange does not occur.  
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Condition 3 used the same 10 equiv. 5-Bromo-2,3-difluoroanisole as the previously reported 
synthesis4 and a slight excess of 10.5 equiv. t-BuLi. These conditions were successful in 
producing 11ad from 11a as the predominate product, but also resulted in formation of small 
amounts of the adduct between t-BuLi and the aldehyde. Purification using flash 
chromatography was especially challenging since the difference between the Rf values of 
the components was less than 0.10 in all solvent systems tested. Solvent systems tested 
included solutions of EtOAc in hexane ranging from 10-40%, MeOH in DCM ranging from 
0.5-2%, and EtOAc in DCM ranging from 10-20%. Furthermore, the developed TLC plate 
often contained two overlapping spots corresponding to the t-BuLi adduct and 11ad. 
Because complete separation of these two components was never achieved, only a few 
fractions collected from each column possessed pure product of interest, and in many 
cases, flash chromatography was performed more than once for the same crude mixture. 
For any given column, most fractions collection from the column possessed the t-Bu adduct 
which was observed in both NMR and mass spectra. For the NMR, peaks at 6.05 and 6.11 
ppm correlated to the vinyl protons for 11ad and the t-Bu adduct, respectively. A discrepancy 
existed between the intensities of the t-Bu adduct (m/z = 381.26541) and 11ad (m/z = 
467.21434) in the mass spectrum and the integrations in the NMR spectrum. Each impure 
fraction possessed a mass spectrum with a ratio of about 1:1 for the 11ad to t-Bu adduct 
while the ratio of the relative integrations in the NMR spectrum was 10:1. Because only a 
few of the final fractions could be isolated that contained pure 11ad, the yield was a mere 
10.5%. 
 
For condition 4, the exact equivalents and conditions of the previously published method 
were conducted except for THF in place of ether as the solvent for the organolithium 
formation. These conditions resulted in an improved yield, 45.41%, averaged over five 
reactions including one reaction conducted using ether as the solvent for the organolithium 
formation. It was observed that using THF in place of ether did not have a significant effect 
on the yield, with the four runs conducted in THF averaging a 47.40% yield and the single 
ether run producing 37.44% yield. The difference of 10% yield was not considered significant 
given the range of yields observed for the reactions run in THF. Purification of the crude 
mixture was again difficult, with the major side product again being the t-Bu adduct 
evidenced by a peak at 6.14 ppm in the NMR of crude 11bd generated by condition 4. The 
ratio of the product to t-Bu adduct ranged from 1.00:0.08 to 1.00:0.15 as determined by 
integration of the protons corresponding to the vinyl protons. 
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Since application of the previously reported conditions were also produced significant t-BuLi 
adduct, five organolithium additions between veratraldehyde and 5-Bromo-2,3-
difluoroanisole were performed using the previously reported equivalents while varying 
temperature and stir time to determine the condition that best ensures the complete 
conversion the aryl halide to the aryl lithium while producing no observable t-BuLi adduct 
(Table 1.3). Condition 4 successfully achieved full conversion with no observable t-BuLi 
adduct in the NMR or mass spectrum of the crude product. The NMR spectrum showed no 
peaks from 9-10 ppm corresponding to the starting aldehyde nor a peak at 0.94 ppm 
observed in other conditions for the methyl groups of the t-Bu group of the t-BuLi adduct. In 
condition 4, after the initial addition of t-BuLi at -78 °C, the dry ice-acetone bath was 
exchanged for a dry ice-acetonitrile bath to achieve the -42 °C temperature and allowed to 
warm to room temperature while observing the color change. The pale-yellow solution 
transitioned to a dark green as the reaction warmed up over 55 minutes and a dry ice-
acetone bath was reinstalled to lower the temperature back to -78 °C for the addition of the 
aldehyde. This color changed was interpreted to suggest a point where complete conversion 
of 5-Bromo-2,3-difluoroanisole to 5-lithio-2,3-difluoroanisole had occurred. With the lessons 
learned from the previous conditions and the test reaction between veratraldehyde and 5-
Bromo-2,3-difluoroanisole, condition 5 was employed using 10 equiv. of 5-Bromo-2,3-
difluoroanisole and t-BuLi, reduced from the 20 equiv. t-BuLi with the intention to reduce the 
amount of t-Bu adduct formed. Adjustments to the organolithium formation reaction time 
were also made. After addition of the t-BuLi at -78 °C, the solution was stirred for 5 min 
followed by raising the temperature to 0 °C for 5 min. After 5 min at 0 °C the solution 
assumed a dark green color, and the solution was then returned to -78 °C for 5 min before 
the addition of the aldehyde. Increasing the temperature to 0 °C for 5 min rather than the -
40 °C used in the test reaction was done to more quickly achieve the dark green color. This 
resulted in a yield of 41.7% and a 1.00:0.14 ratio of product to t-Bu adduct determined by 
the integrations in the NMR spectrum of the crude product. The percentage t-BuLi adduct 
was similar to condition 4, however, when the NMR spectra of the crude product between 
conditions 4 and 5 were compared, peaks at 6.980, 6.75, 6.74, and 3.897 ppm 
corresponding to 2,3-difluoroanisole were observed. The peaks at 6.980, 6.75, 6.74, and 
3.897 ppm matched the spectrum for 2,3-difluoroanisole published by the Spectral 
Database for Organic Compounds (SDBS)46. Additionally, peaks in the electron rich 
aromatic/alkene region from 6.88-6.98 ppm and the methoxy region were observed, which 
likely correspond to side products derived from additional reactions with the unreacted 5- 
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Table 1.3. Optimization of generation and addition of 21 to 22.  
 
 
Table 1.3. Optimization of generation and addition of 21 to 22 was performed to determine a 
temperature gradient to ensure the complete conversion the 20 to the 21 while producing no 
observable t-BuLi adduct.   
 
This was performed to determine a temperature gradient to ensure the complete conversion the 20 
to the 21 while producing no observable t-BuLi adduct.   
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Bromo-2,3-difluoroanisole. The additional side reactions were likely due to the use of a 1:1 
equiv. of ArBr:t-BuLi rather than the typical 1:2 equiv. ArBr:t-BuLi. It was at this point 
hypothesized that full conversion 5-Bromo-2,3-difluoroanisole was achieved, but the 5 min 
stir time at the elevated temperature of 0° was not sufficient for reaction complete reaction 
between t-BuLi and t-butyl bromide (t-BuBr) (Scheme 1.7). The aldehyde was exposed to 
both 5-lithio-2,3-difluoroanisole and t-BuLi so the possibility of adducts between both 
organolithium species was possible. Furthermore, the formation of 2,3-difluoroanisole 
should have always occurred if any excess 5-lithio-2,3-difluoroanisole existed in solution 
after addition to the aldehyde. Its observance suggested that reactions conducted using 
previous conditions employing stir times at -78 °C were very poor at converting 5-Bromo-
2,3-difluoroanisole to 5-lithio-2,3-difluoroanisole since none was previously observed. 
Using 10 equiv. 5-Bromo-2,3-difluoroanisole 15 equiv. t-BuLi, condition 6 resulted in a lower 
yield than condition 5, 31.2% vs 41.7%, but possessed significantly less t-Bu adduct relative 
to previous conditions, a ratio of 1.00:0.05 product:t-Bu adduct based on the integrations 
from the NMR spectrum of the crude product. After addition of the t-BuLi at -78 °C, the 
solution was allowed to warm to 0 °C over the course of 25-30 min upon which a color 
change from pale to dark yellow was observed and held at 0 °C for 5 min. After 5 min at 0 
°C, the solution was returned to -78 °C for 5 min before addition of the aldehyde. The vinyl 
proton corresponding to the t-Bu adduct at 6.21-6.22 ppm was not present in the NMR 
spectrum of the crude product for condition 6 as it was in condition 5. The darkening of the 
yellow color at nearly 30 minutes was interpreted as an indication of complete conversion 
to the aryl lithium. Condition 7, the final optimization, used the same 10 equiv. 5-Bromo-2,3-
difluoroanisole and 20 equiv. t-BuLi, a standard ratio of 1:2 ArBr:t-BuLi, employed in the 
previously reported synthesis along with an optimized temperature gradient to obtain a 
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Scheme 1.7. Adequate stir time at elevated temperatures above -78° are hypothesized to be required 
for the full conversion of 20 to 21 and to ensure no 27 remains upon addition of the aldehyde. A. 
Inadequate stir time between 20 equiv. 27 and 10 equiv.20, will create a distribution of species contains 
two nucleophiles, 27 and 21. B. If aldehyde is added at this point, then two possible product adducts, 
11xd and 11xg, can be observed. C. Additional stir time ensures a complete reaction between 27 and 
28. D. Addition of aldehyde after adequate stir time ensures generation of only the adduct of interest, 
11xd. 
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74.1% yield averaged over two runs with no t-Bu adduct observed. After addition of the t-
BuLi at -78 °C, the reaction was stirred for 20 min at this temperature, raised to 0 °C for 10 
min upon which the solution transitioned from pale to dark yellow as in condition 6, then 
immediately lowered back to -78 °C for 5 min before addition of the aldehyde. The previously 
observed vinyl peak at 6.21-6.22 ppm the corresponded to the t-Bu adduct in conditions 5 
and 6 was absent in the NMR spectrum of the crude 11bd generated from condition 7. The 
trend of increasing the stir time at elevated reaction temperatures succeeded in avoiding 
formation of the t-BuLi adduct. However, the higher temperatures resulted in an increase of 
the total number of components as evidenced by the small peaks slightly above the baseline 
in the vinyl region. The crude mass spectrum also showed the mass for the product of 
interest with no t-Bu adduct present. 
 
Optimization the synthesis of 3-thiophenyl-modified 2° alcohols 11xe (Table 1.4). 
In contrast to the difficulty encountered in generating 5-lithio-2,3-difluoroanisole from 5-
Bromo-2,3-difluoroanisole, the generation of the 3-lithiothiophene from 3-bromo-thiophene 
proceeded smoothly using the previously reported conditions. However, the previously 
reported conditions were insufficient to provide complete addition of 3-lithiothiophene to the 
aldehyde. Fortunately, the resolution between the product and other components in the 
crude mixture, including t-Bu adducts, could be easily accomplished with standard benchtop 
flash chromatography. Reaction optimization was conducted, ultimately achieving complete 
addition after allowing the reaction to warm from -78 °C to 0 °C over the course of 1.5 h 
(Table 1.4). The modification of the previously reported method began after the solution of 
aldehyde in THF was added to the prepared 3-lithiothiophene at -78 °C. In condition 1, the 
reaction was performed as previously reported. The average yield over two runs was only 
30.7 %, with the NMR spectrum of crude 11ae depicting incomplete addition of 3-
lithiothiophene to aldehyde 10a as evidenced by peaks at 9.90 and 9.99 ppm which 
corresponded to unreacted aldehyde. Additionally, other minor, yet significant vinyl protons 
were obs  erved corresponding to the precursor ketone 8a (6.28 ppm) and t-Bu adduct 
(6.15-6.17 ppm). It should be noted that at the time of condition 1, the optimization of the 
Wittig reaction was not complete. Thus, these reactions were conducted with aldehyde 
starting material containing 5-10% of the ketone 8a precursor to aldehyde 10a. Condition 2 
called for removal of the ice bath after 45 min at -78 °C, allowing the reaction to warm to 
room temperature over 20 min.  However, the marginally improved yield of 35.8% was likely 
due to the use of pure aldehyde starting material. Condition 3 saw a significant improvement  
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Table 1.4. Optimization of the organolithium addition between 24 and 10 was performed.  
 
 
Table 1.4. Optimization of the organolithium addition between 24 and 10 was performed. For all 
conditions, the 10 was added as a solution in THF, and the reaction was quenched at -78° C with 
iPrOH. 
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in conversion and yield, 79.5%. The NMR spectrum of 11be suggested complete conversion 
of the aldehyde since no protons corresponding to aldehyde 10c starting material was 
observed. Condition 3 employed a more aggressive temperature gradient. Proceeding 
addition of the solution of aldehyde dissolved in THF to the prepared 3-lithiothiophene, the 
dry ice bath was immediately removed, and the reaction was allowed to warm from -78 °C 
to r.t. over 1.5 h. 
 
Bioassay results. The 36-analogue compound library was tested for their ability to reduce 
IL-1β-induced inflammation, an example of transrepression activity, and their propensity for 
enhancing transcription of pro-inflammatory cytokines via GRE, transactivation, using CCL2 
promoter-luciferase promoter, GRE promoter-luciferase promoter, respectively (Figures 
1.1-1.11). The best candidates from these two bioassays, 11aa and 13ab, were further 
subjected to the GSIS to determine the influence of these molecules on insulin production 
(Figures 1.12 and 1.13). For all CCL2 and GRE bioassay bar graphs, the x-axis reflects the 
concentration of the analogue on log scale from 0.1 nM to 10 µM. The CCL2 promoter-
luciferase promoter measures the ability of an analogue to represses CCL2 expression 
induced by the pro-inflammatory cytokine IL-1β. CCL2 expression has been shown to 
increase during inflammation, and the CCL2 chemokine is tissue responsible for recruitment 
of monocytes, macrophages, and T-lymphocytes47 48-49. The bar graphs for this assay depict 
the gene expression of CCL2, with the black bar being the maximum expression by 1ng/mL 
IL-1β, and the white bars represent the repression of the analogue increasing in 
concentration along the x-axis. The GRE promoter luciferase plasmid is used to measure 
the ability of each analogue to activate transcription of a GRE. Control in this case is no GC 
analogue added, represented by the black bars. The for the analogues, represented by the 
white bars, are expressed as fold over control. All compounds are benchmarked against 
dexamethasone which at 10 nM, reduces IL-1β stimulated CCL2 activity by ~70% and 
produces 10-15 fold activation of the GRE promoter. Among the GC analogues evaluated, 
four significant structure-activity relationships were discovered. First, ketone analogues with 
R1 = F, 11a, generally possessed poor activity or an undesirable biological activity in terms 
of reducing inflammation without enhancing transactivation. Second, the 1-(4-
fluorophenyl)pyrazole-based series were both more active and possessed analogues with 
the best biological activity relative to the 4-methyl or 4-methoxy series. Third, 3° alcohol 
analogues also enhanced transactivation relative to the corresponding 2° alcohol. 
Additionally, it should be noted that the analogues tested in this study were not single  
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Figure 1.1. CCL2 and GRE promoter-luciferase promotor results for all 2° alcohol analogues 11. 
 
Figure 1.1. CCL2 and GRE promoter-luciferase promotor results for all 2° alcohol analogues 11. 
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Figure 1.2. CCL2 and GRE promoter-luciferase promotor results for all 3° alcohol analogues 13. 
 
Figure 1.2. CCL2 and GRE promoter-luciferase promotor results for all 3° alcohol analogues 
13. 
32 
 
  
Figure 1.3. CCL2 and GRE promoter-luciferase promotor results for all ketone analogues 12a. 
 
Figure 1.3. CCL2 and GRE promoter-luciferase promotor results for all ketone analogues 12a. 
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Figure 1.4. Comparison of CCL2 promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11aa-11ae, ketones 12aa-12ae, and 3° alcohols 13aa-13ae. 
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hydrocortisone, 2° alcohols 11aa-11ae, ketones 12aa-12ae, and 3° alcohols 13aa-13ae. 
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Figure 1.5. Comparison of CCL2 promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11af-11bd, ketone 11af, and 3° alcohols 13af-13bd. 
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Figure 1.6. Comparison of CCL2 promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11b and 11ca-11cd, and 3° alcohols 13b and 13ca-13cd. 
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y = methoxy 
R = 3-thiophenyl 
y = fluoro 
R = methyl 
y = fluoro 
R = phenyl 
Figure 1.7. Comparison of CCL2 promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohol 11ce and 3° alcohol 13ce. 
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Figure 1.8. Comparison of GRE promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11aa and 11ab, ketones 12aa and 12ab and 3° alcohols 13aa and 13ab. 
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Figure 1.9. Comparison of GRE promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11ac-11af and 11ba, ketones 12ac-12af and 3° alcohols 13ac-13ae, and 
13ba. 
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Figure 1.10. Comparison of GRE promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11bc-11be, 11ca, and 11cb and 3° alcohols 11bc-11be, 11ca, and 11cb. 
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Figure 1.11. Comparison of GRE promoter-luciferase promotor results among dexamethasone, 
hydrocortisone, 2° alcohols 11cc-11ce and 3° alcohols 11bc-11be, 11ca, and 11cb. 
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Figure 1.12. GSIS is improved in mouse islets treated with GC analogues 11aa and 11ab relative to 
dexamethasone for islets cultured overnight in the presence of 1 µM of 11aa or 10 nM of 
dexamethasone followed by static incubation in 15 mM glucose.  
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Figure 1.13. GSIS is improved in mouse islets treated with GC analogues 11ab relative to 
dexamethasone for islets cultured overnight in the presence of 1 µM of 11ab or 10 nM of 
dexamethasone followed by static incubation in 15 mM glucose.  
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dexamethasone for islets cultured overnight in the presence of  1 µM of  11ab or 10 nM of 
dexamethasone followed by static incubation in 15 mM glucose.  
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enantiomers. The previously reported study by Merck did not rely on synthetic innovation 
obtain single enantiomers during the generation the aldehyde 10 and the secondary 
alcohols 11, each reaction introducing a stereocenter. 10 was obtained as an 8:1 mixture 
of diastereomers. For the 11, the researchers at Merck reported that small amounts of 
minor diastereomers using standard benchtop flash chromatography while in other cases, 
chiral HPLC was necessary to remove diastereomeric impurities. This means that the 
compounds produced in this study were similarly tainted and tested with small amounts of 
the diastereomeric impurity.    
 
Ketone analogues with R1 = F, 11ax, generally possessed the least desirable 
biological activity (Figure 1.3). Ketone analogues with R1 = F, 11a, represent the group 
that generally possesses the least desirable biological activity. Analogues 12aa, 12ab, 
12ac, 12ae, and 12af did not significantly reduce IL-1β-induced CCL2 expression relative 
to control at 1 nM. Increasing concentration to 1 µM did not significantly improve CCL2 
expression, but increased transactivation of 12ab and 12ad was observed. Analogue 12ad 
was more active at 1 µM in both transrepression and transactivation assays. Because the 
activities of ketone analogues 12aa-12af showed little promise, ketones in the 4-methyl 
and 4-methoxy series were not subjected to biological evaluation. It seems that the active 
site of the GR requires sp3-geometry to accomplish coordination of the alcohol and R2 
substituent to the GR active site to elicit a dissociated profile.  
 
Analogues with R1 = F were the most active and analogues possessed the most 
desired biological activity (Figures 1.1 and 1.2). For both 2° and 3° alcohol analogues, 
11aa-11af and 13aa-13ae, respectively, R1 = F was correlated to an increase in activity 
for both transrepression and transactivation assays. This structural feature is the most 
significant in terms of improving activity. Most notably, it was only the 2° alcohol analogues 
with R1 = F that reduced CCL2 expression at 1 nM. At 1 µM, CCL2 expression was further 
reduced with an accompanying enhancement of transactivation. The increase in 
transactivation for 2° alcohols R1 = F is significantly higher when R2 = 3-thiophenyl or 1-
(3,4-difluoro-5-methoxyphenyl), which were also found to be most active in the general 
functional assays of transrepression and transactivation in the previously reported study 
conducted by Merck Research Laboratories.4  Both 4-methyl and 4-methoxy series 2° and 
3° alcohol analogues did not significantly reduce CCL2 expression at 1 nM, but possessed 
marginally improved activity at 1 µM. A lesser correlation between inclusion of an R2 = 3-
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thiophenyl or 1-(3,4-difluoro-5-methoxyphenyl) and increased activity also exists for the 4-
methyl and 4-methosy series. This difference in activity compared to the R1 = fluorophenyl 
series may be attributable to a structure-activity relationship or perhaps a difference in 
solubility between the analogues being that fluorinated drugs are known for their increased 
lipid-solubility making them more easily transported throughout the cell50. Thus, the 4-
fluoro analogue series may have a greater partial agonist profile for the GR or may just be 
more easily transported throughout the cell. Ultimately, 2° alcohol analogues with R1 = F 
possessed analogues the greatest reduction of CCL2 expression, about 50% or less 
maximal IL-1β response, response relative to enhancement of transactivation, which was 
about 5-fold or less enhancement of gene production at the GRE relative to control. 
However, this dissociated activity was only observed at micromolar concentrations. 
Further modifications that reduced CCL2 expression did so at the cost of greatly 
enhancing transactivation, which is not the desired biological activity.   
 
3° alcohol analogues enhanced activity relative to the corresponding 2° alcohol 
(Figures 1.1 and 1.2). Nearly every 3° alcohol analogue, except for 13ad, possessed 
enhanced transrepression activity relative to the corresponding 2° alcohol analogue at 
both 1 nM and 1µ. For 3° alcohol analogues with R1 = methyl or methoxy, the improvement 
was significant, accompanied by minimal enhancement of transactivation, but a marginal 
reduction of CCL2 expression could only be obtained with micromolar concentrations. At 
micromolar concentrations, the 3° alcohol analogues possessing R1 = F reduced CCL2 
gene expression to the greatest extent, less than 50% maximal IL-1β response, but not 
without significant enhancement of transactivation, which was approaching 10-fold. The 
additional steric bulk around the alcohol introduced by a methyl group in 3° alcohol 
analogues seems to increase activity at the cost of selectivity for 3° alcohol analogues 
with R1 = F, which makes 3° alcohol analogue candidates corresponding to the already 
active 2° alcohols with R1 = F undesirable.  
 
Compounds 11aa and 11ab possessed the most desirable biological activity 
(Figures 1.12 and 1.13). Of the molecules screened for their biological activity, two of the 
compounds synthesized displayed a markedly better directionality of therapy. Reduction 
of IL-1β-induced CCL2 gene expression by Compounds 11aa and 11ab at 1 µM were 
comparable to dexamethasone at 10 nM while increasing gene activation only 2-3 fold 
relative to 10-15 fold for dexamethasone. Both compounds 11aa and 11ab maintained 
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insulin levels at the same level as the control, whereas dexamethasone reduced insulin 
levels about 40%. However, these activities of 11aa and 11ab are at two orders of 
magnitude higher than dexamethasone. 
 
Conclusions, implications, and future directions. This results of this study suggest that 
previously reported non-steroidal 1-(4-fluorophenyl)pyrazole-based glucocorticoid 
analogues may possess a greater efficacy than previously thought in terms of the ability 
of specifically reducing inflammation of beta cell islets without an accompanying 
enhancement of undesired gene production or reduction of insulin secretion. These 
activities indicate that this class of molecules may be potential candidates for a T1DM 
therapy. Additionally, these compounds may prove useful alongside other treatments 
more generally aiming to reduce beta cell inflammation with reduced side effects. This 
study provides synthetic optimizations of the previously reported synthesis which allow 
gram-scale generation of a more diverse series of 1-(4-fluorophenyl)pyrazole-based 
glucocorticoid analogues. However, one limitation was that the desired activities were 
observed at micromolar scale, which increases the potential for undesired activities. 
Further studies should be conducted using different bioassays to determine the extent of 
side effects other than the two measured in this study, both in terms of side effects on the 
beta cell, such as promoting insulin resistance, as well as the effects on the immune cells 
that are also associated in the process of beta cell inflammation, dysfunction, and death. 
Measurements such as these, and the desire to evaluate the effect of these compounds 
in mice. Furthermore, a greater scope of R1 and R2 modification of the 1-(4-
fluorophenyl)pyrazole-based scaffold will be synthesized in an attempt to synthesize 
compounds with enhanced anti-inflammatory activities.  
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1.5 Experimental synthetic procedures 
 
Chemistry. Chemical reagents were purchased commercially and used without further 
purification. Dry ethereal solvents were obtained by distillation from a potassium 
benzophenone ketyl still. All other dry solvents were distilled from CaH2(s). Thin-layer 
chromatography (TLC) was carried out using Sorbent Technologies silica G F254 TLC plates. 
All compounds of interest were visualized as single spots using short-wave UV light; more 
permanent staining of TLC spots was achieved using p-anisaldehyde, vanillin, or ceric 
ammonium molybdate (Hannesian’s) TLC staining solutions. Silica gel with a 60A pore size 
and a particle diameter of 40-63 µm was used for flash chromatography. 
 
1H-NMR spectra were obtained on either an Oxford 300 MHz or Varian InNova 500 MHz 
NMR spectrometer in solutions of CDCl3. All 13C-NMR spectra were recorded on a Varian 
InNova 500 MHz NMR spectrometer in solutions of CDCl3. High resolution mass 
spectrometry (HRMS) for characterization of previously unreported compounds was 
performed using a JEOL DART source in positive ion mode coupled to a JEOL AccuTOF 
JMS-T100LC mass spectrometer. HRMS for characterization of crude mixtures was 
performed using the JEOL DART source in positive ion mode coupled to a JEOL AccuTOF 
JMS-T100LC mass spectrometer or a Sciex Turboionspray electrospray ionization source 
in positive mode coupled to an Applied Biosystems QStar Elite mass spectrometer. Optical 
rotation was measured using a Perkin-Elmer 241 polarimeter equipped with a sodium 
source lamp. IR spectra were collected using a Nicolet iS5 spectrophotometer. All 
characterization data can be found in the supplemental information. 
 
Synthetic methods. Synthetic methods, chromatographic methods, and characterization 
data for intermediates and the previously reported 1-(4-fluorophenyl)pyrazole-based GC 
analogues will not be shown except for GC analogues which were subjected to biological 
testing. 
 
Intermediate 6: The synthesis was performed up to this point using the previously reported 
synthesis of 1-(4-fluorophenyl)pyrazole-based GC analogues 4. 
 
General method for the addition of the 4-substituted headgroup to obtain compound series 
(7): To a solution of 6 (5.0 g, 20 mmol) in glacial acetic acid (50 mL) was added the 
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appropriate 4-substituted phenyl hydrazine HCl (23 mmol) and sodium acetate (1.88 g, 23 
mmol) and allowed to stir for 2 h. The reaction mixture was then slowly and carefully poured 
into an actively stirred solution of saturated sodium bicarbonate cooled to 0 °C. The 
neutralized solution was then extracted with EtOAc (5x100 mL), washed with brine, dried 
with anhydrous MgSO4, filtered, and concentrated in vacuo. Purification of the crude product 
was accomplished using flash chromatography to give a give a viscous orange oil. 
 
4a-methyl-1-(p-tolyl)-1,4,4a,6,7,8-hexahydrospiro-[benzo[f]indazole-5,2'-[1,3]dioxolane] 
(7a): Flash chromatography conditions, 20% EtOAc/hexanes. Yield = 44%. TLC Rf = .28 
(30% EtOAc/hexanes). HRMS [M+H]+ = . 1H-NMR (CDCl3, 500 MHz) δ 1.21 (s, 3H), 1.65-
1.83 (m, 4H), 2.28 (dt, 2H), 2.4 (s, 3H), 2.51 (d, 1H), 3.16 (d, 1H), 3.99-4.08 (m, 4H), 6.23 
(s, 1H), 7.24-7.26 (d, 2H), 7.35-7.37 (d, 2H), 7.43 (s, 1H). 
 
1-(4-methoxyphenyl)-4a-methyl-1,4,4a,6,7,8-hexahydrospiro[benzo[f]indazole-5,2'-
[1,3]dioxolane] (7b): Flash chromatography conditions, 25% EtOAc/hexanes. Yield = 38%. 
TLC Rf = .27 (50% EtOAc/hexanes). HRMS [M+H]+ = . 1H-NMR (CDCl3, 500 MHz) δ 1.22 
(s, 3H), 1.68-1.83 (m, 3H), 2.30-2.31 (d, 1H), 2.51-2.54 (d, 2H), 3.15-3.18 (d, 2H), 3.85 (s, 
3H), 4.01-4.13 (m, 4H), 6.17 (s, 1H), 6.97-7.41 (m, 5H). 
 
General method for the acetal deprotection for compound series (8): To a solution of 7 (5.9 
mmol) in THF (50 mL) was added 6 M HCl (3.9 mL, 23.6 mmol) and subjected to reflux for 
3.5 h. The reaction mixture was then poured into saturated sodium bicarbonate, extracted 
with ethyl acetate (4x100 mL). The pooled organic layer was washed with brine, dried with 
anhydrous MgSO4, and concentrated in vacuo. Purification of the crude product was 
accomplished using flash chro-matography to give a dull orange solid. 
 
4a-methyl-1-(p-tolyl)-1,4,4a,6,7,8-hexahydro-5H-benzo[f]indazol-5-one (8b): Flash 
chromatography conditions, 15% EtOAc/hexanes. Yield = 72%. Rf = 0.34 (30% EtOAc/hexanes). 
HRMS [M+H]+ = . 1H-NMR (CDCl3, 500 MHz) δ 1.25 (s, 3H), 1.62-1.71 (m, 1H), 2.06-2.11 (m, 1H), 
2.40 (s, 3H), 2.51-2.57 (m, 2H), 2.60-2.67 (m, 2H), 2.90 (s, 2H), 6.33 (s, 1H), 7.26-7.28 (d, 2H), 
7.35-7.38 (d, 2H), 7.48 (s, 1H). 
 
1-(4-methoxyphenyl)-4a-methyl-1,4,4a,6,7,8-hexahydro-5H-benzo[f]indazol-5-one (8c): 
Flash chromatography conditions, 20% EtOAc/hexanes. Yield = 77%. Rf = 0.28 (40% 
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EtOAc/hexanes). HRMS [M+H]+ = . 1H-NMR (CDCl3, 500 MHz) δ 1.24 (s, 3H), 1.60-1.73 (m, 
1H), 2.04-2.11 (m, 1H), 2.49-2.69 (m, 4H), 2.93 (d, 2H), 3.85 (s, 3H), 6.26 (s, 1H), 6.95-7.47 
(m, 5H). 
 
General method for the Wittig-hydrolysis sequence to obtain aldehyde compound series 
(10): A commercially available solution of 0.5 M potassium bis(trimethylsilyl amide in toluene 
(0.5 M, 33.12 mL, 16.5 mmol) was added dropwise with a syringe to an actively stirred 
suspension of triphenylphosphonium chloride (6.81 g, 19.8 mmol) in THF (65 mL) cooled to 
-40 °C. The solution was warmed to 0 °C and stirred at that temperature for 15 min and a 
color change from pale yellow to dark red was observed. A solution of the appropriate ketone 
8 (6.6 mmol) in THF (16 mL) was transferred dropwise via canula. After stirring for 24 h, the 
reaction was quenched by the addition of 1:1 THF/MeOH (16 mL), diluted with three reaction 
volumes of EtOAc, washed with water and brine, concentrated in vacuo, and subjected to 
flash chromatography (15% EtOAc/hexanes). Fractions containing enol 9 either were 
concentrated in a round bottom flask, and dissolved in THF (60 mL). A solution of 4 M HCl 
(16 mL) was slowly added to the prepared solution of 9 as it was being actively stirred. After 
the reaction was allowed to stir at room temperature for 36 h, the reaction mixture was 
diluted with EtOAc (100 mL), washed with water, saturated NaHCO3, and brine. The pooled 
organic layer was dried over MgSO4, filtered, and concentrated in vacuo to give crude 
aldehyde 10 as a beige solid. Purification of the crude product was accomplished using flash 
chromatography. 
 
4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazole-5-carbaldehyde (10b): 
Flash chromatography conditions, 15% EtOAc/hexanes. Yield = 40.0 %. Rf = 0.31 (25% 
EtOAc/hexanes). HRMS [M+H]+ = . 1H-NMR (CDCl3, 300 MHz) δ 1.12 (s, 3H), 1.30-1.40 (m, 
2H) 1.70-1.78 (m, 2H), 1.90-1.96 (m, 1H), 2.32-2.44 (m, 2H), 2.40 (s, 3H), 2.91 (d, 1H), 3.10 
(d, 1H), 6.21 (s, 1H), 7.26-7.28 (d, 2H), 7.35-7.37 (d, 2H), 7.44 (s, 1H), 9.90 (s, 1H) 
 
1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazole-5-
carbaldehyde (10c): Flash chromatography conditions, 20% EtOAc/hexanes. Yield = 79.1 
% Rf = 0.28 (40% EtOAc/hexanes). HRMS [M+H]+ = . 1H-NMR (CDCl3, 500 MHz) δ 1.11 (s, 
3H), 1.39-1.43 (m, 1H), 1.72-1.75 (m, 1H), 1.90-1.96 (m, 2H), 2.33-2.44 (m, 3H), 2.89-2.92 
(d, 1H), 3.08-3.11 (d, 1H), 3.85-3.86 (s, 3H), 6.15 (s, 1H), 6.95-7.42 (m, 5H), 9.90 (s, 1H). 
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General method for the preparation of R2 = methyl 2° OH analogues (11aa, 11ba, 11ca): A 
commercially available solution of 1.6 M MeLi in diethyl ether (312 µL, 0.5 mmol) was 
transferred to a round bottom flask and cooled to -78 °C. A solution of the appropriate 
aldehyde 10 in THF was added dropwise via canula, and the reaction was stirred at -78 °C 
for 45 min. The reaction was quenched with isopropyl alcohol (IPA), poured into a separatory 
funnel containing saturated NH4Cl, and extracted three times with EtOAc. The organic 
phase was washed with once each with water and brine, dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo. Purification of the crude product was accomplished 
using flash chromatography to give a white solid. 
 
1-(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)ethan-1-ol (11ba): 
Flash chromatography conditions, 15% EtOAc/hexanes. Yield = 50%. Rf = 0.16 (30% 
EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C21H27N2O, 323.21179; 
found 323.21001. 1H-NMR (CDCl3, 500 MHz): δ 1.13 (s, 3H), 1.23-1.29 (m, 3H), 1.34-1.45 
(m, 2H), 1.56-1.62 (m, 2H), 1.72-1.78 (m, 1H), 1.90-1.94 (m, 1H), 2.27-2.30 (m, 1H), 2.32-
2.37 (m, 4H) 2.47-2.50 (d, 1H), 2.97-3.00 (d, 1H), 6.14 (s, 1H), 7.23-7.26 (d, 2H), 7.34-7.36 
(d, 2H), 7.40 (s, 1H) 
 
1-(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)ethan-
1-ol (11ca): Flash chromatography conditions, 15% EtOAc/hexanes. Yield = 58%. Rf = 0.11 
(25% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C21H27N2O2, 
339.20670; found 339.20344. 1H-NMR (CDCl3, 500 MHz): δ 1.13 (s, 3H), 1.23-1.29 (m, 
4H), 1.34-1.45 (m, 3H), 1.74-1.78 (d, 1H),1.88-1.95 (d, 1H), 2.28-2.31 (d, 1H), 2.35-2.39 (m, 
1H), 2.47-2.51 (d, 1H), 2.98-3.01 (d, 1H), 3.84-3.87 (s, 3H), 6.10 (s, 1H), 6.96-7.40 (m, 5H). 
 
General method for the preparation of R2 = phenyl 2° OH analogues (11ab, 11bb, 11cb): A 
commercially available solution of 1.9 M PhLi (3.42 mL, 6.5 mmol) in di-butyl ether was 
transferred to a round bottom flask and cooled to -78 °C. A solution of the appropriate 
aldehyde 10 (0.65 mmol) in THF (2 mL) was added dropwise via canula, and the reaction 
was stirred at -78 °C for 45 min. The reaction was quenched with IPA, poured into a 
separatory funnel containing saturated NH4Cl, and extracted three times with EtOAc. The 
organic phase was washed with once each with water and brine, dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. Purification of the crude product was 
accomplished using flash chromatography. 
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(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(phenyl)methanol 
(11bb). From 21 using PhLi (1.9 M solution in di-n-butyl ether). Flash column conditions, 
15% EtOAc/hexanes, to give a white solid. Yield = 28%. TLC Rf = 0.20 (30% 
EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C26H29N2O, 385.22744; found 
385.22612. 1H-NMR (CDCl3, 500 MHz): δ 1.26 (s, 3H), 1.60-1.81 (m, 5H), 2.23-2.28 (d, 1H), 
2.36-2.43 (m, 4H), 2.74-2.77 (d, 1H) 3.15-3.18 (d, 1H), 5.17 (s, 1H), 6.15 (s, 1H), 7.23-7.27 
(d, 3H), 7.34-7.38 (m, 6H), 7.41 (s, 1H). 
 
(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)(phenyl)methanol (11cb): From 21 using PhLi (1.9 M solution in di-n-butyl ether). Flash 
column mobile phase – 20% EtOAc/hexanes, to give a beige solid. Yield = 73 %. TLC Rf = 
0.11 (30% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C26H29N2O2, 
401.22235; found 401.21952. 1H-NMR (CDCl3, 500 MHz): δ 1.27 (s, 3H), 1.56-1.81 (m, 6H), 
2.24-2.27 (d, 1H), 2.36-2.44 (m, 1H), 2.75-2.78 (d, 1H), 3.17-3.20 (d, 1H), 3.85 (s, 3H), 5.20 
(s, 1H), 6.11 (s, 1H), 6.96-7.44 (m, 9H). 
 
General method for the preparation of R2 = 4-fluorophenyl 2° OH analogues (11ac, 11bc, 
11cc): A commercially available solution of 2.0 M 4-fluorophenylmagnesium bromide in 
diethyl ether was transferred to a round bottom flask and cooled to -78 °C. A solution ofthe 
appropriate aldehyde 10 in THF was added dropwise via canula, and the reaction was 
stirred at -78 °C for 45 min. The reaction was quenched with IPA, poured into a separatory 
funnel  containing saturated NH4Cl, and extracted three times with EtOAc. The organic 
phase  was washed with once each with water and brine, dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo. Purification of the crude product was accomplished 
using flash chromatography to give a white solid. 
 
(4-fluorophenyl)(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)methanol (11bc): Flash chromatography conditions, 10% EtOAc/hexanes. Yield = 11.5 
%. Rf = 0.24 (25% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for 
C26H28FN2O, 403.21802; found 403.21649. 1H-NMR (CDCl3, 500 MHz): δ 1.26 (s, 3H), 1.50-
1.61 (m, 3H), 1.67-1.71 (m, 2H), 1.79-1.82 (d, 1H), 2.25-2.28 (d, 1H), 2.39 (s, 3H), 2.74-2.77 
(d, 1H), 3.16-3.20 (d, 1H), 5.19 (s, 1H), 6.16 (s, 1H), 7.02-7.46 (m, 9). 
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(4-fluorophenyl)(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11cc): Flash chromatography (15% EtOAc/hexanes). Yield 
= 69%. Rf = 0.26 (30% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for 
C26H28FN2O2, 419.21293; found 419.20660. 1H-NMR (CDCl3, 500 MHz): δ 1.26 (s, 3H), 
1.56-1.58 (m, 2H), 1.66-1.70 (m, 2H), 1.79-1.82 (m, 1H), 2.25-2.28 (m, 1H), 2.37-2.40 (m, 
1H), 2.73-2.76 (d, 1H), 3.17-3.20 (d, 1H), 3.85 (s, 3H), 5.20 (d, 1H), 6.11 (s, 1H), 6.96-7.06 
(m, 4H), 7.30-7.44 (m, 5H). 
 
General method for the preparation of R2 = 2,3-difluoroanisolyl 2˚OH analogues (11ad, 
11bd, 11cd): A solution of 5-Bromo-2,3-difluoroanisole (4.6 mmol) was prepared in either 
THF (10 mL) or diethyl ether, cooled to -78 °C, a commercially available solution of 1.9 M t-
BuLi in pentanes (4.6 mmol, 2.9 mL) was added dropwise via syringe. The reaction was 
stirred for 20 min at -78 °C, raised to 0 °C for 5-10 min until the solution transitioned from 
pale yellow to dark yellow-green, and then immediately lowered back to -78 °C for 5 min. A 
solution of the appropriate aldehyde 10 (0.46 mmol) in THF (2 mL) was added dropwise via 
canula, and the reaction was stirred at -78 °C for 1 h. The reaction was quenched with IPA, 
poured into a separatory funnel containing saturated NH4Cl, and extracted three times with 
EtOAc. The organic phase was washed with once each with water and brine, dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo Purification of the crude product was 
accomplished using flash chromatography to give a white solid. 
 
(3,4-difluoro-5-methoxyphenyl)(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11ad): Flash chromatography, 30% EtOAc/hexanes. Yield = 
61.9 %. Rf = (% EtOAc/hexanes). 1H-NMR (CDCl3, 300 MHz) δ 1.26 (s, 3H), 1.54-1.57 (m, 
1H), 1.64-1.72 (m, 1H), 1.82-1.86 (m, 2H), 2,28-2.46 (m, 3H), 2.72-2.77 (d, 1H), 3.17-3.22 
(d, 1H), 3.92 (s, 3H), 5.12 (s, 1H), 6.12 (s, 1H), 6.72-6.80 (m, 2H), 7.15-7.21 (m, 2H), 7.45-
7.54 (m, 3H). 
 
(3,4-difluoro-5-methoxyphenyl)(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11bd): Flash chromatography conditions, 10% 
EtOAc/hexanes. Yield = 76.7 %. Rf = 0.22 (25% EtOAc/hexanes). HRMS (DART-RTOF) 
m/z: [M+H]+ Calcd for C27H29F2N2O2, 451.21916; found 451.21790. 1H-NMR (CDCl3, 500 
MHz) δ 1.25 (m, 3H), 1.37-1.50 (m, 2H), 1.54-1.65 (m, 2H), 1.76-1.79 (d, 1H), 2.04 (s, 3H), 
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2.26-2.29 (d, 1H), 2.72-2.75 (d, 1H), 3.14-3.17 (d, 1H), 3.88 (s, 3H), 5.10 (s, 1H), 6.16 (s, 
1H), 6.72-6.78 (m, 2H), 7.24-7.46 (m, 6H). 
 
(4-fluorophenyl)(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11cd): Flash chromatography conditions, 15% 
EtOAc/hexanes. Yield = 71.4 %. Rf = 0.16 (30% EtOAc/hexanes). HRMS (DART-RTOF) 
m/z: [M+H]+ Calcd for C27H29F2N2O3, 467.21408; found 467.21488. 1H-NMR (CDCl3, 500 
MHz) δ 1.26 (s, 3H), 1.52-1.56 (m, 2H), 1.66-1.69 (m, 2H), 1.80-1.84 (m, 2H), 2.26-2.29 (m, 
1H), 2.73-2.76 (d, 1H), 3.15-3.18 (d, 1H), 3.85 (s, 3H), 3.91 (s, 3H), 5.12 (s, 1H), 6.11 (s, 
1H), 6.72-6.79 (m, 2H), 6.96-6.99 (m, 2H), 7.37-7.44 (m, 3H). 
 
General method for the preparation of R2 = 3-thiophenyl 2˚OH analogues (11ae, 11be, 
11ce): A solution of 3-bromo thiophene (0.6 mL, 6.4 mmol) was prepared in either THF (10 
mL) or diethyl ether, cooled to -78 °C, a commercially available solution of 1.9 M t-BuLi (6.8 
mL, 12.8 mmol) in pentanes was added dropwise via syringe. After the reaction stirred for 
30 min at -78°, a solution of the appropriate aldehyde 10 in THF (6.4 mmol) was added 
dropwise via canula, and the reaction was allowed to gradually warm to room temperature 
over the course of 1.5 h. After returning the reaction to -78 °C, the reaction was quenched 
with IPA, poured into a separatory funnel containing saturated NH4Cl, and extracted three 
times with EtOAc. The organic phase was washed with once each with water and brine, 
dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification of the crude 
product was accomplished using flash chromatography to give a white solid. 
 
(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(thiophen-3-
yl)methanol (11ae): Flash chromatography condition, 10% EtOAc/hexanes. Yield = 35.8 %. 
Rf = 0.26 (25% EtOAc/hexanes). 1H-NMR (CDCl3, 500 MHz) δ 1.24 (s, 3H), 1.65-1.93 (m, 
5H), 2.27-2.48 (m, 2H), 2.67-2.72 (d, 1H), 3.08-3.15 (d, 1H), 5.24 (s, 1H), 6.12 (s, 1H), 6.94-
6.99 (m, 1H), 7.12-7.24 (m, 3H), 7.30-7.33 (m, 1H), 7.43-7.48 (m, 3H). 
 
(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(thiophen-3-
yl)methanol (11be): Flash chromatography conditions, 10% EtOAc/hexanes. Yield = 35.8 
%. Rf = 0.26 (25% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for 
C24H27N2OS, 391.18386; found 391.13976. 1H-NMR (CDCl3, 500 MHz) δ 1.23 (s, 3H), 1.62-
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1.91 (m, 6H), 2.26-2.31 (m, 1H), 2.40 (s, 3H), 2.67-2.72 (m, 1H), 3.06-3.14 (m, 1H), 5.39 (s, 
1H), 6.16 (s, 1H), 6.95-7.43 (m, 8H). 
 
(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)(thiophen-3-yl)methanol (11ce): Flash chromatography, 15% EtOAc/hexanes. Yield = 
79.5 %. Rf = 0.17 (30% EtOAc/hexanes). HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for 
C24H27N2O2S, 407.1787; found 407.1720. 1H-NMR (CDCl3, 500 MHz) δ 1.26 (m, 4H), 1.62-
1.72 (m, 2H), 1.77-1.85 (m, 2H), 2.27-2.41 (m, 2H), 2.69-2.72 (d, 1H), 3.12-3.15 (d, 1H), 
3.85 (s, 3H), 5.25 (s, 1H), 6.12 (s, 1H), 6.96-7.40 (m, 8H). 
 
3-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-3-
hydroxypropanenitrile (11af): A commercially available solution of 1.7 M t-BuLi (0.9 mL, 1.53 
mmol) and 2 mL of THF was transferred to a round bottom flask and cooled to -78 °C. A 
solution of 80 uL of ACN in 2 mL of THL was added dropwise at -78 °C. Following, a solution 
of 400 mg of Compound 12 R1 = F in 1 mL THF was added dropwise via canula, and the 
reaction was stirred at -78 °C for 1 h. The reaction was quenched with saturated NH4Cl, 
acidified to a pH of 7 via dropwise addition of HCl, and extracted three times with diethyl 
ether. The organic phase was washed with once each with water and brine, dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo. Purification of the crude product was 
accomplished using flash chromatography (25% EtOAc/hexanes). Yield = 45.5%. Rf = 0.14 
(25% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C21H23FN3O, 
352.18197; found 352.18293. 1H-NMR (CDCl3, 500 MHz) δ 1.04-1.13 (s, 3H), 1.25-1.46 (m, 
2H), 1.61-1.71 (m, 2H), 1.78-1.97 (m, 2H), 2.30-2.42 (m, 2H), 2.47-2.72 (m, 3H), 2.93-3.21 
(d, 1H), 4.16-4.40 (m, 1H), 6.12 (s, 1H), 7.14-7.44 (m, 5H). 
 
General method for the synthesis of ketones (12): A solution of the appropriate 2° alcohol 
precursor (11) in dichloromethane was transferred dropwise via canula to a suspension of 
pyridinium chlorochromate (1.5 equiv.) and 4 Å molecular sieves (1:1 m/m) in 
dichloromethane. The reaction was stirred at room temperature until complete conversion 
was observed by TLC analysis. Reaction times ranged from 1-7 h. The reaction mixture was 
immediately loaded onto a silica column (25% EtOAc/hexanes) and subjected to purification 
via flash chromatography to afford the ketone 12. 
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3-(1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-4a-methyl-1H-benzo[f]indazol-5-yl)-3-
oxopropanenitrile (12af): Flash chromatography conditions, 20% EtOAc/hexanes. White 
solid. Yield = 16%. TLC Rf = 0.11 (30% EtOAc/hexanes). HRMS (DART-RTOF) m/z: [M+H]+ 
Calcd for C21H21FN3O, 350.16632; found 350.16529. 1H-NMR (CDCl3, 500 MHz) δ 1.20 (s, 
3H), 1.45-1.49 (m, 2H), 1.82-1.87 (t, 2H), 1.93-1.97 (d, 1H), 2.32-2.44 (m, 3H), 2.74-2.77 (d, 
1H), 2.82-2.88 (m, 2H), 3.53-3.61 (s, 2H), 6.15 (s, 1H), 7.14-7.44 (m, 5H). 
 
General method for the synthesis of 3° methyl alcohol GC analogues (13): The appropriate 
ketone 12 was dissolved in diethyl ether and cooled to -40 °C, and a commercially available 
solution of MeLi (1.9 M, 10 equiv.) was added dropwise via syringe. The reaction was stirred 
at -40° for 45 min. The reaction was quenched with IPA (10 equiv.), poured into a separatory 
funnel containing saturated NH4Cl, and extracted three times with EtOAc. The organic 
phase was washed with once each with water and brine, dried over anhydrous MgSO4, 
filtered, and concentrated in vacuo. 
 
Annotated characterization data of novel compounds. This following entries contain 
the characterization data required by the American Chemical Society publication guidelines 
for all previously unreported compounds at the time of writing. 1H and 13C nuclear magnetic 
resonance spectra (NMR), high resolution mass spectra (HRMS), and infrared spectra (IR) 
obtained at the time of writing for all compounds are in the Appendix.    
 
1-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)ethan-1-
ol (11aa): 1H-NMR (CDCl3, 500 MHz) δ 1.14 (s, 3H), 1.26-1.28 (d, 3H), 1.41-.147 (dd, 2H), 
1.63-1.68 (dd, 1H), 1.73-1.80 (m, 1H), 1.90-1.97 (m, 1H), 2.31-2.43 (m, 2H), 2.46-2.52 (d, 
1H), 2.98-3.03 (d, 1H), 4.25 (s, 1H), 6.10 (s, 1H), 7.11-7.19 (m, 2H), 7.41-7.47 (m, 3H). 
 
2-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)propan-
2-ol (13aa): 1H-NMR (CDCl3, 300 MHz) δ 1.14 (s, 3H), 1.26-1.28 (d, 3H), 1.35-1.47 (m, 
2H), 1.58 (s, 3H), 1.63-1.68 (dd, 1H), 1.73-1.80 (m, 1H), 1.89-1.98 (m, 1H), 2.26-2.42 (m, 
2H), 2.46-2.52 (d, 1H), 2.98-3.03 (d, 1H), 6.10 (s, 1H), 7.12-7.18 (m, 2H), 7.41-7.47 (m, 
3H). 
 
(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)(phenyl)methanol (11ab): 1H-NMR (CDCl3, 500 MHz) δ 1.18 (s, 3H), 1.52-1.58 (m, 2H), 
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1.60-1.63 (dd, 1H), 1.70-1.74 (m, 2H), 2.17-2.21 (m, 1H), 2.28-2.36 (m, 1H), 2.66-2.69 (d, 
1H), 3.08-3.11 (d, 1H), 5.10 (d, 1H), 6.02 (s, 1H), 7.04-7.08 (m, 2H), 7.16-7.18 (m, 1H), 
7.27-7.29 (m, 4H), 7.35-7.38 (m, 3H). 
 
1-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-1-
phenylethan-1-ol (13ab): 1H-NMR (CDCl3, 500 MHz) δ 1.27 (s, 3H), 1.56-1.65 (m, 2H), 
1.67 (s, 3H), 1.74-1.80 (m, 1H), 2.02-2.08 (dd, 1H), 2.23-2.44 (m, 2H), 2.58-2.64 (d, 1H), 
3.12-3.17 (d, 1H), 6.09 (s, 1H), 7.10-7.16 (t, 2H), 7.27-7.52 (m, 8H). 
 
(4-fluorophenyl)(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11ac): 1H-NMR (CDCl3, 300 MHz) δ1.26 (s, 3H), 1.65-1.69 
(m, 3H), 1.77-1.86 (m, 1H), 2.26-2.41 (m, 2H), 2.72-2.77 (d, 1H), 3.17-3.22 (d, 1H), 5.19-
5.22 (s, 1H), 6.12 (s, 1H), 7.02-7.08 (t, 2H), 7.13-7.19 (t, 2H), 7.30-7.34 (dd, 2H), 7.44-
7.48 (m, 3H). 
 
1-(4-fluorophenyl)-1-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)ethan-1-ol (13ac): 1H-NMR (CDCl3, 500 MHz) δ 1.25 (s, 3H), 1.51-
1.62 (m, 2H), 1.66 (s, 3H), 1.72-1.81 (m, 2H), 1.95-2.05 (m, 1H), 2.21-2.40 (m, 2H), 2.58-
2.64 (d, 1H), 3.14-3.20 (d, 1H), 6.09 (s, 1H), 7.00-7.06 (t, 2H), 7.11-7.17 (t, 2H), 7.25-7.28 
(m, 1H), 7.41-7.49 (m, 4H). 
 
(3,4-difluoro-5-methoxyphenyl)(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11ad): 1H-NMR (CDCl3, 300 MHz) δ 1.26 (s, 3H), 1.54-
1.57 (m, 1H), 1.64-1.72 (m, 1H), 1.82-1.86 (m, 2H), 2,28-2.46 (m, 3H), 2.72-2.77 (d, 1H), 
3.17-3.22 (d, 1H), 3.92 (s, 3H), 5.12 (s, 1H), 6.12 (s, 1H), 6.72-6.80 (m, 2H), 7.15-7.21 (m, 
2H), 7.45-7.54 (m, 3H). 
 
1-(3,4-difluoro-5-methoxyphenyl)-1-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-
hexahydro-1H-benzo[f]indazol-5-yl)ethan-1-ol (13ad): 1H-NMR (CDCl3, 500 MHz) δ 1.26 
(s, 3H), 1.54-1.60 (m, 2H), 1.62 (s, 3H), 1.64-1.66 (m, 1H), 1.80-1.85 (m, 1H), 1.96-1.99 
(dd, 1H), 2.24-2.30 (m, 1H), 2.34-2.42 (m, 1H), 2.57-2.60 (d, 1H), 3.07-3.11 (d, 1H), 3.91 
(s, 3H), 6.10 (s, 1H), 6.87-6.91 (m, 2H), 7.12-7.16 (t, 2H), 7.28 (s, 1H), 7.42-7.45 (m, 2H). 
(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(thiophen-
3-yl)methanol (11ae): 1H-NMR (CDCl3, 500 MHz) δ 1.24 (s, 3H), 1.65-1.93 (m, 5H), 2.27-
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2.48 (m, 2H), 2.67-2.72 (d, 1H), 3.08-3.15 (d, 1H), 5.24 (s, 1H), 6.12 (s, 1H), 6.94-6.99 (m, 
1H), 7.12-7.24 (m, 3H), 7.30-7.33 (m, 1H), 7.43-7.48 (m, 3H). 
 
1-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-1-
(thiophen-3-yl)ethan-1-ol (13ae): 1H-NMR (CDCl3, 500 MHz) δ 1.27 (s, 3H), 1.52-1.62 (m, 
3H), 1.68 (s, 3H), 2.01-2.06 (m, 1H), 2.24-2.43 (m, 3H), 2.64-2.69 (d, 1H), 3.24-3.30 (d, 
1H), 6.10 (s, 1H), 7.14-7.17 (m, 3H), 7.27-7.30 (m, 1H), 7.33 (s, 1H), 7.42-7.47 (m, 3H). 
 
3-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-3-
hydroxypropanenitrile (11af): white solid obtained in 46% yield; mp 121-123.8 ˚C; TLC 
(Silica G w/UV254) 25% EtOAc in hexanes, Rf = 0.14; [α]D20 = +60 (c 10.0, MeOH); 1H-
NMR (CDCl3, 500 MHz) δ 1.04-1.13 (s, 3H), 1.25-1.46 (m, 2H), 1.61-1.71 (m, 2H), 1.78-
1.97 (m, 2H), 2.30-2.42 (m, 2H), 2.47-2.72 (m, 3H), 2.93-3.21 (d, 1H), 4.16-4.40 (m, 1H), 
6.12 (s, 1H), 7.14-7.44 (m, 5H); 13C-NMR (CDCl3, 500 MHz) δ 19.32, 20.91, 25.37, 26.20, 
32.98, 33.19, 34.64, 52.82, 66.62, 109.76, 115.96, 116.14, 125.32, 137.86; IR (NaCl, thin 
film) νmax (cm-1): 3335 (OH), 3030 (w), 2934, 2867, 2249 (CN), 1619, 1518, 1225, 840; 
HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C21H23FN3O, 352.18197; found 352.18293. 
 
3-(1-(4-fluorophenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-3-
hydroxybutanenitrile (12af):  white solid obtained in 16% yield; mp 192-194 ˚ C; TLC (Silica 
G w/UV254) 30% EtOAc in hexanes, Rf = 0.11; [α]D20 = +60 (c 10.0, CHCl3); 1H-NMR 
(CDCl3, 500 MHz) δ 1.20 (s, 3H), 1.45-1.49 (m, 2H), 1.82-1.87 (t, 2H), 1.93-1.97 (d, 1H), 
2.32-2.44 (m, 3H), 2.74-2.77 (d, 1H), 2.82-2.88 (m, 2H), 3.53-3.61 (s, 2H), 6.15 (s, 1H), 
7.14-7.44 (m, 5H); 13C-NMR (CDCl3, 500 MHz) δ 18.53, 25.21, 25.61, 31.72, 33.85, 34.75, 
41.16, 59.60, 110.18, 112.91, 113.49, 116.00, 135.61, 136.29, 137.72, 146.60, 160.56, 
162.53, 199.38; IR (NaCl, thin film) νmax (cm-1) 2955, 2920, 2850, 1723 (m), 1514 (m), 
1462, 1377, 1222; HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C21H21FN3O, 350.16632; 
found 350.16529. 
 
1-(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)ethan-1-ol 
(11ba): white solid obtained in 50% yield; mp 178.1-181.0 ˚C; TLC (Silica G w/UV254) 
30% EtOAc in hexanes, Rf = 0.16; [α]D20 = -16 (c 10.0, MeOH); 1H-NMR (CDCl3, 500 MHz) 
δ 1.13 (s, 3H), 1.23-1.29 (m, 3H), 1.34-1.45 (m, 2H), 1.56-1.62 (m, 2H), 1.72-1.78 (m, 1H), 
1.90-1.94 (m, 1H), 2.27-2.30 (m, 1H), 2.32-2.37 (m, 4H) 2.47-2.50 (d, 1H), 2.97-3.00 (d, 
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1H), 6.14 (s, 1H), 7.23-7.26 (d, 2H), 7.34-7.36 (d, 2H), 7.40 (s, 1H); 13C-NMR (CDCl3, 500 
MHz) δ 19.21, 20.81, 24.34, 25.85, 33.32, 34.67, 41.14, 54.89, 56.00, 66.11, 109.50, 
113.47, 123.47, 129.65, 136.81, 137.28, 137.60, 149.57; IR (NaCl, thin film) νmax (cm-1): 
3315 (OH), 3043 (w), 2962, 2936, 2862, 1620, 1518 (w), 1425, 1132, 820; HRMS (DART-
RTOF) m/z: [M+H]+ Calcd for C21H27N2O, 323.21179; found 323.21001. 
 
2-((4aR)-4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)propan-2-
ol (13ba): white solid obtained in 55% yield; mp 173-176 ˚C; TLC (Silica G w/UV254) 25% 
EtOAc in hexanes, Rf = 0.17; [α]D20 = -75 (c 10.0, MeOH); 1H-NMR (CDCl3, 500 MHz) δ 
1.19 (s, 3H), 1.33-1.37 (s, 8H), 1.38-1.39 (d, 1H), 1.66-1.69 (d, 1H), 1.77-1.80 (dt, 1H), 
1.84-1.87 (dt, 1H), 2.31 (m, 1H), 2.39 (s, 3H), 2.73-2.76 (d, 1H), 3.53-3.57 (d, 1H), 6.16 
(s, 1H) 7.24-7.25 (d, 2H), 7.35-7.38 (d, 2H), 7.40 (s, 1H); 13C-NMR (CDCl3, 500 MHz) δ 
19.65, 26.38, 27.48, 29.70, 33.91, 34.52, 36.19, 43.57, 57.61, 75.52, 109.76, 115.22, 
123.26, 129.63, 136.59, 137.38, 150.95; IR (NaCl, thin film) νmax (cm-1): 3395 (OH), 2928, 
2855, 1611 (w), 1519 (m); HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for C22H29N2O, 
337.2274; found 337.2200. 
 
(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(phenyl)methanol 
(11bb): white solid obtained in 28% yield; mp 184-187 ˚C; TLC (Silica G w/UV254) 30% 
EtOAc in hexanes, Rf = 0.20; [α]D20 = -12 (c 10.0, MeOH); 1H-NMR (CDCl3, 500 MHz) δ 
1.26 (s, 3H), 1.60-1.81 (m, 5H), 2.23-2.28 (d, 1H), 2.36-2.43 (m, 4H), 2.74-2.77 (d, 1H) 
3.15-3.18 (d, 1H), 5.17 (s, 1H), 6.15 (s, 1H), 7.23-7.27 (d, 3H), 7.34-7.38 (m, 6H), 7.41 (s, 
1H); 13C-NMR (CDCl3, 500 MHz) δ 19.90, 21.05, 25.79, 41.28, 56.66, 71.95, 109.51, 
113.67, 123.52, 125.38, 126.78, 128.16, 129.68, 137.60, 145.70, 149.77; IR (NaCl, thin 
film) νmax (cm-1): 3319 (OH), 3039 (w), 2929, 2868, 1610 (w), 1519 (m), 821; HRMS 
(DART-RTOF) m/z: [M+H]+ Calcd for C26H29N2O, 385.22744; found 385.22612. 
1-((4aR)-4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-1-
phenylethan-1-ol (13bb): white solid obtained in 82% yield; mp 172-174.5 ˚C; TLC (Silica 
G w/UV254) 30% EtOAc in hexanes, Rf = 0.27; [α]D20 = -26 (c 10.0, MeOH); 1H-NMR 
(CDCl3, 500 MHz) δ 1.27 (s, 3H), 1.62-1.66 (m, 2H), 1.68 (s, 3H), 1.74-1.79 (m, 2H), 2.04-
2.07 (d, 1H), 2.24-2.28 (d, 1H), 2.33-2.40 (m, 4H), 2.60-2.63 (d, 1H), 3.10-3.13 (d, 1H), 
6.14 (s, 1H), 7.23-7.29 (m, 4H), 7.33-7.36 (m, 4H), 7.49-7.52 (m, 2H); 13C-NMR (CDCl3, 
500 MHz) δ 20.41, 21.02, 25.82, 26.11, 28.40, 29.68, 34.20, 35.90, 44.00, 56.78, 78.79, 
109.52, 115.37, 123.26, 125.56, 126.74, 128.02, 129.62, 136.05, 136.53, 137.41, 137.72, 
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151.03; IR (NaCl, thin film) νmax (cm-1): 3365 (OH), 3054 (w), 2928, 2858, 1610 (w), 1519 
(m), 821; HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for C27H31N2O, 399.2430; found 
399.2368. 
 
(4-fluorophenyl)(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)methanol (11bc): white solid obtained in 11.5% yield; mp 188-191 ˚C; TLC (Silica G 
w/UV254) 25% EtOAc in hexanes, Rf = 0.24; [α]D20 = -24 (c 10.0, MeOH); 1H-NMR (CDCl3, 
500 MHz) δ 1.26 (s, 3H), 1.50-1.61 (m, 3H), 1.67-1.71 (m, 2H), 1.79-1.82 (d, 1H), 2.25-
2.28 (d, 1H), 2.39 (s, 3H), 2.74-2.77 (d, 1H), 3.16-3.20 (d, 1H), 5.19 (s, 1H), 6.16 (s, 1H), 
7.02-7.46 (m, 9); 13C-NMR (CDCl3, 500 MHz) δ19.19, 21.04, 25.74. 33.25, 35.24, 41.24, 
56.75, 71.47, 109.62, 113.54, 114.58, 123.50, 126.92, 129.69, 136.68, 136.90, 137.23, 
137.58, 141.26, 149.48, 160.71, 162.66; IR (NaCl, thin film) νmax (cm-1): 3312 (OH), 3041 
(w), 2931, 2867, 2830, 1898, 1603, 1518, 1219, 819; HRMS (DART-RTOF) m/z: [M+H]+ 
Calcd for C26H28FN2O, 403.21802; found 403.21649. 
 
1-(4-fluorophenyl)-1-((4aR)-4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)ethan-1-ol (13bc): white solid obtained in 80% yield; mp 188.5-191 
˚C; TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.25; [α]D20 = -9 (c 1.0, MeOH); 
1H-NMR (CDCl3, 500 MHz) δ 1.26 (s, 3H), 1.60-1.63 (m, 3H), 1.66 (s, 3H), 1.75-1.79 (d, 
1H), 1.99-2.02 (d, 1H), 2.24-2.27 (d, 1H), 2.39 (s, 3H), 2.60-2.63 (d, 1H), 3.12-3.15 (d, 
1H), 5.30 (s, 1H), 6.14 (s, 1H), 7.01-7.48 (m, 9H); 13C-NMR (CDCl3, 500 MHz) δ 20.40, 
21.02, 25.83, 26.16, 28.41, 34.15, 36.03, 43.98, 56.89, 78.55, 109.60, 114.59, 115.25, 
123.26, 127.24, 129.63, 136.58, 137.69, 150.94; IR (NaCl, thin film) νmax (cm-1): 3315 
(OH), 3020 (w), 2928, 2860, 1600, 1519, 1222; HRMS (DART-RTOF) m/z: [M+H]+ Calcd 
for C27H30FN2O, 417.23367; found 417.23232. 
 
(3,4-difluoro-5-methoxyphenyl)(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11bd): white solid obtained in 76% yield; mp 97-101 ˚C; 
TLC (Silica G w/UV254) 25% EtOAc in hexanes, Rf = 0.22; [α]D20 = +31 (c 10.0, MeOH); 
1H-NMR (CDCl3, 500 MHz) δ 1.25 (m, 3H), 1.37-1.50 (m, 2H), 1.54-1.65 (m, 2H), 1.76-
1.79 (d, 1H), 2.04 (s, 3H), 2.26-2.29 (d, 1H), 2.72-2.75 (d, 1H), 3.14-3.17 (d, 1H), 3.88 (s, 
3H), 5.10 (s, 1H), 6.16 (s, 1H), 6.72-6.78 (m, 2H), 7.24-7.46 (m, 6H); 13C-NMR (CDCl3, 
500 MHz) δ 14.18, 19.94, 21.04, 25.70, 33.17, 35.31, 41.20, 56.71, 60.38, 71.28, 105.52, 
106.04, 109.70, 113.35, 123.36, 129.66, 136.67, 136.99, 137.17, 137.55, 149.25; IR 
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(NaCl, thin film) νmax (cm-1): 3387 (OH), 3050 (w), 2927, 2850, 1623, 1522, 1454, 1426, 
1339, 1226, 1097; HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C27H29F2N2O2, 451.21916; 
found 451.21790.  
 
1-(3,4-difluoro-5-methoxyphenyl)-1-((4aR)-4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-
1H-benzo[f]indazol-5-yl)ethan-1-ol (13bd): white solid obtained in 94% yield, mp 181-183 
˚C; TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.19; [α]D20 = +13 (c 3.0, MeOH); 
1H-NMR (CDCl3, 500 MHz) δ 1.22-1.35 (m, 6H), 1.58-1.62 (m, 4H), 1.79-1.83 (d, 1H), 
1.96-1.99 (d, 1H), 2.25-2.28 (d, 1H), 2.34-2.44 (s, 3H), 2.57-2.61 (d, 1H), 3.05-3.08 (d, 
1H), 3.91-3.96 (s, 3H), 6.15 (s, 1H), 6.87-6.92 (m, 2H), 7.23-7.30 (m, 4H), 7.36 (s, 1H); 
13C-NMR (CDCl3, 500 MHz) δ 20.53, 25.64, 26.24, 28.90, 33.96, 35.77, 44.02, 56.34, 
123.27, 129.65, 136.66; IR (NaCl, thin film) νmax (cm-1): 3348 (OH), 2927, 2853, 1622, 
1520, 1451, 1420, 1334, 1228, 1101; HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for 
C28H31F2N2O2, 465.2348; found 465.2283. 
 
(4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)(thiophen-2-
yl)methanol (11be): white solid obtained in 36% yield; mp 109-114 ˚C; TLC (Silica G 
w/UV254) 25% EtOAc in hexanes, Rf = 0.26; [α]D20 = -17 (c 10.0, MeOH); 1H-NMR (CDCl3, 
500 MHz) δ 1.23 (s, 3H), 1.62-1.91 (m, 6H), 2.26-2.31 (m, 1H), 2.40 (s, 3H), 2.67-2.72 (m, 
1H), 3.06-3.14 (m, 1H), 5.39 (s, 1H), 6.16 (s, 1H), 6.95-7.43 (m, 8H); 13C-NMR (CDCl3, 
500 MHz) δ 19.07, 21.03, 21.64, 23.60, 24.35, 25.83, 33.32, 33.51, 34.67, 35.08, 40.64, 
41.13, 54.89, 56.02, 66.12, 67.89, 109.57, 114.13, 123.42, 129.65, 136.46, 137.59, 
149.61; IR (NaCl, thin film) νmax (cm-1): 3319 (OH), 3106 (w), 3045 (w), 2928, 2856, 2836, 
1611, 1540 (m); HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C24H27N2OS, 391.18386; 
found 391.13976. 
1-((4aR)-4a-methyl-1-(p-tolyl)-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-yl)-1-
(thiophen-2-yl)ethan-1-ol (13be): white solid obtained in 76% yield; mp 90-95 ˚C; TLC 
(Silica G w/UV254) 25% EtOAc in hexanes, Rf = 0.28; [α]D20 = -12 (c 3.0, MeOH); 1H-NMR 
(CDCl3, 500 MHz) δ 1.25 (s, 3H), 1.40-1.41 (d, 1H), 1.57-1.59 (d, 1H), 1.65 (s, 3H), 1.69-
1.70 (d, 2H), 1.76-1.78 (d, 1H), 2.03-2.06 (d, 1H), 2.26-2.28 (d, 1H), 2.39 (s, 3H), 2.66-
2.69 (d, 1H), 3.22-3.25 (d, 1H), 6.15 (s, 1H), 7.12-7.37 (m, 8H); 13C-NMR (CDCl3, 500 
MHz) δ 20.13, 21.02, 26.16, 28.19, 29.68, 34.31, 35.80, 43.88, 56.70, 109.66, 115.39, 
119.69, 123.26, 125.64, 126.49, 129.63, 136.56, 137.73, 150.91; IR (NaCl, thin film) νmax 
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(cm-1): 3381 (OH), 3105 (w), 3042 (w), 2928, 2859, 1611, 1518 (m), 821; HRMS (ESI-
RTOF) m/z: [M+H]+ Calcd for C25H29N2OS, 405.1995; found 405.1899. 
 
1-(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)ethan-1-ol (11ca): white solid obtained in 58% yield; mp 156-159 ˚C; TLC (Silica G 
w/UV254) 25% EtOAc in hexanes, Rf = 0.11; [α]D20 = +25 (c 10.0, MeOH); 1H-NMR (CDCl3, 
500 MHz) δ 1.13 (s, 3H), 1.23-1.29 (m, 4H), 1.34-1.45 (m, 3H), 1.74-1.78 (d, 1H),1.88-
1.95 (d, 1H), 2.28-2.31 (d, 1H), 2.35-2.39 (m, 1H), 2.47-2.51 (d, 1H), 2.98-3.01 (d, 1H), 
3.84-3.87 (s, 3H), 6.10 (s, 1H), 6.96-7.40 (m, 5H); 13C-NMR (CDCl3, 500 MHz) δ 19.21, 
20.80, 24.36, 25.85, 33.31, 34.68, 41.16, 54.89, 55.49, 66.10, 109.38, 113.42, 114.25, 
133.01, 136.73, 137.32,149.51, 158.54; IR (NaCl, thin film) νmax (cm-1): 3376 (OH), 3020 
(w), 2962, 2931, 2862, 1612, 1517, 1250, 831; HRMS (DART-RTOF) m/z: [M+H]+ Calcd 
for C21H27N2O2, 339.20670; found 339.20344. 
 
2-((4aR)-1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)propan-2-ol (13ca): white solid obtained in 58% yield; mp 194-197 ˚C; TLC (Silica G 
w/UV254) 30% EtOAc in hexanes, Rf = 0.08; [α]D20 = -17 (c 10.0, MeOH); 1H-NMR (CDCl3, 
500 MHz) δ 1.19 (s, 3H) 1.30-1.38 (d, 6H), 1.48-1.55 (m, 1H), 1.66-1.69 (d, 1H), 1.76-1.87 
(dd, 2H), 2.27-2.37 (m, 3H), 2.73-2.76 (d, 1H), 3.53-3.57 (d, 1H), 3.85 (s, 3H), 6.11 (s, 1H) 
6.95-7.41 (m, 5H); 13C-NMR (CDCl3, 500 MHz) δ 19.66, 26.38, 27.48, 28.39, 29.68, 33.91, 
34.51, 36.20, 43.60, 55.52, 57.61, 75.49, 109.57, 114.24, 114.96, 124.86, 133.10, 136.29, 
137.41, 150.90, 158.42; IR (NaCl, thin film) νmax (cm-1): 3349 (OH), 3018, 2928, 2857, 
1612, 1517, 1248, 831; HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for C22H29N2O2, 353.2223; 
found 353.2184. 
 
(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)(phenyl)methanol (11cb): beige solid obtained in 73% yield; mp 109.3-111.5 ˚C; TLC 
(Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.11; [α]D20 = -10 (c 10.0, MeOH); 1H-
NMR (CDCl3, 500 MHz) δ 1.27 (s, 3H), 1.56-1.81 (m, 6H), 2.24-2.27 (d, 1H), 2.36-2.44 (m, 
1H), 2.75-2.78 (d, 1H), 3.17-3.20 (d, 1H), 3.85 (s, 3H), 5.20 (s, 1H), 6.11 (s, 1H), 6.96-
7.44 (m, 9H); 13C-NMR (CDCl3, 500 MHz) δ 19.90, 25.78, 33.28, 35.23, 41.30, 56.65, 
72.02, 114.27, 125.09, 125.36, 126.84, 128.20, 132.99, 145.61, 149.62, 158.58; IR (NaCl, 
thin film) νmax (cm-1): 3307 (OH), 3056 (w), 2932, 2868, 2835, 1611, 1518, 1250, 833; 
HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C26H29N2O2, 401.22235; found 401.21952. 
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1-((4aR)-1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)-1-phenylethan-1-ol (13cb): beige solid obtained in 100% yield, mp 105.1-108 ˚C; TLC 
(Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.20; [α]D20 = -30 (c 10.0, CHCl3); 1H-
NMR (CDCl3, 500 MHz) δ 1.27 (s, 3H), 1.55-1.63 (m, 3H), 1.68 (s, 3H), 1.75-1.77 (m, 1H), 
2.04-2.07 (m, 1H), 2.23-2.26 (m, 1H), 2.33-2.38 (m, 1H), 2.60-2.63 (d, 1H), 3.10-3.13 (d, 
1H), 3.84 (s, 3H), 6.08 (s, 1H), 6.95-7.51 (m, 10H); 13C-NMR (CDCl3, 500 MHz) δ 20.43, 
25.82, 26.20, 28.38, 29.68, 34.19, 35.91, 44.03, 55.48, 56.79, 78.80, 109.33, 114.22, 
115.10, 125.55, 128.01, 133.11, 136.12, 137.46, 151.03, 158.39; IR (NaCl, thin film) νmax 
(cm-1): 3338 (OH), 3020 (w), 2925, 2854, 1611, 1517, 1250, 833; HRMS (DART-RTOF) 
m/z: [M+H]+ Calcd for C27H31N2O2, 415.23800; found 415.23680. 
 
 (4-fluorophenyl)(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)methanol (11cc): white solid obtained in 69% yield; mp 178-182 ˚C; 
TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.26; [α]D20 = +4 (c 4.0, MeOH); 1H-
NMR (CDCl3, 500 MHz) δ 1.26 (s, 3H), 1.56-1.58 (m, 2H), 1.66-1.70 (m, 2H), 1.79-1.82 
(m, 1H), 2.25-2.28 (m, 1H), 2.37-2.40 (m, 1H), 2.73-2.76 (d, 1H), 3.17-3.20 (d, 1H), 3.85 
(s, 3H), 5.20 (d, 1H), 6.11 (s, 1H), 6.96-7.06 (m, 4H), 7.30-7.44 (m, 5H); 13C-NMR (CDCl3, 
500 MHz) δ 19.84, 20.59, 21.04, 25.80, 29.68, 33.28, 35.05, 41.22, 55.69, 69.85, 109.63, 
113.56, 119.81, 123.50, 125.51, 126.00, 129.68, 137.60, 147.31, 149.4; IR (NaCl, thin 
film) νmax (cm-1): 3399 (OH), 2930, 2850, 1602, 1512, 1223, 824; HRMS (DART-RTOF) 
m/z: [M+H]+ Calcd for C26H28FN2O2, 419.21293; found 419.20660. 
 
1-(4-fluorophenyl)-1-((4aR)-1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-
benzo[f]indazol-5-yl)ethan-1-ol (13cc): white solid obtained in 49% yield; mp 182.1-185 
˚C; TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.28; [α]D20 = -51 (c 10.0, MeOH); 
1H-NMR (CDCl3, 300 MHz) δ 1.25 (s, 3H), 1.53-1.62 (m, 2H), 1.67 (s, 3H), 1.73-1.78 (m, 
1H), 1.99-2.02 (d, 1H), 2.24-2.36 (m, 3H), 2.60-2.63 (d, 1H), 3.12-3.15 (d, 1H), 3.85 (s, 
3H), 6.09 (s, 1H), 6.95-7.49 (m, 9H); 13C-NMR (CDCl3, 500 MHz) δ 20.42, 25.82, 26.18, 
28.46, 29.69, 34.14, 36.05, 44.02, 55.53, 56.90, 78.55, 109.48, 114.23, 114.59, 114.76, 
124.84, 127.24, 136.09, 137.48, 151.60; IR (NaCl, thin film) νmax (cm-1): 3363 (OH), 2929, 
2840, 1600, 1517, 1250, 834; HRMS (DART-RTOF) m/z: [M+H]+ Calcd for C27H30FN2O2, 
433.22858; found 433.22897. 
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(3,4-difluoro-5-methoxyphenyl)(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-
1H-benzo[f]indazol-5-yl)methanol (11cd): white solid obtained in 71% yield, mp 174.1-
177.4 ˚C; TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.16; [α]D20 = -50 (c 10.0, 
MeOH); 1H-NMR (CDCl3, 500 MHz) δ 1.26 (s, 3H), 1.52-1.56 (m, 2H), 1.66-1.69 (m, 2H), 
1.80-1.84 (m, 2H), 2.26-2.29 (m, 1H), 2.73-2.76 (d, 1H), 3.15-3.18 (d, 1H), 3.85 (s, 3H), 
3.91 (s, 3H), 5.12 (s, 1H), 6.11 (s, 1H), 6.72-6.79 (m, 2H), 6.96-6.99 (m, 2H), 7.37-7.44 
(m, 3H); 13C-NMR (CDCl3, 500 MHz) δ 20.00, 25.70, 33.15, 35.35, 41.23, 55.54, 56.72, 
71.34, 106.04, 109.62, 113.09, 114.29, 125.09, 136.72, 137.36, 149.14, 158.65; IR (NaCl, 
thin film) νmax (cm-1): 3400 (OH), 2930, 2868, 1611, 1517, 1250, 833; HRMS (DART-RTOF) 
m/z: [M+H]+ Calcd for C27H29F2N2O3, 467.21408; found 467.21488. 
 
1-(3,4-difluoro-5-methoxyphenyl)-1-((4aR)-1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-
hexahydro-1H-benzo[f]indazol-5-yl)ethan-1-ol (13cd): white solid obtained in 65% yield, 
mp 184-187 ˚C, TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.13; [α]D20 = +55 
(c 10.0, MeOH); 1H-NMR (CDCl3, 500 MHz) δ 1.26 (s, 3H), 1.60-1.67 (m, 6H) 1.79-1.82(d, 
1H), 1.96-1.99 (d, 1H), 2.24-2.39 (m, 2H), 2.57-2.60 (d, 1H), 3.05-3.08 (d, 1H), 3.85 (s, 
3H), 3.91 (s, 3H), 6.10 (s, 1H), 6.87-7.01 (m, 4H), 7.32-7.45 (m, 3H); 13C-NMR (CDCl3, 
500 MHz) δ 20.54, 25.65, 26.24, 28.89, 33.95, 35.79, 44.05, 55.53, 56.35, 56.78, 106.27, 
106.78, 109.50, 114.25, 114.75, 124.85, 133.03, 137.42, 150.81; IR (NaCl, thin film) νmax 
(cm-1): 3329 (OH), 2932, 2850, 1622, 1518, 1251, 1100, 834; HRMS (DART-RTOF) m/z: 
[M+H]+ Calcd for C27H30FN2O2, 433.22858; found 433.22897. 
 
(1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)(thiophen-2-yl)methanol (11ce): white solid obtained in 79% yield; mp 171-173.6 ˚C; 
TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.17; [α]D20 = -6.2 (c 10.0, MeOH); 
1H-NMR (CDCl3, 500 MHz) δ 1.26 (m, 4H), 1.62-1.72 (m, 2H), 1.77-1.85 (m, 2H), 2.27-
2.41 (m, 2H), 2.69-2.72 (d, 1H), 3.12-3.15 (d, 1H), 3.85 (s, 3H), 5.25 (s, 1H), 6.12 (s, 1H), 
6.96-7.40 (m, 8H); 13C-NMR (CDCl3, 500 MHz) δ 19.87, 20.59, 25.80, 33.28, 35.04, 41.26, 
55.54, 55.69, 69.83, 109.44, 113.31, 114.29, 119.82, 125.11, 125.51, 126.00, 137.26, 
147.31, 158.65; IR (NaCl, thin film) νmax (cm-1): 3310 (OH), 3090 (w), 2920, 2860, 1610 
(w), 1519, 1230, 830; HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for C24H27N2O2S, 407.1787; 
found 407.1720. 
 
63 
 
1-((4aR)-1-(4-methoxyphenyl)-4a-methyl-4,4a,5,6,7,8-hexahydro-1H-benzo[f]indazol-5-
yl)-1-(thiophen-2-yl)ethan-1-ol (13ce): white solid obtained in 48% yield; mp 146-148.5 ˚C; 
TLC (Silica G w/UV254) 30% EtOAc in hexanes, Rf = 0.16; [α]D20 = +12 (c 10.0, MeOH); 
1H-NMR (CDCl3, 500 MHz) δ1.25 (s, 3H), 1.59-1.65 (m, 2H), 1.68 (s, 3H), 1.73-1.78 (m, 
2H), 2.03-2.06 (d, 1H), 2.25-2.36 (m, 2H), 2.65-2.69 (d, 1H), 3.22-3.25 (d, 1H), 3.84 (s, 
3H), 6.10 (s, 1H), 6.94-7.40 (m, 8H); 13C-NMR (CDCl3, 500 MHz) δ 20.16, 26.16, 28.19, 
34.31, 35.82, 43.91, 55.48, 56.71, 77.52, 109.47, 114.23, 115.13, 119.72, 124.88, 126.51, 
133.11, 136.13, 137.47, 150.93, 152.99, 158.40; IR (NaCl, thin film) νmax (cm-1): 3365 
(OH), 2930, 2850, 1610, 1517, 1250, 835; HRMS (ESI-RTOF) m/z: [M+H]+ Calcd for 
C25H29N2O2S, 421.1944; found 421.1907. 
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CHAPTER II. INSIGHTS INTO THE DEGRADATION OF BISPHENOL 
A AND THE MNO2-MEDIATED DEGRADATION PRODUCT, 4-
HYDROXYCUMYL ALCOHOL, BY FRESHWATER SEDIMENT 
MICROCOSMS 
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The work outlined in this chapter below was performed by Jeongdae Im1,2, Carson W. 
Prevatte3, Hong G. Lee4, Shawn R. Campagna3, and Frank E. Löffler1,2,5,6.  JI, under the 
supervision of FEL, is the primary author in terms of the introduction, biological 
experimentation methods, results, and conclusions. CWP, along with other members of the 
Campagna laboratory and combined research team, authored sections of the original 
manuscript containing chemical data and methods contributions. Two publications have 
been merged without changes to the original content of the articles. The abstract, 
introductions, and methods sections were merged in order to reduce redundancy between 
the articles and edited to present the two articles as two parts of a single, overarching 
project. Additions were also made in the methods section to highlight the synthesis and 
analytical methods implemented to elucidate and confirm unknown structures in the two 
degradation studies. The results and discussion were merged and are as originally 
published.  
 
Im, J., Prevatte, C. W., Campagna, S. R., & Löffler, F. E. Identification of 4-hydroxycumyl 
alcohol as the major MnO2-mediated bisphenol A transformation product and evaluation of 
its environmental fate. Environmental science & technology 2015 49 (10) 6214-21. 
 
Im, J., Prevatte, C. W., Lee, H. G., Campagna, S. R., & Löffler, F. E. 4-Methylphenol 
produced in freshwater sediment microcosms is not a bisphenol A 
metabolite. Chemosphere 2014 117:521-526. 
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37996, United States; 2Center for Environmental Biotechnology, University of Tennessee, 
Knoxville, Tennessee 37996, United States; 3Department of Chemistry, University of 
Tennessee, Knoxville, Tennessee 37996, United States; 4 Department of Chemistry, 
Massachusetts Institute of Technology, Cambridge, MA 02139, United States; 5Department 
of Civil and Environmental Engineering, University of Tennessee, Knoxville, Tennessee 
37996, United States; 6University of Tennessee and Oak Ridge National Laboratory (UT-
ORNL) Joint Institute for Biological Sciences (JIBS) and Biosciences Division, Oak Ridge 
National Laboratory, Oak Ridge, Tennessee 37831, United States 
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The Löffler lab, FEL and JI, conceived the study. The experimental work was performed by 
JI, CWP, and HGL. JI and HGL will be referred to as collaborators. CWP and collaborators 
all contributed to the identification, characterization, and the experiments probing the 
degradation reactions of BPA and 4-hydroxycumyl alcohol (HCA) under difference 
conditions.  Collaborators setup microcosms for both freshwater sediment amended with 
different redox active salts as well as freshwater sediment amended with MnO2. 
Collaborators used gas chromatography-mass spectrometry (GC-MS) and high-
performance liquid chromatography (HPLC) and a diode array detector (DAD) and 
fluorescence detector to detect and quantitate BPA and the putative degradation 
intermediates, 4-methylphenol (4-MP) and HCA. CWP synthesized 13C-labelled BPA to 
determine the role of 4-MP in BPA degradation in anoxic microcosms established with 
freshwater sediment amended with redox active salts. Additionally, CWP synthesized and 
characterized the putative MnO2-induced BPA degradation intermediate HCA to elucidate 
the structure of this previously unreported intermediate for this degradation pathway. 
Collaborators determined the physiochemical properties of HCA, the kinetics of BPA and 
HCA degradation by MnO2, and described the HCA degradation in freshwater sediment 
under oxic and anoxic conditions. The data was generated, analyzed by collaborators. 
Collaborators, CWP, and SRC contributed to the discussion, with CWP contributing to the 
discussion of the elucidation of the structure of HCA.  
 
CWP contribution  
 
The contribution by CWP was vital for each study, applying organic synthesis and analytical 
chemistry characterization methods to facilitate testing each hypothesis and better 
understand the mineral-mediated degradation of bisphenol A (BPA) in microcosms 
containing freshwater sediment under anoxic conditions. The first study initially sought to 
determine the degradation mechanism of BPA induced by various mineral salts acting as 
electron acceptors. 4-methylphenol (4-MP), an intermediate in the degradation of BPA under 
other conditions*, was initially detected and thought to be an intermediate under the 
conditions of interest for this study. CWP synthesized two different versions of 13C-labelled 
BPA, one with both methyl groups labelled and one with all non-aromatic carbons labelled 
using an optimized version of a previously described method, including an entirely new flash 
chromatography method51 (Scheme 2.1). Synthesis was vital to determining if 4-MP was a 
degradation product of BPA. Initially, the 13C2-labelled version was synthesized to specifically 
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track the methyl groups. Though the methyl groups in BPA were most likely to account for 
the methyl group in 4-MP through a Wagner–Meerwein rearrangement* (Scheme 2.3), the 
4-MP isolated did not contain 13C suggesting that 4-MP was not from BPA. The second 13C3-
labelled BPA was made to confirm this and microcosms amended with it also resulted in the 
presence of unlabeled 4-MP. The synthesis of these 13C-labelled BPA molecules by CWP, 
and their amendment into the microcosm, proved to be the most important experiment in 
this study and generated the result which most significantly supports the final conclusions 
of this study.  
 
The second study set out to understand MnO2-induced BPA degradation in microcosms 
containing freshwater sediment under anoxic conditions by identifying, characterizing, and 
synthesizing the major degradation products to understand the environmental fate of BPA 
and the resulting degradation products of BPA. A putative BPA degradation product was 
initially identified by HPLC-fluorescence detection of a peak that emerged in the 
chromatogram as the peak for BPA was consumed, the absence of this peak in microcosms 
not amended with MnO2, and a similar UV absorption spectrum between this unknown 
intermediate and BPA. CWP was tasked with elucidating the structure of the unknown 
intermediate. High-resolution MS analysis resulted in a base peak with an accurate mass of 
135.08011, suggesting a most likely molecular formula of C9H11O+. When combined with 
NMR experiments that suggested p-substituted phenol and 2-substituted isopropyl moiety 
and the knowledge of the tendency for 3° benzylic hydroxy groups to be lost during 
ionization, HCA was tentatively assigned as the structure of the unknown transformation 
product. One step further, CWP contributed to the final confirmation of the tentative 
assignment by synthesizing and characterizing HCA. The accurate mass measurement and 
the NMR spectrum were identical to the isolated BPA transformation product. The synthetic 
HCA also allowed collaborators to determine the physiochemical properties, the kinetics of 
MnO2-mediated degradation under oxic and anoxic conditions, and describe more broadly 
the implication the HCA degradation in freshwater sediment. 
 
2.1 Abstract 
 
Bisphenol A (BPA), an environmental contaminant with weak estrogenic activity, resists 
microbial degradation under anoxic conditions but is susceptible to abiotic transformation. 
In an initial study, 4-methylphenol (4-MP), a putative BPA degradation intermediate, was 
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detected at concentrations reaching 2.1 mg L-1 in anoxic microcosms containing 10 mg L-1 
BPA and 5 g of freshwater sediment material collected from four geographically distinct 
locations and amended with nitrate, nitrite, ferric iron, or bicarbonate as electron acceptors. 
4-MP accumulation was transient, and 4-MP degradation was observed under all redox 
conditions tested. 4-MP was not detected in microcosms not amended with BPA. 
Unexpectedly, incubations with 13C-labeled BPA failed to produce 13C-labeled 4-MP 
suggesting that 4-MP was not derived from BPA. The detection of 4-MP in live microcosms 
amended with lactate, but not containing BPA corroborated that BPA was not the source of 
4-MP. A further study was conducted outlining MnO2-induced degradation of BPA. BPA 
degradation followed pseudo-first-order kinetics with a rate constant of 0.96 (±0.03) min−1 in 
the presence of 2 mM MnO2 (0.017% w/w) at pH 7.2. 4-hydroxycumyl alcohol (HCA) was 
the major transformation product, and, on a molar basis, up to 64% of the initial amount of 
BPA was recovered as HCA. MnO2 was also reactive toward HCA, albeit at 5-fold lower 
rates, and CO2 evolution (i.e., mineralization) occurred. In microcosms established with 
freshwater sediment, HCA was rapidly biodegraded under oxic, but not anoxic conditions. 
With a measured octanol−water partition coefficient (Log Kow) of 0.76 and an aqueous 
solubility of 2.65 g L−1, HCA is more mobile in saturated media than BPA (Log Kow = 2.76; 
aqueous solubility = 0.31 g L−1 ), and therefore more likely to encounter oxic zones and 
undergo aerobic biodegradation. These findings corroborate that BPA is not inert under 
anoxic conditions and suggest MnO2-mediated coupled abiotic−biotic processes may be 
relevant for controlling the fate and longevity of BPA in sediments and aquifers. Furthermore, 
the transient formation of 4-MP as a possible BPA degradation intermediate must be 
interpreted cautiously, as microbial activity in streambed microcosms may generate 4-MP 
from sediment-associated organic material. 
 
2.2 Introduction 
 
Bisphenol A, 2,2-bis(4-hydroxyphenyl)propane (BPA) , a high production volume chemical, 
is used to manufacture polycarbonate, epoxy resins, flame retardants, and lacquer coatings 
on food cans, as well as other products2. The global demand of BPA was estimated to 
exceed 7 million tons in 2013 and has been predicted to grow at a compound annual growth 
rate of 4.7% from 2014 to 2020., making BPA one of the highest production volume 
chemicals in the world52. As a consequence of high capacity use, BPA often has been 
detected in environmental systems, ranging from 0.5−343 μg kg−1 in fresh water sediments, 
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0.5−776 ng L−1 in surface water bodies, 0.02−149.2 μg L−1 in sewage effluents, and 1.3−17 
200 μg L−1 in landfill leachate53-59. Bearing structural resemblance to estrogens, BPA can 
bind to the estrogen receptor and is considered weakly estrogenic. This, along with high 
volume production, have triggered interest in the environmental fate of BPA in recent years. 
Several aerobic BPA degraders have been reported that use BPA as the sole source of 
carbon and energy60-64. On the other hand, a number of studies concluded that BPA 
undergoes little or no microbial degradation in the absence of oxygen61, 65-67. 
 
Based on the identification of intermediates, a few different aerobic BPA degradation 
pathways have been proposed60, 62, 64. A recent survey of 107 soil samples demonstrated 
aerobic BPA degradation in 85 samples, and 26 BPA-degrading isolates were obtained 
belonging to the genera Pseudomonas, Klebsiella, Pandoraea, Alcaligens, Enterobacter, 
Serratia, Bacillus, Bordetella, and Sphingomonas68. These findings suggest that diverse 
bacterial groups are capable of degrading BPA under oxic conditions. A significant mass of 
BPA resides in anoxic sediments53, 55, but very little is known about the fate of BPA under 
anoxic conditions. Several studies investigating microbial BPA degradation under anoxic 
conditions have concluded that BPA is recalcitrant and undergoes ‘‘little or no’’ 
biodegradation in the absence of oxygen61, 67. No microbial BPA degradation was observed 
in anoxic microcosms established with freshwater sediment69, marine sediments70, and 
soil71. Halogenated BPAs were reductively dehalogenated to BPA in estuarine sediment 
microcosms, but no further degradation was observed under different redox conditions67. 
Experimental evidence supporting anaerobic BPA degradation is scarce. Chiou (2010) 
reported a 14% of loss in BPA concentration after a 120 d incubation period with anoxic river 
sediment72. Similarly, Kang and Kondo (2002) reported a 10% loss of initial BPA added to 
anoxic river water microcosms, and (Patterson et al., 2010) reported BPA removal under 
denitrifying conditions73. At best, these studies demonstrated BPA disappearance, but BPA 
degradation intermediates and end-products were not identified or quantified. To predict the 
environmental fate of BPA in anoxic environments, more detailed studies of BPA degradation 
under anoxic conditions are needed. 
 
This study detected 4-MP in anoxic sediment microcosms as a possible BPA degradation 
intermediate but experiments using 13C-labeled BPA implicated that 4-MP was derived from 
another source, presumably sediment-associated organic matter, emphasizing the need for 
careful results interpretation regarding the environmental fate of BPA or similar phenolic 
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compounds. To further understand the anoxic degradation of BPA, a further study was 
performed to identify and characterize major MnO2-mediated BPA transformation 
product(s), evaluate the degradation of the intermediate(s), and assess the potential 
consequences of MnO2-mediated oxidation on the environmental fate of BPA and the 
transformation product(s). 
 
Manganese and iron can form reactive minerals that affect the fate and transport of organic 
contaminants via sorption, hydrolysis and/or oxidative transformation74-76. In particular, 
manganese oxides, such as MnO2, are abundant in soils, as well as freshwater and marine 
sediments74-75, 77-78. MnO2 is the most common manganese mineral in soils−185 μmol cm−3 
of MnO2 have been reported in marine sediments of the Panama Basin, the Skagerrak, the 
Black Sea and the northern Barents Sea79-81. Values up to 1−15% (dry wt., ∼300−4000 μmol 
cm−3 ) of MnO2 have been observed in Lake Zü rich sediments82. In Lake Charlotte, Nova 
Scotia, MnO2 comprised as much as 2.5% (dry wt., 750 μmol cm−3 ) of the sediment79. MnO2 
is a strong oxidant and serves not only as respiratory electron acceptor in microbial 
metabolism but also as a reactive mineral to remove many phenolic compounds, including 
BPA75-76, 83-89. Lin and co-workers proposed 11 BPA transformation products generated in 
aqueous systems amended with MnO2 based on the fragmentation patterns obtained by 
gas chromatography−mass spectrometry methods following derivatization with N,O-
bis(trimethylsilyl)-trifluoroacetamide86. However, a quantitative assessment was not 
performed and no major pathway was established. 
 
2.3 Materials and methods 
 
Chemicals. BPA (>99% purity), p-acetoxyacetophenone, and 3 3 M solution of 
methylmagnesium iodide in diether ether was obtained from Sigma Aldrich (St. Louis, MO), 
4-MP (>99% purity), Amberlyst 15 was purchased from Rohm and Haas (Philadelphia, PA), 
and L-tyrosine (99% purity) was purchased from MP Biomedicals (Chicago, IL). The 13C-
labelled acetone (>99% purity) and the BPA containing 13C-labelled phenyl groups, 2,2-
bis(4-hydroxy[13C6]phenyl) propane (13C6-BPA, >99% purity), were purchased from 
Cambridge Isotopes Laboratories (Andover, MA). Dry diethyl ether employed in the 
synthesis of HCA was obtained by distillation from a potassium benzophenone ketyl still. 
Thin-layer chromatography (TLC) was carried out using Sorbent Technologies silica G F254 
TLC plates. All compounds of interest were visualized as single spots using short-wave UV 
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light; more permanent staining of TLC spots was achieved using p-anisaldehyde, vanillin, 
or ceric ammonium molybdate (Hannesian’s) TLC staining solutions. Silica gel with a 60A 
pore size and a particle diameter of 40-63 µm was used for flash chromatography. 
 
Synthesis of 13C-labelled BPA and HCA. Specifically labeled versions of BPA, 2,2-bis(4-
hydroxyphenyl)[1,3-13C2]propane (13C2-BPA) and 2,2-bis(4-hydroxyphenyl)[13C3]propane (13C3-
BPA), were synthesized by condensation of [1,3-13C2] or [13C3]acetone, respectively, with five 
equivalents of phenol, neat, in the presence of a cation exchange resin catalyst, Amberlyst 15 using 
an optimized version of a previously described method (Scheme 2.1)51. BPA synthesized by this 
method was obtained in 21% yield after purification by flash chromatography eluted with 10% EtOAc 
in hexanes. HCA was not commercially available and was synthesized using a previously 
described method (Scheme 2.2)90. Briefly, 7 mL of 3.0 M methylmagnesium iodide in diethyl 
ether was added dropwise to 20 mL of 0.33 M p-acetoxyacetophenone in diethyl ether under 
a nitrogen atmosphere at room temperature, and the resulting solution was stirred for 5 h. 
After addition of 100 mL saturated aqueous ammonium chloride, the reaction mixture was 
extracted three times with 30 mL ethyl acetate. The organic phase was washed with 75 mL 
saturated NaCl solution, dried over anhydrous magnesium sulfate, filtered, and 
concentrated in vacuo to yield a slightly yellow solid. HCA was obtained in 21% yield after 
purification by flash chromatography eluted with 25% EtOAc in hexanes.  
 
MnO2 preparation. MnO2 was synthesized according to a previously reported method91. 
Briefly, 2.96 g of KMnO4 in 74.1 mL of distilled water was brought to 90 ˚C on a hot plate 
under continuous stirring. With the solution at 90 ˚C, 3.71 mL of 5 M NaOH was added, and 
then 5.55 g of MnCl2 dissolved in 27.8 mL distilled water was slowly added. The formed 
MnO2 particles were allowed to settle at room temperature and the suspension was washed 
five times with distilled water by centrifugation at 6,000 g for 10 min. The precipitate was 
suspended in 100 mL deoxygenated distilled water to achieve a nominal concentration of 
0.4 M. The average surface area of MnO2 particles was determined by the 
Brunauer−Emmett−Teller method using an Autosorb-1 surface area analyzer 
(Quantachrome Instruments, Syosset, NY)92. 
 
Oxidative Transformation of BPA and HCA by MnO2. All glassware was soaked in a 
5% nitric acid bath overnight, and thoroughly rinsed with high purity Milli-Q water (Millipore 
Milli-Q, Bedford, MA) prior to use. Experiments were conducted in 160 mL glass serum 
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Scheme 2.2. Synthesis of HCA. 
Scheme 2.1. Synthesis of 2,2-bis(4-hydroxyphenyl)[1,3-13C2]propane (13C2-BPA) and 2,2-bis(4-
hydroxyphenyl)[13C3]propane (13C3-BPA). 
 
Scheme 2.1 Synthesis of 2,2-bis(4-hydroxyphenyl)[1,3-13C2]propane (13C2-BPA) and 2,2-bis(4-
hydroxyphenyl)[13C3]propane (13C3-BPA). 
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bottles in a total volume of 100 mL containing 44 μM of BPA (10 mg L–1). The following 
buffers were used (10 mM each): phosphate (pH 2), sodium acetate (pH 4.3 and 5.5), 4-
morpholinepropanesulfonic acid (MOPS) (pH 6.5, 7.2 and 8), and 2-
(cyclohexylamino)ethanesulfonic acid (CHES) (pH 9 and 10). An appropriate amount of 
sodium chloride was added to maintain a constant ionic strength of 10 mM for each buffer. 
All solutions were deoxygenated by boiling and cooling under an oxygen-free nitrogen 
atmosphere. The effect of the initial MnO2 loading on BPA transformation rates and extent 
was examined by adding different amounts of MnO2 to achieve initial nominal 
concentrations of 0.2, 0.5, 1, and 2 mM at pH 7.2. To test the effect of pH on BPA 
transformation, the reaction vessels received 44 μM BPA and 0.5 mM of MnO2. The 
conversion efficiency of BPA to HCA, on a molar basis, was calculated by dividing the 
amount (µmol) HCA formed by the amount BPA removed. To test possible mineralization, 
CO2 evolution was examined in reaction vessels containing 2 mM MnO2 and 44 μM BPA or 
44 μM HCA in phosphate buffer (pH 2). The bottles were incubated on a rotary shaker at 
100 rpm at room temperature in the dark. The reactions were initiated by adding MnO2 from 
a 0.4 M stock suspension. Aliquots (0.5 mL) of the reaction mixtures were periodically 
collected, and transferred to 2 mL glass HPLC vials containing 20 µL of L-ascorbic acid 
solution (50 mg mL–1) and immediately vigorously mixed. Ascorbic acid quenches the 
reaction and converts any remaining MnO2 to Mn(II) ions and liberates any sorbed BPA and 
reaction products89, 93. The extent of BPA and HCA sorption onto the MnO2 surface was 
measured by comparing BPA and HCA concentrations in ascorbic acid-treated samples 
versus untreated samples that were filtered through a 0.22 μm membrane (Nalgene, 
Rochester, NY). The pseudo-first-order rate constants were obtained by plotting the natural 
log of BPA concentrations as a function of time using four early time points, where linear 
relationships were observed. Additional vials containing 4.4, 11, 22, and 44 μM BPA and 
ascorbic acid were prepared in triplicates to construct standard curves (Figure 2.1). The 
transformation of HCA by MnO2 and the effect of the initial MnO2 loading were examined as 
described for BPA in vessels containing 44 μM HCA (6.7 mg L–1) at pH 7.2. Different amounts 
of MnO2 were added to achieve nominal concentrations of 0.2, 0.5, 1, and 2 mM. Vials 
containing 0.5 mL of 6.6, 16.4, 32.9, and 65.7 μM HCA and 20 μL ascorbic acid were 
prepared in triplicate to construct standard curves (Figure 2.1).  
 
Physical-chemical properties of HCA. The aqueous solubility of HCA was determined 
at 20 ˚C based on the modified EPA Office of Prevention, Pesticides, and Toxic Substances  
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Figure 2.1. Exemplary standard curves for BPA and HCA constructed using HPLC-FLD measurements. 
Standard curves were prepared with different buffers or mineral salts medium, as necessary, to have 
the same matrix in samples and standards. Error bars smaller than the symbol size are not depicted. 
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(OPPTS) 830.7840 guidelines by stirring an excess amount of HCA in 10 mL Milli-Q water 
with a magnetic stirrer94. An aliquot of the mixture was centrifuged at 8,000 g for 5 min to 
remove any undissolved HCA, and the concentration of HCA in the saturated solution was 
determined by repeated HPLC analysis over the course of 1 week to confirm that equilibrium 
had been reached. The experiments were performed in quintuplicate. The octanol-water 
partitioning coefficient was measured at 20 ˚C following the modified EPA OPPTS 830.7550 
guidelines95. In brief, 10 mL of Milli-Q water containing 50 μg of HCA was mixed with 10 mL 
of n-octanol in ten 20 mL glass vials. The vials were sealed with Teflon-lined rubber septa, 
and shaken by inverting 100 times for 5 min. After quiescence for 24 hours and phase 
separation, the HCA concentration in the lower aqueous phase was measured by HPLC. 
Measurement of HCA concentrations after an additional 24-hour incubation period 
confirmed that chemical equilibrium had established. The molar extinction coefficient of HCA 
was determined by measuring the S3 absorbance of HCA solutions at room temperature 
using a PerkinElmer Lambda 35 UV–Vis spectrophotometer (PerkinElmer, Waltham, MA). 
 
Microcosm setup for initial 4-MP study. Microcosms were established in 60 mL serum 
bottles closed with black butyl rubber stoppers (Geo-Microbial Technologies, Ochelata, OK). 
Sediment samples were collected from four geographically distinct locations (latitude, 
longitude), including the Third Creek (35.949284, −83.939861), the Partnach Gorge 
(47.459198, 11.122777), the Neckar River (48.780193, 9.245422), and the Hainbach Creek 
(48.776559, 9.300439). The Third Creek location has a history of contamination of 
chlorinated solvents, the Neckar River flows along industrial areas, and the Partnach Gorge 
and Hainbach Creek are considered pristine water bodies. Each serum bottle received 5 g 
of sediment material (wet weight) and reduced (0.2 mM L-cysteine and 0.2 mM sodium 
sulfide) mineral salts medium to achieve a total volume of 30 mL in each vessel as well as 
a single addition of 2 mM of lactate as a readily fermentable substrate to ensure rapid 
establishment of anoxic conditions. BPA was added to the microcosms to a final aqueous 
phase concentration of 10 mg L-1 (44 µM). Autoclaved control microcosms with BPA, and 
live microcosms without BPA, electron acceptor, or lactate were established for each 
sediment sample. All manipulations were performed inside an anoxic chamber (Coy 
Laboratory Products, Ann Arbor, MI) containing a nitrogen/hydrogen (97/3; v/v) atmosphere. 
The microcosms were incubated at room temperature in the dark without shaking. To 
establish different redox conditions, electron acceptors including nitrate (2 mM), nitrite (0.5 
mM), amorphous ferric oxyhydroxide (FeOOH, 10 mM, nominal concentration), ferric citrate 
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(5 mM), sulfate (10 mM), and bicarbonate (30 mM) were added from anoxic, sterilized stock 
solutions at the concentrations indicated in parentheses. FeOOH was prepared following an 
established procedure96. Electron acceptors were replenished by syringe when depleted. To 
test BPA degradation under oxic conditions, microcosms were established using the same 
mineral salts medium except that the bicarbonate buffer system was replaced with 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer (10 mM, pH 7.0) and 
the reductants and lactate were omitted. These microcosms were incubated in the dark, and 
the headspace was purged with filter-sterilized air every second day. Additional microcosms 
were prepared with the Third Creek sediment to access the biodegradability of 4-MP. Ten 
mg L-1 of 4-MP and 2 mM of lactate were added and electron acceptors were replenished 
as above. 
 
Microcosm Setup for the MnO2-induced BPA degradation study. Sediment samples 
used for microcosm setup were collected from four geographically distinct locations (latitude, 
longitude), including the Third Creek in Knoxville, TN (35.949284, −83.939861), the Axton 
Cross brown field site located alongside the Housatonic River in CT (47.459198, 
11.122777), and the Shady Valley, a restored wetland area in TN (36.519554, −81.933327). 
An additional Third Creek sample was collected upstream (35.950664, −83.941932 ) of the 
site with reported chlorinated solvent contamination. Microcosms were established in 160 
mL glass serum bottles containing 100 mL of reduced (0.2 mM L-cysteine and 0.2 mM 
sodium sulfide), 30 mM bicarbonate-buffered basal salts medium and sealed with black butyl 
rubber stoppers (Geo-Microbial Technologies, Ochelata, OK). Each serum bottle received 5 
g (wet wt.) of sediment material. HCA was added to the microcosms from a filter-sterilized 
1 g L−1 stock solution to a final aqueous phase concentration of 5 mg L−1 (33 μM). Autoclaved 
microcosms with HCA, live microcosms without HCA, and autoclaved, sediment-free 
medium with HCA served as controls. All manipulations were performed inside an anoxic 
chamber (Coy Laboratory Products, Ann Arbor, MI) containing a nitrogen/ hydrogen (97/3; 
v/v) atmosphere. To establish different redox conditions, electron acceptors including nitrate 
(2 mM), sulfate (10 mM), and amorphous ferric oxyhydroxide (FeOOH, 10 mM, nominal 
concentration) were added from anoxic, sterilized stocks at the concentrations indicated in 
parentheses. To examine HCA degradation under oxic conditions, microcosms were 
established using the same mineral salts medium except that the bicarbonate buffer system 
was replaced with phosphate buffer (5 mM, pH 7.0) and no reductants were added. The 
microcosms were incubated at room temperature in the dark without shaking, and the 
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electron acceptors were replenished by syringe when depleted. FeOOH was prepared 
following an established procedure97. 
 
Analytical procedures. The amount of BPA associated with the sediments was 
determined after sampling by an ultrasonic solvent extraction method with some 
modifications98. In brief, 5 g of sediment was mixed with 10 mL of acetone/ethyl acetate 
(50:50, v/v), sonicated at 20 kHz for 15 min using a Branson Sonifier 250 (Branson 
Ultrasonic, Danbury, CT), and centrifuged at 5000g for 10 min. The extracts from three 
consecutive solvent extractions were combined and evaporated to dryness under a stream 
of filtered (0.25 lm) nitrogen. The residue was dissolved in 10 mL water/acetonitrile (50:50, 
v/v) and subjected to HPLC analysis. The adsorption capacity of BPA on Third Creek 
sediment was also evaluated. Triplicate 60 mL vessels that received 5 g of autoclaved 
sediment, 30 mL of mineral salt medium, and 300 µg (10 mg L-1) of BPA each were incubated 
for 5 d. The slurry was removed from the vessels and transferred into 30 mL glass centrifuge 
tubes. The supernatants obtained after centrifugation at 5000g for 10 min and analyzed by 
HPLC. 
 
An Agilent 1200 Series HPLC equipped with a diode array detector (DAD) and fluorescence 
detector (FLD) was used for the detection and quantification of BPA, its potential 
metabolites, and L-tyrosine. Separation was achieved on an Agilent Eclipse XDB C18 
column (4.6 mm × 150 mm, 5 µm) using isocratic elution with 1 mL min-1 of acetonitrile/water 
(50:50, v/v). The FLD was set at excitation and emission wavelengths of 226 and 310 nm, 
respectively. For the initial 4-MP study, the DAD recorded the entire UV/Vis absorption 
spectra of peaks ranging from 190 to 400 nm. For the MnO2-induced BPA degradation study, 
UV spectra from 220 to 400 nm were recoded to detect possible aromatic reaction 
intermediates. 
 
Ferric and ferrous iron were measured using the ferrozine assay86, and other electron 
acceptors were monitored by ion chromatography using a Dionex ICS 2100 system 
equipped with an 4 mm × 250 mm Ion-Pac AS18 hydroxide-selective anion exchange 
column (Sunnyvale, CA) with 23 mM potassium hydroxide solution as the eluent at a flow 
rate of 1 mM min−1 and an ERS 500 suppressor (4 mm) set at a current of 57 mA. 
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To identify putative BPA transformation products in the initial 4-MP study, liquid–liquid 
extraction coupled with GC–MS was used. Three water-immiscible solvents including 
dichloromethane, ethyl ether, and ethyl acetate were employed for separation and 
purification of the metabolites. For metabolite extraction, a 2 L Pyrex glass vessel received 
1 L of bicarbonate-buffered medium and 20 g of Third Creek sediment, and was incubated 
inside the anoxic chamber. After 30 d of incubation, 18 mL of sample was withdrawn from 
the vessel, and mixed with 2 mL of each solvent. The mixtures were shaken for 1 h and 
allowed to settle for 10 min. The organic phases were separated using a glass pipette and 
evaporated under a stream of nitrogen. The residues were dissolved in 100 L acetonitrile for 
GC–MS and HPLC analyses. Compound identity was confirmed by comparing HPLC 
retention times, UV/Vis absorption spectra, and mass spectra with authentic standards. 
 
MnO2-mediated degradation of BPA and HCA to carbon dioxide (CO2) was monitored using 
a Micro-GC (Agilent 3000A, Agilent Technologies, Santa Clara, CA) equipped with a thermal 
conductivity detector using a PLOT Q column. A dimensionless Henry’s constant of 1.24 
was used to calculate the total amount of CO2 in the incubation vessels99. 
 
1H-NMR spectra were obtained on a Varian InNova 500 MHz NMR spectrometer in solutions 
of CDCl3. All 13C-NMR spectra were recorded on a Varian InNova 500 MHz NMR 
spectrometer in solutions of CDCl3.  
 
Accurate mass measurements were performed on an Exactive Plus Orbitrap MS (Thermo 
Fisher Scientific, Waltham, MA) via ESI with a spray voltage of 4,000 V. The samples were 
direct injected as solutions in methanol using a Hamiltonian 250-μl syringe (Hamiltonian 
Company, Reno, NV) at a flow rate of 20 μl/min. Detection was done in positive-ion mode 
with nitrogen as the sheath gas. 
 
2.4 Results and discussion 
 
BPA associated with sediment. No BPA was detected in extracts from the untreated 
sediment samples indicating that no extractable BPA was associated with any of the 
sediments used in this study. Following the addition of BPA, 20–50% sorbed to the solids 
depending on the origin of the sediment (Table 2.1). The ultrasonic solvent extraction 
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method efficiently desorbed BPA from the sediments with recoveries of 96–100% (Table 
2.1). 
 
 
 
 
 
Fate of BPA in sediment microcosms. Aqueous phase BPA concentration profiles in 
microcosms established with the Third Creek sediment demonstrated an initial decrease in 
BPA concentrations, which was expected based on the sorption experiments (Figure 2.2). 
Under oxic conditions, aqueous phase BPA was completely degraded within 1 week of 
incubation. Aerobic BPA degradation has been demonstrated previously61, 68-69, 100 and these 
findings indicate that microorganisms capable of oxygen-dependent BPA catabolism are 
present in freshwater sediments. In the absence of oxygen, none of the live microcosms 
showed a statistically significant loss of aqueous phase BPA compared to negative control 
incubations (p > 0.05, Figure 2.2), although the mean concentrations were slightly lower 
than those of the negative control incubations. Interestingly, a putative BPA transformation 
product was detected in all microcosms except those amended with sulfate or incubated 
under oxic conditions (Figure 2.3). The same peak was observed in BPA-amended 
microcosms established with the other three freshwater sediment materials after a 1 month 
incubation period under the same conditions. The transformation product was not detected 
in live control microcosms without BPA suggesting that this compound was a possible BPA 
transformation product. The formation of this putative BPA metabolite did not coincide with 
a decrease in aqueous BPA concentrations, which remained near 5 mg L-1. We initially 
concluded that the rates of BPA desorption from the sediment exceeded the BPA 
degradation rates, or that sorbed BPA was preferentially degraded.  
  
Table 2.1. Adsorption and recovery of BPA from spiked sediment samples.  
 
Table 2.1. Adsorption and recovery of BPA from spiked sediment samples. Values in parenthesis 
represent the standard deviations of three replicates. Third Creek Partnach Gorge Neckar River Hainbach Creek
% Adsorption 53 (4) 22 (3) 34 (3) 50 (4)
% Recovery 98 (1) 99 (1) 97 (2) 100 (3)
Values in parenthesis represent the standard deviations of three replicates. 
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Figure 2.2. Concentration profiles of BPA in the microcosm established with the Third Creek sediment 
under nitrate-reducing (N), Fe (III)-reducing (FeCit-amended, j), and oxic conditions (_), and two 
autoclaved negative controls in the absence (h) or presence (s) of sediment. All data points are the 
means of three replicates. Error bars represent the standard deviations. 
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Figure 2.3. Representative HPLC chromatograms obtained from a negative control microcosm (A) and 
a microcosm established with the Third Creek sediment amended with nitrate after 30 d of incubation 
(B). The black arrow indicates the retention time of the putative BPA metabolite. 
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After a 1 year incubation period, each vessel was sacrificed to determine the total amount 
of BPA remaining (Table 2.2). In the microcosms incubated under oxic conditions, no BPA 
was detected associated with the sediment indicating complete removal. In contrast, BPA 
was detected in all microcosms incubated without oxygen. A 2-tailed t-test was used to 
determine the statistical significance of the discrepancies between live treatments and 
negative controls in each microcosm (SPSS 20.0, SPSS Chicago, IL). Based on the 
analyses, the decreases in BPA amounts extracted from live microcosms were significantly 
larger compared to the negative controls (p < 0.01, Table 2.2) suggesting a process that 
reduced the amount of extractable BPA was present in live incubations only. For example, 
aging and the formation of covalently bound residues can affect the extraction efficiency101-
103. Alternatively, reactive mineral-mediated86 or microbial BPA transformation may have 
occurred. 
 
 
 
 
 
 
 
 
 
Identification of a putative BPA metabolite. In order to identify the putative BPA 
degradation intermediate, liquid–liquid extraction procedures were evaluated. Among the 
solvents used for the extraction, ethyl ether showed the best extraction yields. The GC–MS 
analysis of the extract identified the putative metabolite as 4-MP (Figure 2.4). The identity 
of 4-MP was confirmed by comparing the HPLC retention times, UV–Vis absorption spectra, 
and mass spectra with authentic 4-MP. The maximum 4-MP concentrations detected in the 
Third Creek sediment microcosms ranged from 6.3 × 10-1 to 20.8 × 10-1 mg L-1 depending 
on the electron acceptor provided. A hypothetical pathway to explain the formation of 4-MP  
Table 2.2. Mass balance of BPA after 1 year of incubation period.  
Third Creek sediment Partnach Gorge sediment
BPA-S BPA-L Discrepancy BPA-S BPA-L Discrepancy
Nitrate 107.1 128.2 64.7 (5.5) 122.9 125.7 51.4 (5.6)
Nitrite 103.9 136.4 59.7 (8.2) 126.3 124.2 49.5 (7.7)
Sulfate 111.7 133.7 54.6 (12.2) 127.6 126.7 45.6 (8.6)
Methanogenic 120 129.1 50.9 (10.0) 121.9 129.9 48.2 (9.2)
FeOOH 108.3 128 63.7 (6.6) 131.5 119.4 49.1 (9.3)
FeCit 104.3 137.2 58.5 (9.2) 119.4 126.5 54.0 (9.8)
Negative 115.9 141.5 42.7 (8.8) 133.1 134.3 32.6 (9.8)
Neckar River sediment Hainbach Creek sediment
BPA-S BPA-L Discrepancy BPA-S BPA-L Discrepancy
Nitrate 123.4 138.9 37.7 (5.5) 138.2 110 51.8 (2.6)
Nitrite 129 132.4 38.6 (8.2) 146 103.9 50.1 (9.2)
Sulfate 131.4 144.8 23.8 (12.2) 139.7 101.7 58.6 (9.7)
Methanogenic 126.7 140.6 32.7 (10.1) 119.1 120 60.9 (8.1)
FeOOH 128.2 129.7 42.1 (6.6) 158 100.4 41.6 (12.2)
FeCit 116.7 138.1 45.1 (9.2) 137.2 104.3 58.5 (7.2)
Negative 132 145.5 22.4 (14.7) 151.5 115.9 32.7 (8.3)
The unit is μg. Values in parenthesis represent the standard deviations of duplicate samples. BPA-
S represents the total amount of BPA extracted from the solid phase, and BPA-L represents that of 
BPA extracted from the liquid phase. Discrepancy was obtained by subtracting BPA-S and BPA-L 
from the initial amount (300 μg) added to each bottle. 
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Figure 2.4. Full scan GC–MS chromatogram and the mass spectrum of 4-MP. The arrow indicates the 
retention time of 4-MP. 
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from BPA is shown (Scheme 2.3). The oxidation of one of the phenol rings can lead to a 
cationic intermediate, which undergoes a methyl shift (i.e., Wagner–Meerwein 
rearrangement). Subsequent C–C bond cleavage and rearomatization can form the putative 
intermediate 4-MP. To test if this pathway contributes to 4-MP formation in the microcosms, 
13C2-BPA with only methyl carbons labeled, 13C3-BPA with all non-aromatic carbons labeled, 
and 13C12-BPA with all aromatic carbons labeled were added to Third Creek sediment 
microcosms. Material labeled only outside of the aromatic rings was not commercially 
available, and 13C2-BPA and 13C12-BPA were synthesized from phenol and 13C-acetone with 
yields of 90–92%. The formation of 4-MP was observed in the microcosms supplied with 
13C-labeled BPA; however, no label was detected in 4-MP indicating that BPA was not the 
source of 4-MP. A series of control experiments demonstrated that 4-MP did not originate 
from laboratory plastic materials (e.g., syringes) chemicals used for medium preparation, 
and implicated the sediments as possible sources. To assess if the sediments were the 
source of 4-MP, microcosms without organic amendments and electron acceptors were 
monitored. None of these microcosms produced 4-MP. Another set of microcosms received 
2 mM of lactate but no BPA or electron acceptors. Unexpectedly, after a 1 month incubation 
period, the formation of 4-MP was observed in these microcosms. This finding indicated that 
4-MP formation from the sediment required the addition of an electron donor (e.g., lactate). 
No 4-MP was detected in the lactate stock solution or the sediment, indicating that 4-MP 
was formed during microcosm incubation. 4-MP was not detected in the live microcosms 
amended with sulfate (Figure 2.5) suggesting that (i) 4-MP was not generated from the 
sediment-associated organic matter in the presence of sulfate or that (ii) 4-MP was rapidly 
degraded in the presence of sulfate and evaded detection. The microcosms amended with 
4-MP showed that this molecule was degraded under all redox conditions tested (Figure 
2.6), as has been demonstrated previously104-107.  
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Scheme 2.3. Putative anaerobic microbial transformation of BPA leading to 4-MP as an 
intermediate. 
 
Scheme 2.3. Putative anaerobic microbial transformation of BPA leading to 4-MP as an 
intermediate. 
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Figure 2.5. Concentration profiles of 4-MP in Third Creek microcosms under different redox conditions, 
including nitrate-reducing (●), Fe (III)-reducing (△), sulfate-reducing (▴), and methanogenic conditions 
(■). All data points are the means of three replicates. Error bars represent the standard deviations. 
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Figure 2.6. Concentration profiles of 4-MP in the microcosms established with the Third Creek 
sediment under selected redox conditions, including nitrate-reducing (●), Fe (III)-reducing (△), sulfate-
reducing (▴), and methanogenic (■) and autoclaved negative controls in the presence of sediment (×). 
All data points are the means of three replicates. Error bars represent the standard deviations. 
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The rates of 4-MP degradation varied depending on the electron acceptor provided, and the 
degradation was significantly faster in nitrate compared to sulfate-amended microcosms 
(Figure 2.6). This observation suggested that 4-MP formation from sediment organic matter 
was repressed in the presence of sulfate, possibly due to sulfide toxicity108.  
 
Several anaerobic intestinal bacteria such as Lactobacillus sp. and Clostridium difficile can 
form 4-MP from L-tyrosine via decarboxylation in the absence of oxygen, but 4-MP formation 
from soils or sediments has not been reported109-110. Furthermore, L-tyrosine was not 
observed in any microcosm (detection limit of 50 µg L-1) (data not shown). Lactate addition 
and microbial activity were essential for 4-MP formation in the microcosms, suggesting 
microbial biomass or sediment-associated organic matter as possible sources of 4-MP; 
however, the detailed formation mechanism(s) remain to be determined. Since the formation 
of 4-MP was observed in microcosms established with sediments collected from different 
geographical locations, it is likely that the mechanisms and pathways leading to 4-MP 
formation are common to freshwater sediments. The 13C-labeling experiments excluded 
BPA as a source of 4-MP, and our findings emphasize that the detection of possible aromatic 
BPA degradation products such as 4-MP in sediments or sediment-derived microcosms 
must be interpreted carefully to avoid erroneous conclusions regarding the fate of BPA or 
similar compounds. 
 
Detection of a Major MnO2-generated BPA Transformation Intermediate. BPA 
disappearance was observed in abiotic incubations with MnO2 as oxidant. The average 
surface area of the MnO2 particles used in these experiments was 529 ± 14 (n = 3) m2 g−1. 
Typical BPA concentration profiles correlated with the initial MnO2 loading and are shown in 
(Figure 2.7). No significant (< 0.01) suggesting that BPA loss due to sorption to the glass 
surface or the rubber stopper was negligible. In the presence of MnO2, BPA transformation 
gave rise to a new peak in HPLC chromatograms with a shorter retention time of 1.7 min 
(Figure 2.8). The peak area representing the unknown transformation product increased 
concomitantly with BPA consumption. The similarity between the UV spectra of the unknown 
transformation product (λmax1 = 220 nm, λmax2 = 273) and BPA (λmax1 = 225 nm, λmax2 = 277) 
(Figure 2.9), the correlation of the area increase of the new peak with BPA decrease (Figure 
2.7), and the absence of this peak in control incubations suggested that this peak 
represented a transformation product of MnO2-mediated BPA oxidation. Throughout the 
incubation, UV spectra were recorded over a range of 220−400 nm but neither the DAD nor  
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Figure 2.7. Effect of MnO2 loading on BPA degradation (A) and conversion efficiency of BPA to HCA 
(B) in MOPS buffer (pH 7.4) initially containing 44 μM (10 mg L–1) BPA. The legend shown in panel A 
also applies to panel B. Error bars represent the standard deviation of triplicate samples. MnO2 is 
expressed as nominal concentration. Error bars smaller than the symbol size are not depicted. 
 
Figure 2.7. Effect of MnO2 loading on BPA degradation (A) and conversion efficiency of BPA to HCA 
(B) in MOPS buffer (pH 7.4) initially containing 44 μM (10 mg L–1) BPA. The legend shown in panel 
A also applies to panel B. Error bars represent the standard deviation of triplicate samples. MnO2 is 
expressed as nominal concentration. Error bars smaller than the symbol size are not depicted. 
Figure 2.8. HPLC-FLD chromatogram of 44 μM of BPA after incubation for 1 hour with 0.2 mM nominal 
concentration of MnO2 at pH 7. LU refers to luminescence units.  
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Figure 2.9. Comparison of UV spectrum of BPA and HCA (10 µM, each) at pH 7 in high purity Milli-Q 
water (Millipore Milli-Q, Bedford, MA) analyzed by a PerkinElmer Lambda 35 UV–vis 
spectrophotometer. 
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the FLD generated signals indicative for the formation of other aromatic compounds. 
 
Identification of the BPA Transformation Product. High-resolution MS analysis 
resulted in a base peak with an accurate mass of 135.08011 (Figure 2.10A). The most likely 
molecular formula containing only C, H, and O for this ion was predicted to be C9H11O+. 1H 
NMR spectra also were obtained from several samples of the transformation product, 
originally in CDCl3 and later in CD3OD, in order to determine the probable chemical 
environment of protons in the molecule (Figure 2.11A and 2.11C). In CDCl3 at 500 MHz, 
three peaks were observed: a singlet integrating for 6 H at δ 1.53, a doublet integrating for 
2 H at δ 6.80, and a doublet integrating for 2 H at δ 7.37. The two doublets were coupled 
with a J value of 8.6 Hz. The chemical shift and coupling for the doublets at δ 6.80 and δ 
7.37 are indicative of p-substituted phenol, whereas the chemical shift and integrations for 
the singlet at δ 1.53 is suggestive of a 2-substituted isopropyl moiety. These observations 
led to HCA being assigned as the tentative structure of the BPA transformation product. The 
discrepancy between the expected mass-to-charge ratio (m/z) of 153.09101 for the [M + H]+ 
ion of HCA and the observed m/z of 135.08011 suggested that the 2-position substituent 
had likely been lost during ionization, and the chemical shift of the methyl groups of the 
isopropyl moiety fell in a range that would not unambiguously report the nature of this 
functional group. The accurate mass measurement of synthetic HCA displayed an identical 
base peak (135.0801 m/z) to that of the BPA transformation product (Figure 2.10B). The 
NMR spectra of synthetic HCA and the BPA transformation product, both in CD3OD, 
revealed matching spectra (Figure 2.11B and 2.11C). Further, the BPA transformation 
product and HCA shared identical HPLC retention times and UV−Vis spectra. Agreement 
between MS data, 1H NMR data in CD3OD, retention times and UV−Vis spectra confirmed 
that HCA was the major BPA transformation product.  
 
Physicochemical Properties of HCA. Several physicochemical properties including 
octanol-water partition coefficient (Kow), aqueous solubility, and UV−Vis spectral properties 
for HCA were determined (Table 2.3, Figures 2.9 and 2.12). An HCA partition coefficient 
Log Kow of 0.76 ± 0.04 (n = 10) and an aqueous solubility of 2.65 ± 0.04 g L−1 at 25 °C (n = 
5) were measured. For BPA, the same procedures determined a Log Kow of 2.76 ± 0.08 (n 
= 10) and an aqueous solubility of 0.31 ± 0.02 g L−1 at 25 °C (n = 5), and both of these 
measurements were in the range of literature values reported for BPA (Log Kow = 2.2−3.82; 
aqueous solubility 0.12−0.3 g L−1 )2, 111-112. Compared to BPA, the Kow of HCA is at least 2  
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Figure 2.10. Electrospray ionization mass spectrum of the BPA transformation product (A) and 
synthesized authentic HCA (B). An accurate mass measurement of m/z = 135.08011 was obtained. 
 
Figure 2.10. Electrospray ionization mass spectrum of the BPA transformation product (A) and 
synthesized authentic HCA (B). An accurate mass measurement of m/z = 135.08011 was obtained. 
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Figure 2.11. 1H NMR spectrum of HCA predicted using ChemBioDraw Ultra 12.0 (A); 500 MHz 1H NMR 
spectrum of the BPA transformation product in CDCl3, δ 7.37 (d, J =8.5 Hz, 2H), 6.80 (d, J = 8.5 Hz, 
2H), 1.53 (s, 6H) (B); 500 MHz 1H NMR spectrum of synthesized authentic HCA in CD3OD, δ 7.29 (d, 
J = 8.8 Hz, 2H), 6.72 (d, J = 8.8 Hz, 2H), 1.50 (s, 6H) (C); 500 MHz 1H NMR spectrum of the BPA 
transformation product in CD3OD; δ 7.29 (d, J = 8.8 Hz, 2H), 6.72 (d, J = 8.8 Hz, 2H), 1.49 (s, 6H) (D). 
 
Figure 2.11. 1H NMR spectrum of HCA predicted using ChemBioDraw Ultra 12.0 (A); 500 MHz 1H 
NMR spectrum of the BPA transformation product in CDCl3, δ 7.37 (d, J =8.5 Hz, 2H), 6.80 (d, J = 
8.5 Hz, 2H), 1.53 (s, 6H) (B); 500 MHz 1H NMR spectrum of synthesized authentic HCA in CD3OD, 
δ 7.29 (d, J = 8.8 Hz, 2H), 6.72 (d, J = 8.8 Hz, 2H), 1.50 (s, 6H) (C); 500 MHz 1H NMR spectrum of 
the BPA transformation product in CD3OD; δ 7.29 (d, J = 8.8 Hz, 2H), 6.72 (d, J = 8.8 Hz, 2H), 1.49 
(s, 6H) (D). 
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Table 2.3. Physicochemical properties of HCA and BPA determined in this study.  
 
Table 2.3. Physicochemical properties of HCA and BPA determined in this study. Literature values 
are reported in parenthesis. Not available (NA)a. measured at 25 °Cb. HCA = 220 nm, BPA = 225 
nmc. HCA = 273 nm, BPA = 277 nmd. 
molar extinction coefficient (1/mM*cm)
λmax1
c
λmax2
d
HCA 0.76 ± 0.04 2.65 ± 0.02 7.6 2.1
(NA)a (NA) (NA) (NA)
BPA 2.76 ± 0.08 0.31 ± 0.02 16.5 3.7
(2.2-3.82) (0.12-0.3) 16 4
Compound octanol-water 
parition coefficient 
(Log Kow)
aqueous 
solubilityb (g/L)
Literature values are reported in parenthesis. Not available (NA)a. measured at 25 °Cb. HCA = 220 
nm, BPA = 225 nmc. HCA = 273 nm, BPA = 277 nmd. 
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  Figure 2.12. UV spectrum of HCA (10 μM) at different pH analyzed by a PerkinElmer Lambda 35 UV–
vis spectrophotometer. For pH < 2 and pH > 12, 0.02 M of HCl and NaOH was used, respectively, and 
for pH 5.5- 8.5, 1 mM Tris buffer was used.  
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orders of magnitude lower and the aqueous solubility about 10-fold higher, suggesting that 
HCA has increased mobility in saturated environmental systems. HCA had more than 2-fold 
lower molar extinction coefficients than BPA at each λmax (Table 2.3, Figure 2.10). The UV 
spectrum maxima obtained with HCA at circumneutral pH shifted to higher wavelengths at 
alkaline pH (>pH 12) (Figure 2.12). Under acidic conditions (pH 2), no spectral shifts were 
observed compared to pH 7 spectra; however, the absorbance at λmax1 decreased (Figure 
2.12). Comparable absorbance maxima at both λmax were observed in the pH range of 5.5 
to 8.5 (Figure 2.12). 
 
Kinetics of BPA and HCA Degradation by MnO2. When 44 μM BPA was incubated 
with 0.5 mM (nominal concentration) MnO2 at pH 7.2, 39.2 ± 0.4 μM BPA was consumed 
and 25.1 ± 0.3 μM HCA was formed in 10 min. A BPA removal rate of 0.10 ± 0.01 min−1 was 
measured with 0.2 mM MnO2, and a 10-fold higher rate of 0.96 min−1 was observed with 2 
mM MnO2. The conversion efficiency of BPA to HCA reached 64% with 0.2 mM MnO2 
(Figure 2.7). With higher MnO2 loadings (i.e., > 0.5 mM), HCA concentrations decreased 
after reaching a maximum (Figure 2.13) suggesting that HCA was also susceptible to MnO2-
mediated oxidation. 
 
 
 
 
The conversion efficiency of BPA to HCA with 0.2 mM MnO2 did not decrease over time 
(Figure 2.7), indicating that MnO2 preferentially reacted with BPA over HCA. An independent 
experiment with 44 μM HCA in MOPS buffer (pH 7.2) (no BPA present) demonstrated that 
HCA was indeed degraded by MnO2 (Figure 2.14), but the reaction rates were  
Figure 2.13. Effect of MnO2 loading (A) and pH (B) on formation of HCA in MOPS buffer (pH 7.4) initially 
containing 44 µM (10 mg L-1) BPA. Error bars represent the standard deviation of triplicate samples. 
MnO2 is expressed as nominal concentration. Error bars smaller than the symbol size are not depicted. 
 
Figure 2.13. Effect of MnO2 loading (A) and pH (B) on formation of HCA in MOPS buffer (pH 7.4) 
initially containing 44 µM (10 mg L-1) BPA. Error bars represent the standard deviation of triplicate 
samples. MnO2 is expressed as nominal concentration. Error bars smaller than the symbol size are 
not depicted. 
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Figure 2.14. Effect of MnO2 loading on HCA degradation in MOPS buffer (pH 7.4) initially containing 
44 μM HCA. Error bars represent the standard deviation of triplicate samples. MnO2 is expressed as 
nominal concentration. Error bars smaller than the symbol size are not depicted. 
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approximately 5-fold lower than those measured for BPA (Figure 2.15). During the early 
stages of the reaction (up to 10 min), the BPA and HCA concentration decreases followed 
pseudo-first order reaction kinetics, but the rates slowed down in the later stage of the 
reaction (Figure 2.16). 
 
Thus, to evaluate the reaction kinetics, the initial rate constants, kinit (min−1), were calculated 
from four early time points (i.e., < 10 min) where a linear relationship was maintained (Figure 
2.16). A linear relationship between the initial rates and the loading of MnO2 was observed 
for both BPA and HCA (Figure 2.15). Solution pH affected the BPA and HCA degradation 
reaction kinetics, and higher rate constants were observed with decreasing pH over the 
tested pH range from 4.5 to 10 (Figures 2.15 and 2.17). The solution pH did not significantly 
affect the conversion efficiency of BPA to HCA (Figure 2.17), suggesting that the pathway 
leading to the formation of HCA occurs over a broad pH range. CO2 evolution was observed 
during the incubations with BPA and HCA, suggesting that BPA and HCA were mineralized 
(Figure 2.18). When 44 μM BPA was incubated with 2 mM MnO2 at pH 2, both BPA and its 
degradation intermediate HCA were completely consumed within 10 min of incubation, and 
up to 73% (mol/mol) of the initial amount of BPA was recovered as CO2 during a 24 day 
incubation period (Figure 2.18). Under the same conditions, 44 μM HCA was consumed 
within 10 min and up to 69% of the HCA carbons were recovered as CO2 over a 24 day 
incubation period (Figure 2.18). The extent of BPA and HCA sorption onto MnO2 was 
examined. When 44 μM BPA was incubated with 0.5 mM MnO2 for 10 min at pH 7.2, 4.8 ± 
0.4 μM BPA was detected in the ascorbic acid-treated samples. However, no BPA was 
detected in the filtrates of untreated samples, indicating that all BPA had sorbed to the MnO2 
particles. Under the same reaction conditions, similar amounts of 37 ± 0.5 μM and 35 ± 0.6 
μM HCA were detected in the ascorbic acid-treated and in the filtrates of untreated samples, 
respectively (Figure 2.14), indicating that HCA had a lower sorption tendency to MnO2 than 
BPA. 
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Figure 2.15. Effect of MnO2 loading on BPA and HCA degradation rate constants (A) and effects of pH 
on BPA degradation rate constants (B). Error bars represent the standard deviation of triplicate 
samples. Error bars smaller than the symbol size are not depicted. 
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Figure 2.16. BPA (A) and HCA (B) concentrations in incubations (10 mM MOPS buffer, pH 7.4) with 
different amounts (shown are the nominal concentrations) of MnO2. 
 
Figure 2.16. BPA (A) and HCA (B) concentrations in incubations (10 mM MOPS buffer, pH 7.4) with 
different amounts (shown are the nominal concentrations) of MnO2. 
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Figure 2.17. Effect of pH on BPA degradation (A) and conversion efficiency of BPA to HCA (B) in MOPS 
buffer (pH 7.4) initially containing 44 μM (10 mg L–1) BPA. The legend shown in panel A also applies to 
panel B. Error bars represent the standard deviation of triplicate samples. Error bars smaller than the 
symbol size are not depicted. 
 
Figure 2.17. Effect of pH on BPA degradation (A) and conversion efficiency of BPA to HCA (B) in 
MOPS buffer (pH 7.4) initially containing 44 μM (10 mg L–1) BPA. The legend shown in panel A also 
applies to panel B. Error bars represent the standard deviation of triplicate samples. Error bars 
smaller than the symbol size are not depicted. 
Figure 2.18. Percent mineralization of BPA and HCA in phosphate buffer (pH 2) initially containing 4.4 
μmol BPA and HCA, respectively. Inset: the release of CO2 from BPA and HCA over time. 
 
Figure 2.18. Percent mineralization of BPA and HCA in phosphate buffer (pH 2) initially containing 
4.4 μmol BPA and HCA, respectively. Inset: the release of CO2 from BPA and HCA over time. 
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Biodegradation of HCA. Aqueous phase HCA concentration profiles in microcosms 
established with Third Creek sediment demonstrated that sorption of HCA was not 
significant after several days of incubation (Figure 2.19). In contrast, 50% of BPA 
instantaneously sorbed to the same sediment material65. In oxic microcosms established 
with sediment materials from four distinct locations, HCA was completely removed within 3 
weeks of incubation at slightly different rates depending on the origin of the sediment 
(Figure 2.20). No degradation products were observed suggesting that mineralization 
occurred. Repeated transfers from oxic Third Creek microcosms to fresh medium yielded a 
sediment-free, HCA-degrading enrichment culture. In the presence of oxygen, this mixed 
culture consumed HCA with a concomitant increase in optical density at 600 nm indicating 
microbial growth (data not shown). In anoxic incubations, nitrate, sulfate, ferric iron, and CO2 
reduction occurred as evidenced by electron acceptor depletion and/or reduced product 
formation. Although active nitratereducing, sulfidogenic, ferric iron-reducing, and 
methanogenic conditions established in the microcosms, no HCA disappearance was 
observed over a 5 month incubation period (Figure 2.19). Similar results were obtained with 
microcosms established with Shady Valley and Axton Cross sediment materials, and Third 
Creek sediment collected from an upstream location (data not shown). 
 
 
 
 
 
 
Figure 2.19. Concentration profiles of HCA in microcosms established with Third Creek sediment. HCA 
concentration profiles of microcosms incubated under sulfidogenic, Fe(III)-reducing, and methanogenic 
conditions were similar to those incubated under nitrate-reducing conditions (data not shown for clarity). 
The error bars represent the range of duplicate samples. Error bars smaller than the symbol size are 
not depicted. 
 
Figure 2.19. Concentration profiles of HCA in microcosms established with Third Creek sediment. 
HCA concentration profiles of microcosms incubated under sulfidogenic, Fe(III)-reducing, and 
methanogenic conditions were similar to those incubated under nitrate-reducing conditions (data not 
shown for clarity). The error bars represent the range of duplicate samples. Error bars smaller than 
the symbol size are not depicted. 
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Figure 2.20. Concentration profiles of HCA in microcosms incubated under oxic conditions 
using sediment materials obtained from two Third Creek (TC) locations, and the Axton Cross 
(AC) and the Shady Valley (SV) sampling sites. The error bars represent the range of duplicate 
samples. No significant HCA decrease was observed in microcosms incubated under nitrate-
reducing, sulfidogenic, Fe(III)-reducing, and methanogenic conditions compared to negative 
control incubations (see Figure 2.19). 
 
Figure 2.20. Concentration profiles of HCA in microcosms incubated under oxic conditions 
using sediment materials obtained from two Third Creek (TC) locations, and the Axton Cross 
(AC) and the Shady Valley (SV) sampling sites. The error bars represent the range of 
duplicate samples. No significant HCA decrease was observed in microcosms incubated 
under nitrate-reducing, sulfidogenic, Fe(III)-reducing, and methanogenic conditions 
compared to negative control incubations (see Figure 2.19). 
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Discussion. Manganese oxides are strong, naturally occurring oxidants, and play relevant 
roles in the biogeochemical cycling of carbon and other elements. Abiotic and microbial 
processes have been implicated in the formation of manganese oxides; however, the full 
range of pathways and mechanisms is not understood113. Mn(II) ions can be abiotically 
oxidized in aqueous solution via mineral surface-catalyzed oxidation, but microbial oxidation 
of Mn(II) to Mn(III/IV) is likely a major process leading to the formation of manganese 
oxides75. The average total manganese amount was reported to range between 40 and 900 
mg kg−1 in U.S. soils114. Manganese oxides are also abundant in marine and freshwater 
sediments, for example, 25−185 μmol mL−1 of MnO2 have been detected in marine 
sediments, and 300− 4000 μmol mL−1 of MnO2 have been observed in freshwater 
sediments79, 81-82. Our experiments used nominal MnO2 concentrations of 0.2 to 2 μmol mL−1, 
which is in the range of MnO2 amounts observed in natural soils and sediments. Thus, the 
abiotic transformation of BPA by MnO2 leading to HCA formation could be an 
environmentally relevant pathway for BPA attenuation. 
 
The particle size or surface area of metal oxides is known to affect the reactivity, and smaller 
particle size generally more reactive resulting in higher rates. The average surface area of 
MnO2 prepared with conventional preparative methods has been reported to range from 128 
to 270 m2 g−1, which is in the range of naturally occurring MnO292, 115-116. Our experiments 
used slightly finer MnO2 particles with an average surface area of 529 ± 14 m2 g−1 , and it is 
likely that nanoparticulate MnO2 (i.e., smaller particles) will result in higher rates. 
 
Oxidative transformation of BPA by MnO2 has been demonstrated previously using synthetic 
MnO2 and MnO2-coated sand85-86, 117. In a previous study, 11 reaction intermediates were 
proposed, including HCA, but a mass balance approach was not applied and no quantitative 
assessment was provided. In our experiments, up to 64% (mol/mol) of BPA was recovered 
as HCA, suggesting that HCA was the major reaction intermediate over a broad pH range86. 
HCA has an over 2-fold lower molar extinction coefficient than BPA at each λmax (Figure 
2.8), and HCA may have been overlooked due to the low response to UV light and 
associated high detection limits with the UV detector. Compared with UV detection, an 
approximately 10-fold higher response was obtained with the fluorescence detector, which 
enabled HCA detection and quantification. Further, HCA may have evaded detection in 
previous studies that used high MnO2:BPA ratios because HCA is also susceptible to 
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degradation by MnO2 resulting in merely transient formation of low amounts of HCA (Figure 
2.14). 
 
The identification of HCA as the major BPA transformation product was not straightforward. 
One of the obstacles was a m/z difference of 18.01057 between the observed mass of 
135.08011 and the mass of HCA (153.09068). It is not uncommon for molecules to lose 
water during electrospray ionization, and the discrepancy accounts for the fragmentation of 
the C−OH bond at the benzylic position generating a tertiary, resonance stabilized 
carbocation with a m/z of 135.08011. It should also be noted that samples of the BPA 
transformation product possessed minimal impurities (Figure 2.11A and 2.11C), suggesting 
that other minor transformation products were formed. 
 
HCA was proposed as a hypothetical BPA degradation intermediate during aerobic 
degradation by Sphingomonas sp. strain TTNP3 and by Cupriavidus basilensis strain JF160, 
62. Kolvenbach et al. speculated that a P450-type enzyme system could be involved in the 
degradation process. HCA was detected as an intermediate in mammalian metabolism of 
BPA, and microsomal cytochrome P450 catalyzed BPA transformation to HCA via ipso 
substitution90. Hydroquinone was formed in addition to HCA in these microsomal 
cytochrome P450 assays, suggesting the other phenol ring yielded hydroquinone. However, 
we were unable to detect this compound in any of the incubations suggesting the MnO2-
mediated BPA transformation does not follow the microsomal cytochrome P450-catalyzed 
reaction pathway. An additional experiment demonstrated that MnO2 was less reactive 
toward hydroquinone than toward HCA (data not shown), suggesting that hydroquinone was 
not a reaction intermediate. A previous study identified reaction intermediates including HCA 
in BPA incubations with MnO266, 86. For example, 4-(2-(4-(4- 
hydroxyphenoxy)phenyl)propan-2-yl)phenol was detected and proposed to contain the 
remaining phenolic moiety of BPA86. However, HCA was the only major BPA transformation 
product in incubations with MnO2 and no other aromatic compounds were observed in DAD 
3-D scans (220−400 nm). These observations suggest that the missing C6 moiety 
intermediate is susceptible to rapid reaction with MnO2, thereby evading detection, or is an 
aliphatic compound. 
 
Based on the percent mineralization of BPA and HCA, Figure 2.21 schematically depicts 
the carbon flux during MnO2-mediated degradation of BPA. BPA (C15H16O2) is converted to 
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HCA (C9H12O2) and an unidentified, presumably aliphatic C6 compound(s). HCA contains 
60% of the BPA carbons and the data depicted in Figure 2.18 indicate that 69% of the HCA 
carbons were recovered as CO2, indicating that 41% (60% × 69%) of the BPA carbons were 
mineralized via HCA as an intermediate. As shown in Figure 2.18, a total of 73% of the BPA 
carbons were recovered as CO2. Thus, the remaining 32% of BPA carbon atoms recovered 
as CO2 could be attributed to the mineralization of the unidentified C6 compound(s). MnO2-
mediated ring cleavage and mineralization have been previously reported for compounds 
such as 2-mercaptobenzothiazole and sulfadiazine118-119. 
 
The results depicted in Figure 2.7 demonstrate that complete BPA oxidation was achieved 
with ≥0.5 mM (nominal concentration) MnO2, suggesting that most of the experiments in this 
study were performed with excess amounts of MnO2. Independent of the amount of MnO2 
added, the initial (i.e., up to 10 min) BPA and HCA transformation rates were high but then 
declined and deviated from the pseudo-first-order kinetics (Figure 2.9). Such MnO2-
mediated reaction patterns have been observed with other organic compounds, and this 
reaction pattern has been attributed to the blockage of MnO2 surface area by reactants and 
reaction products over time89, 92-93, 116, 120. 
 
A linear decrease of logkinit, BPA was observed with increasing pH (Figure 1.19), similar to 
what has been described for the MnO2-mediated oxidation of triclosan, oxytetracycline, and 
4-chloroaniline92, 120. This pH dependence has been explained by the effect of pH on the 
sorption of organic compounds to metal oxide surfaces (i.e., precursor complex formation) 
and/or the redox potential of the reactants89, 92, 116, 120. Most metal oxide surfaces carry 
negative charges over a wide pH range and the protonated forms of phenolic organic 
compounds are more susceptible to complex with MnO2. The first and second acid 
dissociation constants (pka1, pka2) of BPA are 9.6 and 10.2,1 suggesting that the effect of 
deprotonation of BPA was negligible over the pH range tested (Figure 2.18). Meanwhile, 
lower pH increases the reduction potential of MnO2; for example, the reduction potential of 
MnO2 increases from 0.76 to 0.99 V when the pH decreases from 8 to 4.51 According to 
MnO2(s) + 4H+ + 2e− → Mn2+(aq) + 2H2O, 50 protons are required for the reduction of MnO2 
to Mn(II), which may explain why BPA degradation rates increased with decreasing pH. 
 
The daughter products generated from contaminant transformation may still have potential 
to adversely impact ecosystem and human health. Some BPA transformation products have 
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been reported to have increased estrogenic activity relative to the parent compound90, 121-
122. For example, the in vitro estrogen receptor binding assay suggested that HCA has 100-
fold higher binding affinity to the estrogen receptor than BPA90. Therefore, understanding 
the fate of HCA is relevant for predicting environmental concerns associated with BPA. 
Although HCA was further degraded by MnO2, the degradation rate constants of HCA were 
5-fold lower than those of BPA suggesting that BPA can be a source of HCA. The lower 
MnO2 reaction rates with HCA compared to BPA may be a consequence of differential 
adsorption to the MnO2 surface, and the higher affinity of BPA resulting in preferential 
degradation (Figure 2.7, Figure 2.13). We determined that HCA has higher aqueous 
solubility and a lower Kow than BPA, suggesting that HCA has a lower tendency for sorption 
(Table 2.3, Figure 2.19) and is potentially more mobile than BPA. The microcosms study 
suggested that rapid microbial HCA degradation under anoxic conditions cannot be 
expected; however, HCA was readily metabolized in the presence of oxygen in microcosms 
established with four different sediment materials, suggesting that aerobic HCA degraders 
may be common members of freshwater sediment microbial communities. Environmental 
Implications. 
 
Environmental Implications. BPA is recalcitrant to microbial degradation under anoxic 
conditions, and its high partition coefficient (Kow) indicates that BPA is relatively immobile in 
sediments and soils2, 65-67, 101, 123. Not surprisingly, up to 343 μg/kg of BPA has been detected 
in anoxic sediments53, 55. Given the prevalence of MnO2 in soils and sediments, MnO2-
mediated BPA oxidation leading to HCA formation and mineralization could be an 
environmentally relevant process. HCA is more mobile than BPA suggesting that MnO2-
mediated BPA oxidation could lead to faster environmental distribution. However, with 
enhanced mobility, HCA is more likely to encounter oxic environments where it is susceptible 
to microbial degradation. We suggest that such coupled abiotic−biotic processes may be 
relevant for controlling the fate and longevity of BPA in sediments and aquifers. 
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CHAPTER III. PHAEOBACTER SP. STRAIN Y4I UTILIZES TWO 
SEPARATE CELL-TO-CELL COMMUNICATION SYSTEMS TO 
REGULATE PRODUCTION OF THE ANTIMICROBIAL INDIGOIDINE 
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The work outlined in this chapter was originally published by 1Nathan W. Cude, Carson W. 
Prevatte, 1Mary K. Hadden, Amanda L. May, Russell T. Smith, Caleb L. Swain, Shawn R. 
Campagna, and 1Alison Buchan. NWC, under the supervision of AB, is the primary author 
in terms of the introduction, biological experimentation methods, results, and conclusions. 
CWP, along with other members of the Campagna laboratory and combined research team, 
authored sections of the original manuscript containing chemical data and 
methods contributions. The content of this article has been kept as originally submitted with 
modifications to the format only. 
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WNC and AB conceived the study. WNC and CWP performed the majority of the 
experimental work. WNC was assisted by MKH, and CWP was assisted by RTS and CLS. 
WNC and MKH will be referred to as the Buchan lab. Growing Phaeobacter sp. strain Y4I 
cultures was performed by the Buchan lab. Culture extraction and processing was 
performed by WNC and CWP. CWP performed the identification and quantitation of the 
AHLs using isotope dilution high-performance liquid chromatography-tandem mass 
spectrometry (ID-HPLC-MS/MS). CWP also synthesized the dideuterated (D2) N-acyl 
homoserine lactones (AHLs) used as internal standards. WNC conducted the attached-
biomass and motility assays and AHL and indigoidine quantification. WNC and CWP 
generated and analyzed the data for their respective experimental contributions. WNC, 
ALM, SRC, and AB contributed to the discussion.  
 
CWP contribution  
 
This chapter is the first of two chapters involving similar contributions by CWP, in which 
dideuterated (D2) N-acylhomoserine lactones (AHLs) are synthesized to facilitate 
quantitation or annotation using isotope dilution high-performance liquid chromatography-
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tandem mass spectrometry (ID-HPLC-MS/MS) of these bacterial cell-to-cell signaling 
molecules to correlate AHL production to bacterial phenotype, community behavior, and 
exclusive to this chapter, expression of the genes responsible regulation of AHL synthesis. 
This study was an extension of previous work by the Buchan lab which had reported that 
marine roseobacter Phaeobacter sp. strain Y4I possessed two luxRI homologues 
responsible for regulating the production of AHLs that was shown to likely contribute to the 
regulation of the blue antimicrobial secondary metabolite indigoidine, motility, and biofilm 
density. CWP performed an initial identification of the AHLs Y4I produced. A standard 
mixture of (D2)AHLs was added to extracts of liquid cultures from early log and stationary 
phase to measure retention time match the AHL gene products of the two luxRI homologues. 
(D2)AHLs containing acyl chains that were 4 to 20 carbons in length and included masses 
for acyl chains with either hydroxy or keto modifications at position 3. Two AHLs were initially 
identified as C8-HSL and N-(3-oxododecenoyl)-homoserine lactone (3OC12-HSL). The 
confirmation of C8-HSL was easily accomplished by comparison to the (D2)C8-HSL internal 
standard present in the standard mixture (Figure 3.1A). The standard mixture possessed 
(D2)C4-HSL, (D2)3OHC4-HSL, (D2)C6-HSL, (D2)C3OC6-HSL, (D2)C7-HSL, (D2)C8-HSL, 
(D2)C12-HSL, and (D2)C14-HSL. Since a deuterated standard for 3OC12-HSL was not present 
in the standard mixture, the tentative assignment was made based on the ionized parent 
mass of 298 m/z = 298, the retention time of 5.80-6.20 min, and a knowledge of the 
commonly occurring sidechains. Synthesis of 3OC12-HSL was accomplished and 
comparison of the retention times between the standard and naturally occurring AHL 
revealed a marginal but significant difference between the two (Figure 4.1C). Ultimately, an 
accurate mass measurement using an Orbitrap mass analyzer, knowledge of the impact of 
structure on retention time, and direct injection of (D2)3OHC12:1-HSL internal standard, 
verified the final structural assignment as 3OHC12:1-HSL (Figures 4.1D-4.1F). Though the 
location and chirality of the double bond could not be determined by these analyses, 
3OHC12:1-HSL with one unit of unsaturation at any position of the sidechain represents a 
previously unreported AHL. A simple synthesis was also developed to access this previously 
unreported AHL. The identification and synthesis of deuterated internal standards by CWP 
made quantitation of the AHLs produced by Y4I possible. This was a significant contribution 
to the final experiment in which Y4I was grown on agar plates over a 48 h time period 
quantitating AHL concentration, AHL and indigoidine gene production, and indigoidine 
concentration. CWP developed the AHL extraction and processing method that allowed 
AHLs to be extracted from the agar plates with high efficiency. Ultimately, quantitation at the 
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levels of transcription, cell-to-cell chemical signaling, and phenotype over the 48 h time 
period, along with previous gene knock-out data, was used to describe the interplay among 
pgaRI and phaRI, responsible for synthesis and regulation of C8-HSL and 3OHC12:1-HSL 
respectively, local AHL concentration, indigoidine biosynthesis, and growth-phase-
dependent motility and biofilm size.  
 
3.1 Abstract  
 
The marine roseobacter Phaeobacter sp. strain Y4I synthesizes the blue antimicrobial 
secondary metabolite indigoidine when grown in a biofilm or on agar plates. Prior studies 
suggested that indigoidine production may be, in part, regulated by cell-to-cell 
communication systems. Phaeobacter sp. strain Y4I possesses two 
luxR and luxI homologous N-acyl-L-homoserine lactone (AHL)-mediated cell-to-cell 
communication systems, designated pgaRI and phaRI. We show here that Y4I produces 
two dominant AHLs, the novel monounsaturated N-(3-hydroxydodecenoyl)-L-homoserine 
lactone (3OHC12:1-HSL) and the relatively common N-octanoyl-L-homoserine lactone (C8-
HSL), and provide evidence that they are synthesized by phaI and pgaI, respectively. A 
Tn5 insertional mutation in either genetic locus results in the abolishment (pgaR::Tn5) or 
reduction (phaR::Tn5) of pigment production. Motility defects and denser biofilms were also 
observed in these mutant backgrounds, suggesting an overlap in the functional roles of 
these systems. Production of the AHLs occurs at distinct points during growth on an agar 
surface and was determined by isotope dilution high-performance liquid chromatography–
tandem mass spectrometry (ID-HPLC-MS/MS) analysis. Within 2 h of surface inoculation, 
only 3OHC12:1-HSL was detected in agar extracts. As surface-attached cells became 
established (at ∼10 h), the concentration of 3OHC12:1-HSL decreased, and the concentration 
of C8-HSL increased rapidly over 14 h. After longer (>24-h) establishment periods, the 
concentrations of the two AHLs increased to and stabilized at ∼15 nM and ∼600 nM for 
3OHC12:1-HSL and C8-HSL, respectively. In contrast, the total amount of indigoidine 
increased steadily from undetectable to 642 μM by 48 h. Gene expression profiles of the 
AHL and indigoidine synthases (pgaI, phaI, and igiD) were consistent with their metabolite 
profiles. These data provide evidence that pgaRI and phaRI play overlapping roles in the 
regulation of indigoidine biosynthesis, and it is postulated that this allows Phaeobacter sp. 
strain Y4I to coordinate production of indigoidine with different growth-phase-dependent 
physiologies. 
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3.2 Introduction  
 
Bacteria are in constant competition for niches in the environment, and the ability to 
coordinate gene expression may provide a competitive advantage124. Some bacteria are 
able to synchronize gene expression in a cell-density-dependent manner by sensing and 
responding to small diffusible molecules synthesized by individuals; in proteobacteria, 
members of the broadly distributed and chemically diverse class of N-acyl-L-homoserine 
lactones (AHLs) are among the best-characterized signaling molecules3. Proteobacterial 
AHL synthases are fairly well conserved and form the LuxI protein family. Members of the 
LuxR protein family are cytoplasmic transcriptional regulators that can modulate gene 
expression, most typically when bound to the corresponding cognate AHL125-130. It has been 
shown that luxI-luxR (luxIR) pairs are frequently colocalized within chromosomes and 
constitutively expressed at low concentrations when bacterial densities are low126, 129. Thus, 
bacteria possessing luxIR homologs produce and release AHLs into the external 
environment129. At high cell densities, AHL concentrations can reach a threshold 
concentration, bind to the corresponding cognate cytoplasmic LuxR proteins, and affect 
transcription of various genetic loci130-133. AHLs have also been shown to activate regulators 
other than the corresponding cognate LuxR, suggesting that cross talk may play an 
important role in intra- and interspecies interactions134-139. Furthermore, AHL concentrations 
have been shown to change throughout the growth cycle of some bacteria, suggesting that 
the type and concentration of an AHLs may also convey information about the metabolic 
state of the population140-141. Examples of physiologies mediated by AHLs include biofilm 
formation, suppression of immune responses during infection, exoenzyme production, 
swarming motility, colonization of host by a symbiont, and antimicrobial production131, 142-144. 
Roseobacters are a biogeochemically active group of marine alphaproteobacteria, within 
the Rhodobacteraceae family, that are prevalent in the coastal ocean145-148. 
The Roseobacter clade currently contains more than 50 described genera149, 
including Phaeobacter, Sulfitobacter, and Ruegeria. The prevalence of luxRI homologs 
in Roseobacter genomes suggests that AHL-based cell-to-cell communication is a core trait 
of this successful lineage of aquatic bacteria150-151. Representative members of the 
Roseobacter clade have been shown to produce multiple AHLs, and these compounds have 
been linked to biofilm formation, motility, and antimicrobial production in a limited number of 
strains152-158. Relatively few Roseobacter AHLs have been linked to the LuxI homologs that 
mediate their syntheses, and many Roseobacters possess multiple luxRI systems, 
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suggesting the presence of complex AHL-mediated regulatory schemes in these strains that 
have not been explored153. Furthermore, the presence of non-AHL quorum sensing systems 
has been characterized within other Roseobacter strains, including Ruegeria sp. strain 
TM1040, which uses at least two different chemical signals to regulate the physiologies 
associated with its symbiosis with an algal host159-160. 
 
Roseobacter representative strain Y4I produces the blue antimicrobial secondary 
metabolite indigoidine, which suppresses the growth of other marine bacteria. 16S rRNA 
gene analysis places strain Y4I within the Phaeobacter genus; however, the researchers 
who published a recent genome-scale study161 suggested that a formal reclassification of 
this genus may be forthcoming. We have previously demonstrated that indigoidine 
production is an exclusively surface-attached phenotype in Y4I and that its production allows 
this strain to outcompete Vibrio fischeri for surface niches in coculture150. In addition, the Y4I 
genome carries two luxRI systems, and transposon insertional mutations in either of those 
loci alter indigoidine production and, subsequently, the ability of Y4I to inhibit V. fischeri150, 
153. In this study, we sought to identify the dominant AHLs produced by Phaeobacter sp. 
strain Y4I, determine the genes mediating their synthesis, and examine the contribution of 
the two luxRI systems to the regulation of indigoidine biosynthesis during surface-attached 
growth. 
 
3.3 Materials and methods 
 
Growth conditions, strains, and media. The following culture conditions were used, 
unless otherwise noted: Phaeobacter sp. strain Y4I and Tn5 derivatives were maintained 
in YTSS broth (per liter, 2.5 g yeast extract, 4 g tryptone, 15 g Sea Salts [Sigma-Aldrich, 
St. Louis, MO]) at 30°C, with shaking (200 rpm). YTSS agar (1.5%) plates were used for 
streaking and isolation and were also incubated at 30°C. Y4I transposon Tn5 insertional 
mutants were isolated from a previously generated transposon mutant library and 
maintained with 50 μg/ml kanamycin150. Kanamycin was not, however, included in the 
assays described below. 
 
AHL identification and deuterated (D2) AHL synthesis. Triplicate Y4I cultures were 
grown in 200 ml of YTSS broth and analyzed at 5 h (early log phase) and 24 h (stationary 
phase) following inoculation. At the end of the incubation period, the entire culture was 
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pelleted by centrifugation at 3,700 × g for 20 min at 4°C using a Sorvall Legend RT 
centrifuge (Thermo Fisher, Waltham, MA). The supernatant was filtered through a 47-mm-
diameter 0.45-μm-pore-size nylon filter (GE Osmonics, Feasterville Trevose, PA). The 
filtrate was extracted twice with 150 ml of 1% (vol/vol) acetic acid–ethyl acetate (EtOAc). 
The organic layer was collected and concentrated in vacuo to give an off-white solid, 
which was reconstituted with 300 μl EtOAc and transferred to an autosampler vial. 
 
AHL identification was accomplished using a previously developed high-performance 
liquid chromatography–tandem mass spectrometry (HPLC-MS/MS) method162. Briefly, 10 
μl of the concentrated extract was injected onto a reverse-phase C18 core-shell column 
(Phenomenex Kinetex, Torrance, CA) (2.6-μm pore size, 100-Å particle size, 100 by 2.1 
mm) by the use of a Surveyor Autosampler Plus autosampler (Thermo Electron, Waltham, 
MA) at 25°C. LC was performed with an electron surveyor MS pump at a flow rate of 200 
μl/min, and the effluent was introduced into a TSQ Quantum Discovery Max triple-
quadrupole mass spectrometer (MS) for ion detection (Thermo Electron, Waltham, MA) 
via electrospray ionization (ESI) with a spray voltage of 4,500 V. Samples were analyzed 
by the use of selected-reaction monitoring (SRM) with a scan time of 0.05 s and a scan 
width of 0.1 m/z. Detection was done in positive-ion mode with nitrogen as a sheath gas 
and argon as the collision gas. AHLs were identified using the chromatographic retention 
time as well as the characteristic parent m/z-fragment m/z pair. The screened parent 
masses corresponded to AHLs containing acyl chains that were 4 to 20 carbons in length 
and also included masses for acyl chains with either hydroxy or keto modifications at 
position 3. Fragment masses of 102 and 104 m/z were used, which corresponded to the 
conserved HSL core in the naturally occurring and deuterated AHLs, respectively. 
Detection was done in positive-ion mode with nitrogen as the sheath gas and argon as 
the collision gas. 
 
Accurate mass measurements were performed on an Exactive Plus Orbitrap MS (Thermo 
Fisher Scientific, Waltham, MA) via ESI with a spray voltage of 4,000 V. For these 
measurements, 300 μl of Y4I culture–YTSS taken 4 h after inoculation was direct injected 
using a Hamiltonian 250-μl syringe (Hamiltonian Company, Reno, NV) at a flow rate of 20 
μl/min. Detection was done in positive-ion mode with nitrogen as the sheath gas. 
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The deuterated AHL standards N-octanoyl-homoserine lactone [(D2)C8-HSL] and N-(3-
hydroxy-6E-dodecenoyl)-homoserine lactone [(D2)3OHC12:1-HSL] were synthesized for 
quantitation of AHLs as previously reported162-163. Following accurate identification of the 
AHLs in question, subsequent experiments were performed with a TSQ Quantum 
Discovery Max triple-quadrupole MS as it provided more-accurate quantitation. 
 
Attached-biomass and motility assays. Attached biomass was quantified for wild-type 
Y4I and for the pgaR::Tn5 and phaR::Tn5 strains using a crystal violet assay164. Briefly, 
each culture was diluted to 106CFU/ml and 100-μl aliquots were transferred to a 96-well 
polypropylene plate (Costar; Corning Incorporated, Corning, NY) in octuplet. The plates 
are incubated at 27°C for 18 h. A total of 25 μl of crystal violet was added to each well and 
left at room temperature for 15 min. The wells were rinsed three times with deionized 
water, and the crystal violet was solubilized in 95% ethanol for 1 h. Absorbance readings 
were measured using a plate reader (BioTek, Winooski, VT) at 600 nm. 
 
Motility was assessed using semisolid (0.35%) 1/10 YTSS agar plates (per liter, 0.25 g 
yeast extract, 0.4 g tryptone, 15 g Sea Salts, and 3.5 g agar). A 20-μl volume of stationary-
phase liquid cultures was spotted to the center of a motility agar plate in triplicate. The 
plates were incubated at 30°C for 48 h, after which the diameter of the swim circle was 
measured. 
 
AHL and indigoidine quantification. A 47-mm-diameter 0.45-μm-pore-size nylon filter 
(GE Osmonics, Feasterville Trevose, PA) was placed onto 60-mm-diameter petri dishes 
containing 10 ml of YTSS agar medium. A 100-μl volume of early-stationary-phase wild-
type Y4I culture (∼108 CFU/ml) was inoculated on the membrane, and the plates were 
incubated at 30°C. Plates were harvested in sextuplet 13 times over 48 h of growth. For 
each set of six plates, three filters were removed and placed in 4-ml cryovials and flash 
frozen in liquid nitrogen for reverse transcription-quantitative PCR (RT-qPCR) analysis. 
Indigoidine concentrations were determined for the remaining three filters by first placing 
them in 10 ml of dimethyl sulfoxide (DMSO) and then incubating in the dark with frequent 
vortex mixing until the indigoidine was solubilized. The tubes were centrifuged at 6,000 
× g for 5 min. A 1-ml volume of the supernatant was removed, and the absorbance was 
measured at 612 nm. Indigoidine quantitation was achieved with a calibration curve 
determined using extracted indigoidine derived from 20 lawns of a hyperpigmented Y4I 
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mutant on YTSS agar plates as previously described150. The mass of the extracted 
indigoidine was recorded, and the indigoidine was solubilized in 1 ml of DMSO. Quarter-
log dilutions were performed, and the absorbance at 612 nm was plotted to generate a 
calibration curve. 
 
After the filters were removed, an internal standard was added to the cell-free agar plates 
via addition of 90 μl of a solution containing 3.30 μM (D2)C8-HSL and 0.299 μM 
(D2)3OHC12:1-HSL and was allowed to diffuse into the plate. The 10-ml volume of agar 
was minced and transferred to a 250-ml Erlenmeyer flask. AHL extraction from the agar 
was performed by addition of 100 ml of EtOAc followed by stirring for 3 h. Afterward, the 
EtOAc was decanted and concentrated in vacuo to give an off-white solid, which was 
reconstituted with 300 μl EtOAc and transferred to an autosampler vial for analysis via 
isotope dilution high-performance liquid chromatography–tandem mass spectrometry (ID-
HPLC-MS/MS). AHL concentrations in the plate were calculated using the previously 
described ID-HPLC-MS/MS methodology162. Briefly, the concentrations of the 
endogenous AHLs were determined by integrating the area under the peak and comparing 
it to the stable isotope-labeled internal standards using the following formula: [area of 
endogenous AHL/area of (D2)AHL] × [final concentration of (D2)AHL in the plate]. As the 
cells were physically separated from the agar surface by a nylon filter, the AHLs measured 
are only those that diffused across the membrane into the agar. As the rate of diffusion for 
these AHLs in agar is unknown, the measured concentrations could be lower than those 
in the bacterial biomass. It should be noted, however, that the rate of diffusion of many 
nutrients in agar has been reported to be relatively high165-166. 
 
RT-qPCR for igiD, phaI, and pgaI expression. igiD, phaI, and pgaI gene expression 
was analyzed for the wild-type cells grown on nylon filters on agar plates in the time course 
described above and for the phaR::Tn5 and pgaR::Tn5 strains on agar plates with nylon 
filters at 24 h. Primers were designed to amplify products ranging in size between 160 and 
240 bp of three reference genes (alaS, map, and rpoC) as well as of the igiD gene 
encoding the indigoidine nonribosomal peptide synthetase (NRPS)150, a 216-bp portion of 
phaI (forward, 5′-CAGCCTTGGCGCCTCGGAAA-3′; reverse, 5′-
TGCAGCGGAGCGAATTGCGA-3′), and a 155-bp portion of pgaI (forward, 5′-
GGCGGCTCCATGCGGTTTCT-3′; reverse, 5′-CCTGCTGCGATCCTGCCCTG-3′). 
Frozen filters were thawed in the cryovials, and 640 μl of 200 μM zirconium grinding beads 
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(OPS Diagnostics, Lebanon, NJ) was added with 1.5 ml of 1:100 β-mercaptoethanol–
buffer RLT (Qiagen, Germantown, MD). The vial was subjected to vortex mixing for 10 
min at 13,000 × g and incubated for 5 min at 70°C. After a brief centrifugation, 700 μl of 
the liquid phase was transferred to a microcentrifuge tube. A 700-μl volume of 100% 
ethanol was added, and the lysate was transferred to an RNeasy Mini spin column. RNA 
was isolated per the RNeasy minikit protocol (Qiagen, Germantown, MD). All time points 
were relativized to the initial time point, ∼15 min after plating of the liquid culture, and data 
were normalized to the reference gene data. In all cases, RT-qPCR data analysis and the 
normalized relative transcript quantity were calculated using the qBASE method167 (45). 
 
Statistical analysis. Analysis of variance (ANOVA) mean separations were done using 
the Holm-Sidak method in SigmaPlot 11.0 (Systat Software, Inc., Chicago, IL). 
 
3.4 Results  
 
Phaeobacter sp. strain Y4I produces two dominant AHLs. Isotope dilution high-
performance liquid chromatography-tandem mass spectrometry (ID-HPLC-MS/MS) was 
used to characterize the AHLs produced by Phaeobacter sp. strain Y4I. Two AHLs were 
consistently recovered from broth cultures with ionized parent masses of 228 m/z and 
298 m/z and retention times of 5.80 to 6.00 min and 5.80 to 6.20 min, respectively. Given 
these characteristics, the AHLs were initially predicted to be C8-HSL and N-(3-oxo-
dodecenoyl)-homoserine lactone (3OC12-HSL). The C8-HSL structure was verified by 
comparison to a (D2)C8-HSL internal standard (Figure 1A and B). Comparisons of the 
retention times of the 298 m/z endogenous AHL to an added 3OC12-HSL standard, 
however, revealed a marginal but significant difference between the two (Figure 1C). As 
the mass accuracy of the triple-quadrupole instrument alone was not sufficient to fully 
confirm a molecular formula(e) or differentiate 3O C12-HSL from other isobaric candidate 
structures, such as C13-HSL, a high-resolution, accurate mass measurement was 
obtained using electrospray ionization and an Orbitrap mass analyzer. This analysis 
revealed a value of m/z of 298.20129. The two most likely molecular formulae for the AHLs 
based on the low-resolution mass data were C16H28NO4, which corresponds to either 
3OC12-HSL or 3OHC12:1-HSL, and C17H23NO3, which corresponds to C13-HSL. These 
formulae have calculated m/z values of 298.20128 (3OC12-HSL or 3OHC12:1-HSL) and 
298.23822 (C13-HSL), resulting in mass errors of 0.034 ppm and 123.827 ppm for the two  
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Figure 3.1. ID-HPLC-MS/MS of extracts from Phaeobacter sp. strain Y4I grown in YTSS for 4 to 5 h 
with added standards to identify and confirm AHL identities. (A) Extracted ion chromatogram (EIC) for 
C8-HSL with a parent m/z of 228 and fragment m/z of 102. (B) EIC for the deuterated C8-HSL internal 
standard with a parent m/z of 230 and fragment m/z of 104. (C) EIC for the parent-fragment pair of 
298 m/z to 102 m/z with an added 3OC12-HSL standard. (D) EIC for the deuterated 3OHC12-HSL 
internal standard with a parent m/z of 300 and fragment m/z of 104. The retention times for the 
endogenous 3OHC12:1-HSL and the added (D2)3OHC12:1-HSL were identical, indicating that this is the 
most probable structure for the unknown AHL. (E) EIC for 3OHC12:1-HSL with a parent m/z of 298 and 
fragment m/z of 102. (F) EIC for the deuterated 3OHC12:1-HSL internal standard with a parent m/z of 
300 and fragment m/z of 104. The peak at 1.99 min represents a medium component that is typical of 
samples. The chemical structure for each AHL is shown next to its chromatogram. The location of the 
double bond in 3OHC12:1-HSL cannot be determined by this analysis, and its position in the structure is 
based on that of a structurally similar AHL found in a Rhizobium species. 
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candidates, respectively. Following these results, the 3OHC12:1-HSL isomer was 
predicted as it had a chemical formula consistent within the 5-ppm mass accuracy of the 
Orbitrap MS, and this structure was verified by direct comparison to a (D2)3OHC12:1-HSL 
internal standard (Figure 1D to F). The location of the double bond and the chirality of the 
3OHC12:1-HSL could not be determined by these analyses. The position and chirality 
depicted in the structure is based on that of a structurally similar AHL found in 
a Rhizobium species168. The concentrations of these AHLs in stationary-phase broth 
cultures were 11.2 ± 3.5 μM and 226.5 ± 48.7 nM for C8-HSL and 3OHC12:1-HSL, 
respectively.  
 
This bacterium possesses two separate luxRI cassettes within its genome, 
termed pgaRI (RBY4I_1689 and RBY4I_3631) and phaRI (RBY4I_1027 and 
RBY4I_3464) (Figure 2). In order to gain insight into the contributions of the PgaRI and 
PhaRI systems to the phenotypes predicted to be influenced by AHL-mediated cell-to-cell 
communication systems, we analyzed previously generated Tn5 derivatives of Y4I with 
interruptions in either pgaR or phaR (28). Both the pgaR:Tn5 strain and 
the phaR:Tn5 strain showed a significant alteration in indigoidine production. It should be 
noted that transposon insertions in both of these loci could be polar to downstream genes, 
most notably, the luxI homologs that are immediately downstream of these genes and are 
expected to be cotranscribed (Figure 2). Pigment production is completely abolished in 
the pgaR:Tn5 strain, while the phaR:Tn5 mutant produces pigment later (∼3 days 
following inoculation on an agar plate) than the wild type and to a lesser degree. 
Consistent with these observed indigoidine phenotypes, expression of these genes was 
significantly diminished in both mutants (P = <0.001) relative to the wild-type level. 
The pgaR:Tn5 mutant yielded the fewest transcripts of the three strains. The expression 
of both luxI homologs was also depressed in both of the mutant strains (Figure 3A). In 
addition, the LuxR-deficient strains showed an enhanced ability to grow in biofilms (Figure 
3B) as well as defects in motility (P = <0.001). Moreover, the pgaR::Tn5 mutant was 
significantly less motile than the phaR::Tn5 mutant (P = <0.001) (Figure 3C). In contrast, 
the growth dynamics on agar surfaces were indistinguishable from the wild-type growth 
dynamics for both mutants. All strains showed a 50-fold increase in cell numbers during 
the first 24 h following plate inoculation, and the cell numbers did not change over the 
subsequent 24-h period (data not shown). The concentrations of the two identified AHLs 
were determined from agar extracts for  
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Figure 3.2. Gene orientation for the two luxRI loci in Phaeobacter sp. strain Y4I. White arrows 
indicate luxR and luxI homologs. Gene designations are listed above these arrows. Black arrows 
represent adjacent open reading frames, and putative protein annotations are indicated above each 
arrow. Abbreviations used: CCR, crotonyl coenzyme A (CoA) reductase; CHP, conserved hypothetical 
protein; SCD, short-chain dehydrogenase; TctA, tripartite tricarboxylate transporter family; HTH, 
uncharacterized protein containing a helix-turn-helix motif. 
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Figure 3.3. Genotypes and phenotypes of wild-type Y4I and luxR mutants. (A) Indigoidine 
pigmentation and synthase gene expression. The images show colony pigmentation in the wild-
type, pgaR:Tn5, and phaR::Tn5 strains 6 days following inoculation on agar plates. Normalized 
transcript quantities for the indigoidine synthase (igiD) and two luxI homologs (pgaI and phaI) are 
shown for the two mutant strains below the images. The gene expression assay was performed on 
colonies 24 h following inoculation on agar plates, and the values are relativized to wild-type transcript 
values for bacteria grown in parallel. Standard errors of the means of the results of triplicate biological 
and technical experiments are shown. (B) Total attached biomass for Y4I and the luxR mutants after 
18 h. Data represent absorbance of solubilized crystal violet. Error bars represent the standard 
deviations of the results determined in octuplet experiments. Letters represent significantly different 
values (P ≤ 0.003). WT, wild type. (C) Motility of wild-type Y4I and the luxR mutants. Error bars 
represent the standard deviations of the results of triplicate biological experiments. Lowercase letters 
above the columns represent significantly different values (P < 0.001). 
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the luxR-like insertional mutants and the wild-type strain at two time points during growth 
on an agar plate, 6 h and 24 h post-inoculation, where relatively high concentrations of 
each AHL were observed in a preliminary, coarse temporal experiment performed using 
the wild-type strain (data not shown). The highest concentrations of C8-HSL were 5-fold 
higher than those of 3OHC12:1-HSL, and the former displayed a cell density dependence 
not apparent for 3OHC12:1-HSL. The (∼10 nM) concentrations of 3OHC12:1-HSL in wild-
type Phaeobacter sp. strain Y4I plate cultures were statistically indistinguishable at the two 
time points analyzed. In contrast, C8-HSL was not detected at the early time point but was 
present at a relatively high (>500 nM) concentration by the 24-h time point. 
The phaR::Tn5 strain produced significantly less 3OHC12:1-HSL and significantly more C8-
HSL than the wild type at both time points (Figure 4; P < 0.001). In contrast, the 3OHC12:1-
HSL concentration for the pgaR::Tn5 strain was indistinguishable from the concentration 
seen with the wild type at the 6-h time point but was considerably less than the 
concentration seen with the wild type at 24 h (Figure 4A). The ability of 
the pgaR::Tn5 strain to produce C8-HSL at both time points was significantly diminished 
(Figure 4B; P < 0.001). 
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Figure 3.4. 3OHC12:1-HSL (A) and C8-HSL (B) concentrations for Phaeobacter sp. strain Y4I 
and luxR mutants on agar plates at 6 and 24 h postinoculation. Values and error bars represent averages 
and standard deviations of the results from three biological replicate experiments and two MS injection 
replicate experiments. Stars represent values significantly different from the wild-type values; three stars 
indicate P < 0.001, and two stars indicate P = 0.005. 
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The distinct temporal patterns of the AHL concentrations identified in the previous 
experiment prompted us to undertake a higher-resolution temporal analysis of synthesis 
of the two characterized AHLs when the strain was grown on agar plates over 48 h. The 
terminal time point was selected to capture AHL concentrations in populations in which 
growth had slowed considerably, as viable counts were static between 24 and 48 h. To 
complement these data, we also monitored the gene expression of the two putative AHL 
synthases, pgaI and phaI. In addition, the indigoidine concentration was quantified, and 
the expression of an indigoidine biosynthetic gene (igiD) was profiled over the course of 
the experiment. Only 3OHC12:1-HSL was detected in the intermediate stages of growth 
(∼2 to 10 h) on the agar plate at a maximum concentration of 13 ± 2 nM. After 10 h, the 
concentration of 3OHC12:1-HSL dropped, and the C8-HSL concentration concomitantly 
increased steadily until it reached a maximum of 795 ± 44 nM at 24 h. At this point, the 
concentration of C8-HSL dropped ∼30% (to 607 ± 28 nM), and the concentration remained 
relatively stable thereafter. By 15 h, the 3OHC12:1-HSL concentration again began to 
slowly increase, reaching a maximum of 18 ± 1.5 nM at 48 h (Figure 5A). The C8-HSL 
concentration correlated strongly with the pgaR gene expression profile (r2 = 0.99). In 
contrast, the expression of phaI was out of sync with the 3OHC12:1-HSL concentrations 
during the first 12 h (r2 = −0.60) but showed better agreement at the later time points when 
the concentration of this AHL was maximal (i.e., 36 and 48 h; Figure 5). Concentrations of 
indigoidine, extracted from microbial biomass, increased in a nearly linear fashion over 
the course of 48 h. In contrast, the expression of the indigoidine NRPS (igiD) showed 
some variability, particularly within the first 12 h. In fact, igiD expression levels correlated 
better with the 3OHC12:1-HSL concentration (r2 = 0.81) than with the indigoidine 
concentration (r2 = 0.69) (Figure 5). 
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Figure 3.5. Concentrations of AHLs and indigoidine (A) and the gene expression profiles of their 
synthases (B) from Phaeobacter sp. strain Y4I over 48 h of growth on an agar plate. Error bars 
represent standard deviations (A) or standard errors of the means (B) of the results of biological and 
technical replicate experiments. 
 
Figure 5. Concentrations of AHLs and indigoidine (A) and the gene expression profiles of their 
synthases (B) from Phaeobacter sp. strain Y4I over 48 h of growth on an agar plate. Error bars 
represent standard deviations (A) or standard errors of the means (B) of the results of biological and 
technical replicate experiments. 
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3.5 Discussion 
 
While Roseobacters are known to produce long-chain AHLs with various degrees of 
oxidation and side-chain saturation133, 152, 157-158, 169, the full complement of AHLs synthesized 
by lineage members and the contribution of these chemical signals to roseobacter ecology 
are not yet known. Here we identified a novel AHL, 3OHC12:1-HSL, in Phaeobacter sp. strain 
Y4I that is most structurally similar to a 14-carbon HSL from the soil 
alphaproteobacterium Rhizobium leguminosarum168. The 3OHC14:1-HSL is at the top of a 
hierarchical regulatory network of four different AHL-based quorum sensing systems in this 
plant-associated bacterium170. In contrast, the other AHL identified in Phaeobacter sp. strain 
Y4I, C8-HSL, has previously been reported in Roseobacter species, as well as in many other 
proteobacteria131, 171-176. There are several lines of evidence providing support for the 
conclusion that PgaI and PhaI synthesize C8-HSL and 3OHC12:1-HSL, respectively. The 
concentrations of each AHL produced by the phaR::Tn5 and pgaR::Tn5 regulatory mutants 
support this assignment (Figure 4). Furthermore, the concentration of C8-HSL correlates 
strongly with the pgaI gene expression profile (Figure 5), which is consistent with the 
bacterium's growth dynamics on plates (i.e., the cell abundance increases until 24 h, after 
which it levels off; data not shown). The correlation between 3OHC12:1-HSL 
and phaI transcript abundance is not as strong due to a temporal lapse in the correlation 
between phaI transcript abundance and the AHL concentration during the first 12 h following 
inoculation onto the agar surface (Figure 5). These inconsistences may be the result of a 
carryover of gene expression from the stationary-phase broth culture inoculum. It is feasible 
that phaI expression was already induced in the initial inoculum and continued to result in 
the production of AHLs during the initial growth period on the agar surface. Indeed, it has 
been shown in Vibrio harveyi that feedback mechanisms ensure a graded, rather than 
abrupt, response to AHL concentrations177. Alternatively, these findings may suggest that 
3OHC12:1-HSL is an important signal when the bacterial cell density is relatively static, a 
state that is to be expected for cultures during the lag phase. 
 
The contribution of AHL-mediated signals to the regulation of indigoidine biosynthesis 
in Phaeobacter sp. strain Y4I is undoubtedly complex. The strain appears to utilize 
both luxRI-like systems for full induction of indigoidine, though the contributions of the two 
systems are not equivalent (see, e.g., Figure 3A) and though high levels of these AHLs 
alone are not sufficient to induce indigoidine expression. Instead, surface-attached growth 
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is a prerequisite for indigoidine biosynthesis150. Given that the production of secondary 
metabolites diverts energy from cellular division178-180, utilization of quorum sensing in 
connection with surface colonization may provide to Y4I a means of tightly controlling 
indigoidine production under the various environmental conditions that the strain 
encounters. In addition, the two luxRI systems appear to modulate other physiologies in this 
strain. Again, though, the contributions of the two systems to these behaviors do not appear 
to be equivalent, which is further suggestive of the presence of a hierarchical regulatory 
network or of one that is modulated by a combinational response to multiple AHL signals181. 
 
Both luxR-like mutants show enhanced biofilm growth and limited motility (Figure 3B and 
C) Similar phenotypes have been reported in another roseobacter, Ruegeria sp. strain 
KLH11; it has been suggested that quorum sensing may control the lifestyle switch between 
the sessile (biofilm) and planktonic forms of that strain158, 182. An analogous cell-to-cell 
communication may be used to induce dispersion of Phaeobacter sp. strain Y4I bacteria 
once the biofilm reaches a threshold concentration or level of maturity. This may be a 
mechanism to control the biofilm structure such that it is maintained at an optimal state, 
particularly with respect to microscale oxygen gradients, which have been shown to 
influence bacterial activities within biofilms183-184. Indeed, the reduced form of indigoidine 
(leucoindigoidine) is predicted to be the antimicrobial form of the molecule, and it 
spontaneously oxidizes to the nonactive form in the presence of atmospheric oxygen150, 185-
186. Thus, oxygen concentrations within biofilms may need to be low enough to maintain the 
antimicrobial form of indigoidine, in order to suppress colonization of competing organisms, 
and yet high enough to facilitate the aerobic respiration of Y4I. Sequential and multitiered 
quorum sensing regulatory networks have been described for several proteobacterial 
strains, including Vibrio fischeri, in which quorum sensing is used to modulate intermediate 
and late symbiotic colonization of the Euprymna scolopes light organ and 
bioluminescence134, 139, 187-188.V. fischeri has two AHL-based quorum sensing systems that 
synthesize different AHLs at different stages of squid colonization134, 139, 187. Moreover, it has 
been shown that the response regulator that directly controls bioluminescence (LuxR) can 
respond to the two AHLs at different binding efficiencies, thus inducing bioluminescence at 
different cell densities and stages of colonization127, 189. This type of sequential activation of 
quorum sensing systems, and cross talk between these systems, may be similar to the 
induction of indigoidine biosynthesis in Y4I at the intermediate and late stages of biofilm 
colonization. These systems are not completely analogous, however. Unlike the V. 
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fischeri bioluminescence operon, a TetR repressor homolog is encoded directly upstream of 
the indigoidine biosynthesis operon in Y4I and likely directly mediates expression of that 
gene cluster150. While bioluminescence in V. fischeri is directly activated by the quorum 
sensing-induced LuxR protein, in Y4I, quorum sensing of other stimuli, such as surface 
sensing, likely inactivates this repressor to induce indigoidine biosynthesis. Indeed, the 
underlying mechanism(s) that facilitates recognition of a surface and signals cells to switch 
from a motile lifestyle to a sessile lifestyle, the latter of which includes indigoidine 
biosynthesis, is unknown in this strain. We speculate that flagellum-mediated 
mechanosensing of surfaces190 results in a signal transduction process evidently involving 
a master transcriptional regulatory circuit, perhaps the two-component CckA-CtrA master 
regulator of flagellar and motility genes in several alphaproteobacteria, 
including Ruegeria sp. strain TM1040160. This master regulatory circuit likely contributes to 
the hierarchical regulatory network seen in Phaeobacter sp. strain Y4I, and this is an area 
ripe for further investigation. 
 
We have demonstrated that Phaeobacter sp. strain Y4I synthesizes 3OHC12:1-HSL during 
the initial colonization of a surface by the strain and that C8-HSL is synthesized during later 
stages of growth. Therefore, 3OHC12:1-HSL may activate either PhaR or PgaR to initiate a 
regulatory cascade that leads to indigoidine production. Insertional mutations 
in phaR significantly impair 3OHC12:1-HSL production and result in delayed pigmentation, 
suggesting that PhaR may induce expression of the quorum sensing regulon during 
intermediate colonization and initiate pigment production. Further, insertional mutations 
in pgaR lead to the abolishment of indigoidine production in the strain, implying a key role 
for this regulator and cross talk between the systems (Figure 2 and 3). Utilizing both 
systems at different stages of growth could lead to antimicrobial production both during 
intermediate colonization and after establishment. In this way, the bacterium may be best 
able to ensure its success as not only a pioneering colonizer but also an enduring resident 
of marine surfaces. 
 
The complexity of AHL-mediated signaling is enhanced when interspecies interactions are 
considered. Indeed, we have shown here that Y4I produces C8-HSL, a trait that it shares 
with a number of other proteobacteria131, 171-176, including V. fischeri, a bacterium 
outcompeted in coculture by indigoidine-producing Y4I strains150. Given the prevalence of 
this signal among bacteria, it can be predicted that Y4I may use this signal to acquire 
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information concerning not only its own population status but also that of a variety of 
potentially competing proteobacterial populations in the ocean. In contrast, 3OHC12:1-HSL 
may represent a species-specific signal for Y4I. Thus, these two molecules likely provide 
Y4I cells with distinct information on metabolic status as well as on local population size and 
structure (e.g., Phaeobacter sp. strain Y4I versus the total proteobacterial population size), 
and Y4I populations mediate gene expression accordingly. 
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CHAPTER IV. BLACK BAND DISEASE-ASSOCIATED QUORUM 
SENSING SIGNAL PRODUCTION, MICROBIAL INTERACTIONS, 
AND TEMPERATURE-ENHANCED ACYLHOMOSERINE 
LACTONE PRODUCTION BY VIBRIOS 
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The work outlined in this chapter was originally performed by 1,2Beth L. Zimmer, 3Amanda 
L. May, 1Chinmayee D. Bhedi, 3Stephen P. Dearth, 3Carson W. Prevatte, 1Zoe Pratte, 
3Shawn R. Campagna, and 1Laurie L. Richardson reported in one publication and 
1Chinmayee D. Bhedi, 3Carson W. Prevatte, 3Maggie S. Lookadoo, 1Patricia A. Waikel, 
4Patrick M.Gillevet, 4Masoumeh Sikaroodi, 3Shawn R. Campagna, and 1Laurie L. 
Richardson and reported in a second publication. BLZ and CDB, under the supervision of 
LLR, is the primary author in terms of the introduction, biological experimentation 
methods, results, and conclusions. CWP, along with other members of the Campagna 
laboratory and combined research team, authored sections of the original manuscript 
containing chemical data and methods contributions. The two publications are listed below.  
The articles have been merged without changes to the original content of the articles. The 
abstract, introductions, and methods sections were merged in order to reduce redundancy 
between the articles and edited to present the two articles two parts of a single, overarching 
project. The results and discussion were merged and are as originally published.  
 
Zimmer, B. L., May, A. L., Bhedi, C. D., Dearth, S. P., Prevatte, C. W., Pratte, Z., Campagna, 
S. R., & Richardson, L. L. Quorum sensing signal production and microbial interactions in a 
polymicrobial disease of corals and the coral surface mucopolysaccharide layer. PloS one 
2014 9 (9), e108541. 
 
Bhedi, C. D., Prevatte, C. W., Lookadoo, M. S., Waikel, P. A., Gillevet, P. M., Sikaroodi 
M., Campagna, S. R., Richardson, L. L. Elevated temperature enhances short- to medium-
chain acyl homoserine lactone production by black band disease-associated vibrios. FEMS 
Microbiology Ecology 2017 93 (3). 
 
Affiliation: 1Department of Biological Sciences, Florida International University, Miami, 
Florida, USA; 2Atkins North America, Miami, Florida, USA; 3Department of Chemistry, 
University of Tennessee, Knoxville, Tennessee, USA; 4Microbiome Analysis Center, 
Department of Biology, George Mason University, Fairfax, VA 20110, USA 
 
The Richardson lab and SRC and ALM of the Campagna lab conceived the study. BLZ, 
ALM, CDB, SPD, CWP, ZP, MSL, PAW, PMG, and MS all performed the experimental work. 
The field sampling, sample preparation, quorum sensing (QS) signal reporter strain assays, 
16S rRNA gene sequencing of isolates and metagenomics experiments were performed by 
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the Richardson lab and collaborators. The Campagna lab contributed to sample preparation 
and high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) 
analysis of the QS signals. CWP and MSL synthesized the (D2)AHLs used to annotate the 
(N-acyl homoserine lactone) AHL signals reported. SPD and ALM synthesized the 13C-
labelled DPD used to quantitate DPD. Each lab generated the data for their respective 
experimental contributions. The Richardson lab analyzed the data for their respective 
experimental contributions. SPD and CWP analyzed the data for 4,5-dihydroxy 2,3 
pentanedione (DPD) quantitation and AHL annotation, respectively.  BLZ, CDB, ALM, SRC, 
LLR contributed to the discussion.  
 
CWP contribution 
 
In both studies, CWP performed the extraction, sample preparation and high performance 
liquid chromatography-tandem mass spectrometry HPLC-MS/MS analysis of isolates grown 
over a time course. The N-acyl homoserine lactones (AHLs) produced by these isolates, 
which had previously tested positive for AHLs in bioassays performed by collaborators, were 
detected, annotated, and identified using a modified version of a previously described 
HPLC-MS/MS. This method screened for an expanded number of masses, including AHLs 
possessing chain lengths ranging from 4 to 20 carbons with a single hydroxyl or ketone 
group at the 3-position as well as one unit of unsaturation in the chain. The AHL extraction 
and processing method for agar plates developed by CWP was used in the first study.  CWP 
synthesized dideuterated (D2) AHLs that were used as internal standards that allowed easy 
identification of many AHLs through retention time matching. Internal standards included 
(D2)C4-HSL, (D2)3OHC4-HSL, (D2)C6-HSL, (D2)C3OC6-HSL, (D2)C7-HSL, (D2)C8-HSL, 
(D2)C12-HSL, and (D2)C12:1-HSL, and (D2)C14-HSL. However, the mass accuracy of the triple-
quadrupole instrument used cannot differentiate some isobaric product ions. Additionally, 
the possibility of the production of an AHL of one of the 19 isolated analyzed not included 
among the internal standards employed is likely. As a result, annotation of many unknown 
structures for which standards were not available. This was accomplished by comparing the 
unknown AHL retention to that of the known using knowledge of how structure and chain 
length effect retention time and biological information, such as precedence for the 
compound in literature. Identification of the AHLs produced by the 19 isolates screened was 
a very significant contribution in demonstrating that AHLs are present in an active coral 
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disease and the production of them is enhanced above the temperature threshold of black 
band disease (BBD) of corals. 
 
4.1 Abstract 
 
Black band disease (BBD) of corals is a globally distributed diseased composed of a 
complex horizontally migrating, pathogenic, polymicrobial mat community active above a 
temperature threshold of 27.5 °C. BBD is considered to be a threat to coral reef health, as 
it can lead to mortality of massive reef-building corals. The BBD community is dominated 
by gliding, filamentous cyanobacteria with a highly diverse population of heterotrophic 
bacteria. Microbial interactions such as quorum sensing (QS) and antimicrobial production 
may be involved in BBD disease pathogenesis. In the first in a series of two studies, BBD 
(whole community) samples, as well as 199 bacterial isolates from BBD, the surface 
mucopolysaccharide layer (SML) of apparently healthy corals, and SML of apparently 
healthy areas of BBD-infected corals were initially screened for the production of 
acylhomoserine lactones (AHLs) and for autoinducer-2 (AI-2) activity using three bacterial 
reporter strains. AHLs were detected in all BBD (intact community) samples tested and in 
cultures of 5.5% of BBD bacterial isolates. Over half of a subset (153) of the isolates were 
positive for AI-2 activity. AHL-producing isolates were further analyzed using LC-MS/MS 
to determine the identity of AHLs present and the concentration of (S)-4,5-dihydroxy-2,3-
pentanedione (DPD), the biosynthetic precursor of AI-2. C6-HSL was the most common 
AHL variant detected, followed by 3OC4-HSL. In addition to QS assays, 342 growth 
challenges were conducted among a subset of the isolates, with 27% of isolates eliciting 
growth inhibition and 2% growth stimulation. 24% of BBD isolates elicited growth inhibition 
as compared to 26% and 32% of the bacteria from the two SML sources. With one 
exception, only isolates that exhibited AI-2 activity or produced DPD inhibited growth of 
test strains. In the following study of the series of two studies, bacterial isolates of the 
same sample type were preliminarily screened for production of acylhomoserine lactones 
(AHLs) using the Chromobacterium violaceum CV026 reporter strain. Of 229 bacterial 
isolates tested, 27 produced AHLs and 23 of these were from BBD. Eight AHLs were 
identified using LC-MS/MS, with 3OHC4-HSL the most commonly produced followed by 
C6-HSL. Exposing AHL-producing isolates to three temperatures (24°, 27°, 30 °C) 
revealed that production of four AHLs (C6, 3OHC4, 3OHC5, and 3OHC6) significantly 
increased at 30 °C when compared to 24°C. 16S rRNA gene sequencing revealed that all 
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but one of the AHL producing BBD isolates were vibrios. Metagenomic analysis of the 
BBD community showed the presence of AHL (and AI-2) genes, most of which are known 
to be associated with vibrios. The first study demonstrates for the first time that AHLs are 
present in an active coral disease. Proceeding the first study, it was hypothesized that AI-
2 production and quorum sensing among BBD and coral SML bacteria may be involved in 
the structuring the microbial communities of both a polymicrobial infection and the healthy 
coral microbiome as well as the pathobiology of BBD. The results of the second study 
corroborate this hypothesis due to the enhanced production of AHLs above the 
temperature threshold of BBD. 
 
4.2 Introduction 
 
There has been a significant decline in coral cover and diversity on tropical and subtropical 
reefs worldwide, and one of the foremost contributing factors has been coral disease191. 
Disease could affect the coral animal itself or one or more of its associates, including 
bacteria, fungi, endolithic algae, zooxanthallae, protozoa, and other partners, collectively 
termed the coral holobiont192-193. The diverse and host specific coral-associated microbial 
community is harbored within the tissue, skeleton, and protective surface 
mucopolysaccharide layer (SML) secreted by the coral epidermal mucus cells194-195. 
Interactions within this microbial community have been proposed to be cooperative as well 
as antagonistic in nature and its members have been proposed to be potentially pathogenic 
and/or probiotic196-197. The composition and taxonomy of microbial communities of the SML 
layer of apparently healthy 57 corals have been well researched198-209. Such studies have 
shown that there is a shift in the heterotrophic microbial population within the SML when 
corals are stressed, including in the case of disease198, 200, 204-205, 210. One of the most 
destructive and intricate coral diseases is black band disease (BBD)211. It is also one of the 
most widely distributed diseases, affecting sixty-four species of corals and exhibiting coral 
host and geographic specificity212-215,216-217. BBD is easily distinguished in the reef 
environment (Figure 4.1), manifesting as a dark pigmented band (phycoerythrin) separating 
healthy coral tissue from recently exposed coral skeleton. 
 
 
 
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.1. Black band disease infection on a colony of Diploria strigosa on a reef of Curaçao. 
The dark-colored black band disease microbial mat separates apparently healthy coral tissue from 
white, denuded coral skeleton. Photograph provided by Abigael Brownell. 
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The band migrates horizontally across the surface of a coral colony, causing coral tissue 
necrosis at a rate of approximately 3.0 mm per day218. The tissue loss on an individual colony 
infected with BBD can be substantial and can result in total colony mortality219-221. Massive 
reef-building corals are susceptible to BBD which exacerbates the impact of the disease on 
reef ecology and function 213, 218, 220, 222. The BBD mat consists of a microbial consortium 
volumetrically dominated by a dense population of the gliding, filamentous cyanobacterium 
Roseofilum reptotaenium223-224, and consists of a highly variable polymicrobial consortium 
of microbes that contains four known functional groups: photoautotrophs (cyanobacteria)218, 
sulfate-reducing bacteria225, sulfide oxidizing bacteria226, and heterotrophs225. By far, the 
heterotrophic bacteria have been found to be the most taxonomically rich and varied 
community within the disease consortium215. Several research groups have proposed that 
this diverse set of microbes includes potential primary, as well as secondary, pathogens200, 
203, 210, 227-228. A number of studies have targeted BBD heterotrophic bacteria221, 226-227, 229-230. 
Mechanisms of BBD pathogenicity include anoxic conditions within the BBD mat in 
combination with sulfide production by BBD sulfate reducing bacteria, and BBD 
cyanobacterial toxin (microcystin) production231-235. A recent microscopic study documented 
cellular necrosis (i.e., loss of tissue confluence, cell-to-cell adhesion, cytoplasmic 
disintegration, nuclear breakdown, and the presence of artophagous bodies, pyknotic 
nuclei, and apoptotic bodies) in the coral tissue surrounding cyanobacterial filaments in 
active BBD infections236. These microscopic observations support the previous studies 
demonstrating the role cyanobacterial toxins in BBD pathogenicity. BBD infections occur on 
the surface tissues of infected coral colonies, which are also known to be microbially diverse. 
In particular, the coral surface mucopolysaccharide layer (SML) supports a dynamic 
microbial community which is believed to play an important role in coral disease 
resistance237-239. Interactions between several bacterial coral pathogens and the microbial 
community of the coral SML have been the subject of multiple studies, and the coral SML 
and its associated microbes have been shown to produce antimicrobial agents and biofilm 
inhibitors that may be acting to protect corals from pathogen growth239-244. However, 
relatively little is currently known about the interactions between microbes within the SML. 
Bacterial 16S rRNA gene clone libraries demonstrated shifts in bacterial ribotypes during 
transitions from cyanobacterial patches (CP) shown to develop into BBD on corals on the 
Great Barrier Reef (GBR)229. In these studies, α-proteobacteria-affiliated sequences were 
dominant in CP libraries, whereas γ-proteobacterial ribotypes became more abundant after 
transition to the BBD community229. The CP-to-BBD transition has only been seen on reefs 
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of the GBR. A meta-analysis of 87 published BBD clone libraries from the Caribbean and 
Indo-Pacific detected a common cyanobacterial sequence, recently characterized 
as Roseofilum reptotaenium gen. et sp. nov., as present in 78% of the clone libraries215, 223. 
In contrast to the low diversity of BBD cyanobacterial taxa, the meta-analysis also revealed 
an extremely high diversity of heterotrophic BBD bacteria, with 73% of all sequences 
detected present as singletons (only 1 copy in the 87 clone libraries). Very little is known 
about the role of BBD heterotrophic bacteria, the one exception being that BBD has a well-
documented and very active sulfur cycle generated by sulfate reducing bacteria within the 
disease consortium245-246. The meta-analysis also found α-proteobacteria to be the most 
diversely represented group of bacteria in a meta-analysis of clone libraries produced from 
87 BBD samples collected on reefs world-wide215. While the gene sequence corresponding 
to the dominant BBD cyanobacterium is by far the most common in BBD clone libraries, the 
second most common sequence detected has been Roseovarius crassostreae203, 215, 227-229, 
247, an α-proteobacterium which is the causative agent of Roseovarius Oyster Disease in 
juvenile oysters248-249. R. crassostreae has also been detected in clone libraries constructed 
from several other coral diseases such as white band disease250, white plague-like 
disease251 and more recently, Australian subtropical white syndrome252. A second bacterium 
of potential interest is Ferrimonas sp., a selenite and iron reducing genus which has also 
been detected in 93 BBD clone libraries203. Since iron reduction is a known virulence factor 
in a number of bacteria,253 Ferrimonas is of particular interest for targeted study of the BBD 
consortium. BBD most actively infects corals when the sea water temperature rises above 
27.5 °C219, 222, 254-255. Since bacterial species and communities have stringent tolerance 
thresholds regarding the environment (including temperature), any change in surroundings 
surpassing a threshold may lead to a perturbation of the delicate relationship with a host. 
Environmental factors can also lead to decreased host health and fitness, and an increase 
in temperature has been shown to cause a switch from a symbiotic to a pathogenic role in 
some host associated microbes256. In several cases this transition has been shown to be 
controlled by quorum sensing257. 
 
Quorum sensing is a type of pheromone-based cell to cell communication system that is 
often density regulated and that allows bacteria to converse with the aid of chemically 
synthesized signals called autoinducers (AIs)258-259. Different bacteria synthesize different 
AIs and release them into the environment. While different bacteria can synthesize unique 
AIs, many different bacteria can also synthesize the same AIs, allowing the potential for 
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intra- and inter-species species signaling and coordination between different bacterial 
genera as well as species129. After extracellular accumulation of AI molecules reaches a 
threshold (the "quorum" in quorum sensing), bacteria regulate their behavior to coordinate 
expression of specific genes to adapt and thrive in that specific environment. This is 
achieved by inducing production of an array of physiological and functional adaptations129, 
257, 260-264. Quorum sensing as a phenomenon is responsible for regulating a wide range of 
bacterial behaviors that include virulence, bioluminescence, biofilm maintenance and 
maturation, motility, symbiosis, antibiotic synthesis, exoenzyme production, and 
swarming127, 265-269. 
 
Chemical signaling in tropical and subtropical coastal environments is a relatively 
unexplored area that may be important in coral health and disease. It has been noted that 
QS systems in Vibrios often integrate other information, including environmental 
parameters, with cell density when using these networks270. Quorum sensing is one 
mechanism by which coral pathogenic bacteria and SML bacteria may be interacting125. 
Acylhomoserine lactones (AHLs) and autoinducer-2 (AI-2) are two of the more well-
characterized groups of QS signaling molecules271. The latter (AI-2) is a family of related 
molecules derived from (S)-4,5-dihydroxy-2,3-pentanedione (DPD)271.  AHLs are 
considered to be intraspecies signaling molecules272, although it has been shown that cross-
talk between bacteria using these molecules can occur273-275. AHL production has been well 
documented among members of the proteobacteria257, 276 a group that is commonly detected 
in BBD clone libraries200, 203, 227-229, making AHL production a prime target for BBD research. 
AI-2 signaling is widely recognized as having an important role in interspecies 
communication269, 277-279, since DPD production is common in both Gram-negative and 
Gram-positive bacteria280-281. AI-2 signaling may also play a role in the complex bacterial 
communities of both BBD and coral SML. 
 
Gram negative bacteria specifically produce AHLs which are constituted of a fatty acid (acyl) 
side chain attached to a homoserine lactone ring131. The side chains vary on the basis of 
their length, saturation and presence/absence of functional groups, creating a suite of AHL 
molecules that bacteria use to communicate in complex environments131. As the side chain 
length increases, the solubility of the signaling molecule decreases while the stability 
increases282-283. Various factors such as temperature, pH, oxygen availability, and redox 
state have been known to affect QS regulation and QS regulatory gene expression170, 284. 
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The structural integrity of the homoserine lactone ring has been observed to be reversibly 
susceptible to alkaline conditions, affecting long chain AHLs to a lesser extent282-283, 285  
which is significant in terms of environmental influence since lactone ring hydrolysis disables 
the AHL molecule from signaling283. 
 
Overall, QS is associated with a wide range of interactive social responses in bacteria269, 286 
and has been shown to regulate virulence in both Gram-positive and Gram-negative 
pathogens277, including upregulation of antibiotic biosynthesis287-288. AHL production has 
been observed in coral-associated bacteria isolated from the SML of healthy corals289, 
isolates from other marine invertebrates and their endosymbiotic dinoflagellates240, and from 
the tissues of 10 cnidarian species (all healthy) examined recently290. Vibrio spp. isolated 
from the mucus of healthy and diseased corals have been shown to produce both AHLs and 
DPD291. In one study, QS was proposed to play a major role in the pathogenicity of the coral 
pathogen Vibrio coralliitycus292. This study extends the research on BBD to examine the 
variation of QS (AHL) molecules produced by BBD and coral-associated bacteria in 
response to environmental (temperature) changes, including a comparison of AHLs 
produced across different coral health states. As mentioned above, BBD is typically 
observed in summers when sea water temperatures exceed 27.5 °C222, 254. Therefore, we 
examined AHL production at temperatures close to, above, and below this threshold. The 
QS experiments were performed in conjunction with assays to assess antimicrobial activity 
of the isolates to further broaden our understanding of bacterial interactions within BBD and 
the coral SML. Metagenomics analysis was done to assess the presence and nature of 
quorum sensing genes in the BBD mat in addition to culture dependent methods. 
 
The first study of the two-study series demonstrates the in situ presence of AHLs in an active 
coral disease for the first time. Following the hypothesis that AHL production among BBD 
and coral SML bacteria may structure both the microbial communities of a polymicrobial 
infection as well as the native coral microbiome, the second study suggests that quorum 
sensing may be involved in BBD pathobiology and community structure due to enhanced 
production of AHLs above the temperature threshold of this globally distributed coral 
disease. 
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4.3 Materials and Methods 
 
Field sampling and isolation of bacteria for the initial AI screening study. BBD, 
apparently healthy SML from BBD infected coral (BSML) and SML from apparently healthy 
coral (HSML) samples were collected from reefs in Ft. Lauderdale, Florida under Florida 
Fish and Wildlife Conservation Commission sampling license SAL-11-1344-SRP and from 
Florida Keys reefs under permits FKNMS-2007-026 and FKNMS 2009-045-A3. Freshly 
collected BBD mat as well as both bacterial (N = 191) and cyanobacterial (N = 8) isolates from 
BBD and coral mucus samples were examined for production of autoinducers in this study 
(Table 4.1). The bacterial isolates included 182 newly isolated strains cultured from colonies 
of Montastraea cavernosa, Colpophyllia natans, and Diploria strigosa located on the Florida 
Reef Tract [Ft. Lauderdale, Florida, USA (26° 11.35′ N, 80° 5.49′ W); Horseshoe Reef, 
Florida Keys, USA (25° 08.362′ N, 80° 17.641′); and Algae Reef, Florida Keys, USA (25° 
08.799′ N, 80° 17.579′ W)] (Table 4.1). Thirty-nine of the 191 bacteria were newly isolated 
from Diploria strigosa on a reef of Curaçao (Water Factory 3, 12° 06.779′ N, 68° 57.662′ W). 
Samples were collected using sterile, needleless 10 ml or 60 ml syringes. SML from 
apparently healthy areas of BBD-infected colonies (designated BSML) was sampled at the 
farthest distance (minimum of 20 cm) from the BBD mat. SML samples were also collected 
from apparently healthy colonies (HSML) of the same coral species located in the near 
vicinity of BBD-infected corals. To collect SML, the coral surface was gently agitated using 
the syringe tip (to cause mucus secretion) and the resulting mucus aspirated into the 
syringe. The BBD mat was easily collected by syringe as it is loosely attached to the coral 
surface. 
 
Syringes with freshly collected samples were held in coolers at ambient seawater 
temperature during transport to the laboratory, where the SML sample syringes were 
inverted to allow sampled mucus to settle to the syringe tip for collection. BBD samples 
clumped within the syringe shortly after aspiration (a behavioral response of the filamentous 
cyanobacteria) and each clump was directly collected and transferred into sterile 2.0 ml 
cryovial. Each SML sample was extruded into a sterile 2.0 ml cryovial to limit the amount of 
seawater in the sample. Autoclaved artificial seawater was then added to each cryovial. 
Samples were mixed by vortexing and spread plated, after a standard dilution series, onto 
plates containing the following media: Difco marine agar (MA), 1/10 strength MA, Thiosulfate 
Citrate Bile Salts Sucrose (TCBS; Vibrio-specific, BD) agar, and Sea Water Tryptone (SWT)  
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  Table 4.1. Sampling and bacterial isolate designations.  
 
Site Name and 
Location
Date of 
Collection
Water 
Depth (m)
Water 
Temp (°C)
Colony No. Host Coral Sample 
Type(s)a
Bacterial Isolate 
Designations b,c,d
No. of Isolates Examined
Ft. Lauderdale, 
Broward County, FL, 
USA; 26° 11.35' N, 
80° 5.49' W
17-May-08 3.7 28 FTL 1 BBD BBD-FTL-1x 109 (41 BBD, 23 BSML, 45 HSML)
27-Jun-08 4.6 28 FTL 2 Montastraea 
cavernosa
BBD BBD-FTL-2x
27-Jun-08 4.3 28 FTL 3 M. cavernosa BBD BBD-FTL-3x
27-Jun-08 4 28 FTL 4 M. cavernosa BBD BBD-FTL-4x
27-Jun-08 3.3 28 FTL 5 M. cavernosa BBD BBD-FTL-5x
1-Aug-09 4.6 29 FTL 6 M. cavernosa BBD, BSM BBD-FTL-6x, BSM-FTL-6x
31-Jul-10 3.7 30 FTL 7 M. cavernosa BBD, BSM BBD-FTL-7x, BSM-FTL-7x
31-Jul-10 4.3 30 FTL 8 M. cavernosa BBD, BSM BBD-FTL-8x, BSM-FTL-8x
31-Jul-10 4.6 30 FTL 9 Diploria 
strigosa
HSML HSML-FTL-9x
31-Jul-10 4.3 30 FTL 10 M. cavernosa HSML HSML-FTL-10x
31-Jul-10 4.3 30 FTL 11 M. cavernosa HSML HSML-FTL-11x
Algae Reef, Florida 
Keys, FL, USA; 25° 
08362' N, 80° 17.579' 
W
24-Oct-09 6.7 25 FLK 1 D. strigosa BBD, BSM BBD-FLK-1x, BSM-FLK-1x5 27 (13 BBD, 14 BSML)
Horseshoe Reef, 
Florida Keys, FL, 
USA; 25° 08.3629' N, 
80° 17.6419' W
7-Sept-12, 
30-Sept-12
3.7 29 FLK 2f Colpophyllia 
natans
BBD BBD-FLK-1Mx, BSM-FLK-15Mx, 
BBD-FLK-2Mx, BSM-FLK-25Mx 
7
Water Factory 3, 
Curacao; 12° 
06.7799' N, 68° 
57.6629' W
23-Feb-13 2.5 27 CUR 1 D. strigosa BBD BBD-CUR-3Mx, BBD-CUR-3Sx 39
Horseshoe Reef, Lee 
Stocking Island, 
Bahamas; 23° 
46.309' N, 76° 5.339 
W
9-Jul-04 8.2 29 216 Siderastrea 
siderea
BBD BBD-216-x 5
7.3 28 217 S. siderea BBD BBD-217-x 4
BBD samples were obtained from a BBD mat sample; BSML samples were obtained from the SML 
of an apparently healthy area of a BBD-infected colony; HSML samples were obtained from the SML 
of an apparently healthy colonya. The "x" in the isolate designation refers to an individual isolate from 
the source colony [e.g. BBD-FTL-1a, BBD-FTL-1b, etc.]b. The "M" in the isolate designation refers to 
isolates that were selected from a marine agar platec. The "S" in the isolate designation refers to 
isolates that were selected from a sea water tryptone agar plated. Includes BBD-216-1b, BBD-216-
2d, BBD-216-3d, BBD-216-4a, BBD-214-4e, BBD-217-2b, BBD-217-2d, BBD-217-2g, and BBD-217-
3me. Two BBD samples were collected from the single colony of C. natans on separate days. Sample 
1 and Sample 2 were collected on 27-Sept-12 and 30-Sept-12, respectively. 
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agar. Plates were incubated at room temperature (∼23°C) and unique colonies were 
selected on the basis of color and morphology for further isolation and evaluation. In addition 
to the above isolates, 17 previously isolated BBD bacteria (N = 9) and cyanobacteria (N = 8), 
collected in the Florida Keys, Bahamas, and Philippines were tested for QS signal 
production (Table 4.1). The nine bacterial cultures (strains BBD-216-1b, BBD-216-2d, BBD-
216-3d, BBD-216-4a, BBD-216-4e, BBD-217-2b, BBD-217-2d, BBD-217-2g, and BBD-217-
3m, all documented in203, 228 were maintained on MA slants at room temperature. The eight 
cyanobacterial cultures (strains BBD 1991, HS 217, HS 223, W-1, FLK BBD1, Phil 2b-2, 
102a-1, and 96-2) are all members of the genera Geitlerinema and Leptolyngbya and were 
collected on various reefs in the Florida Keys, Bahamas, and the Philippines222, 230, 232, 234, 293-
294. The cyanobacterial cultures were maintained in 125 ml Erlenmeyer flasks in algal 
mineral media ASNIII or marine BG11 at 26°C under a 12∶12 h light:dark cool white 
fluorescent light regime at an intensity of 20 µE m−2 s−1.  
 
Field sampling and isolation of bacteria for the AHL temperature enhancement 
study. BBD, BSML and HSML samples were collected from reefs of the northern Florida 
Keys, USA (Algae Reef and Horseshoe Reef) and the Water Factory in Curaçao, 
Netherlands Antilles, from two scleractinian coral species, Montastraea cavernosa and 
Pseudodiploria strigosa. Sterile needleless 60 ml syringes were used for sampling. BBD 
mat and SML were suctioned off of the coral host with slight agitation, after which the 
syringes were capped. BSML samples were collected at a minimum distance of 10 cm 
from the BBD mat. HSML samples were collected from adjacent (healthy) colonies of the 
same coral species. Once on the boat, syringes with samples were held in coolers 
containing sea water at ambient temperature and transported to the shore. BBD mat and 
SML were then transferred to artificially sterilized sea water (ASW) to minimize 
contamination from sea water bacteria. Isolation of bacteria from three coral health states 
Heterotrophic bacteria were isolated from samples of each of the three coral health 
conditions from both reef systems and coral host species. Dilution series (10-1 to 10-10) 
of BBD, HSML and BSML samples were prepared using both ASN III medium and filtered 
sea water, and incubated at both room temperature and 30 °C under a 12 hours light:12 
hours dark regime. 100 μl from dilution tubes 10-3, 10-4, 10-5 and 10-6 were plated every 
day for a period of seven days and incubated 183 at 30 ºC. Direct streaking from the 
original mat and SML samples was also carried out. All plating was onto Difco marine agar 
(MA) and sea water tryptone (SWT) agar plates, in triplicate. Uniquely distinct colonies 
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were chosen based on colony color and morphology followed by streaking for purification 
by plating onto the same medium. 
 
Processing Cell-free culture filtrates. Cell-free culture filtrates (CFs) from the bacterial 
isolates were collected for use in QS assays. Isolates were grown in sterile Difco marine 
broth (MB) that was filtered twice (Whatman 1 paper filters, 5.5 cm) to remove the medium 
precipitate. The cultures were grown to stationary phase at 29°C with shaking. This 
temperature is ecologically relevant, since BBD is most active in the wider Caribbean 
when surface water temperatures are above approximately 28°C222, 254, 295-297. Bacterial 
cell concentrations were monitored by measuring the optical density at 600 nm (OD600) 
using either a Modulus Microplate Multimode Reader (Turner BioSystems, Sunnyvale, CA, 
USA) or a Thermo UV1 Spectrophotometer (Thermo Electron Ltd., Cambridge, UK) with 
sterile MB as a zero/blank. 
 
At early stationary phase, CF samples were prepared by centrifugation at 12,000 g for 10 
min, and the supernatant was divided into two, 1.0 ml aliquots. Because alkaline 
conditions have been shown to result in AHL lactonolysis282, 285, 298, prior to division of the 
sample the pH of the supernatant was measured using a Jenco Model 60 Digital pH meter 
(Jenco Electronics, Ltd., Taipei, Taiwan). Since AHLs have been shown to remain stable 
for extended time periods at pH 5.0–6.0299, the pH of the supernatant to be used in the 
AHL assays was adjusted to this pH range using a sterile HCl solution (1 N). Each CF was 
then filter sterilized (0.22 µm membrane, Millipore, Billerica, MA, USA) and the CFs were 
stored at −20°C. For the cyanobacterial strains, CFs were prepared by obtaining a 2.0 ml 
aliquot from an active cyanobacterial culture. The culture was vortexed and cells were 
removed using a combination of centrifugation (12,000 g for 10 min) and filter sterilization. 
The cyanobacterial CFs were used immediately in the QS assays (with no acidification). 
 
AHL reporter strain assays. Chromobacterium violaceum CV026 and Agrobacterium 
tumefaciens NTL4(pZLR4) reporter strains were used to detect the presence of short-
chain and medium- to long-chain AHLs, as indicated (Table 4.2). The C. violaceum CV026 
assay used in this study follows a previously reported protocol with slight 
modification300. C. violaceum CV026 was cultured in sterile Difco Luria-Bertani (LB) broth 
overnight at 30°C and used to prepare the assay plates. The assay plates (triplicates) 
contained a base of 1.5% Difco LB agar with an overlay of 100 µl of the C.  
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  Table 4.2. Quorum sensing reporter strains and positive control strains used in this study.  
 Name Strain characteristics
Chromobacterium violaceum 
CV026 a Detects short-chain AHLs (i.e. C4-AHL, C6-AHL, C6-3-oxo-AHL, C8-AHL, C8-3-oxo-AHL).
Agrobacterium tumefaciens 
NTL4(pZLR4) b
Detects medium- to long-chain AHLs (i.e. C6-AHL, C10-AHL, C12-AHL, C14-AHL, C6-3-
hydroxy-AHL, C8-3-hydroxy-AHL, C10-3-hydroxy-AHL, all 3-oxo-AHLs).
Agrobacterium tumefaciens 
NT1(pTiC58accR) b
Synthesizes C8-3-oxo-AHL which is recognized by A. tumefaciens NTL49pZLR4). 
Culture filtrates of this strain were used as a positive control in the A. tumefaciens 
NTL4(pZLR4) assay.
Vibrio harveyi BB170 c Detects the DPD and the CAI-1d signals.
Vibrio harveyi BB152 c
Synthesizes the DPD signal. Culture filtrates of this train were used as a positive 
control in the DPD assay. 
Strain obtained from K. mathee, Florida International Universitya. Strains obtained from S.K. Farrand, 
University of Illinoisb. V. harvei strains BB170 (ATCC BAA-1117) and BB152 (ATCC BAA-1119) 
obtained from the American Type Culture Collectionc. CAI-1 is the Vibrio-specific QS signal (S)-3-
hydroxytridecan-4-oned.  
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violaceum CV026 culture (OD600 = 1.0) in 5.0 ml of 0.7% LB agar. Samples tested for the 
presence of short-chain AHLs consisted of both CFs and biomass (colonies from a plate) 
of the 199 bacterial and cyanobacterial isolates, as well as freshly collected (full 
community) BBD mat (Table 4.3).  
 
To test the bacterial CFs, wells were punched in the assay plates using the wide end of a 
sterile pipette tip. To each experimental well, 75 µl of the appropriate CF was added. To test 
the BBD mat material, a portion of each BBD sample was placed in 1.0 ml of sterile 
seawater. The mixture was shaken on a vortexer and 75 µl of the solution was placed into 
an experimental well in each assay plate. Each assay plate contained a positive control (i.e., 
0.01 µl of 50 mM N-hexanoyl-L-homoserine lactone spotted on the agar surface) and a 
negative control (i.e., a well containing 75 µl of sterile MB for the CF assays or a well 
containing 75 µl of sterile seawater for the BBD mat assays). The assay plates were 
incubated for 24 h at 30°C and then examined for purple coloration (violacein) surrounding 
the wells which indicated a positive result. For the bacterial isolate patch tests, each isolate 
was streaked onto a plate containing MA and incubated at 29°C until colonies were visible. 
Colonies were collected using a sterile loop and transferred to the surface of C. 
violaceum CV026 assay plates. In the case of the cyanobacterial strains, clumps of 
cyanobacteria were selected from the culture flask using sterile forceps and transferred to 
the surface of the assay plates. Each experiment was conducted in triplicate with positive 
and negative controls, incubated for 24 h at 30°C, and then assessed for violacein presence. 
The Agrobacterium tumefaciens NTL4(pZLR4) assay used in this study follows a previously 
reported protocol with slight modification301. A. tumefaciens NTL4(pZLR4) from frozen 
glycerol stock was streaked on a plate containing autoinducer bioassay minimal (ABAt) agar 
(i.e., 3 g/L K2HPO4, 1 g/L NaH2PO4, 1 g/L NH4Cl, 0.3 g/L MgSO4·7H2O, 0.15 g/L KCl, 0.01 
g/L CaCl2, 0.0025 g/L FeSO4·7H2O)302, along with 5 g/L mannitol (0.5%) and gentamicin (30 
µg/ml) and grown at 28°C until colonies were visible. A single colony was transferred via 
sterile loop to 1.0 ml of ABAt medium with gentamicin (30 µg/ml) and grown overnight at 
28°C with shaking. The day of the assay, a fresh solution of ABAt medium with gentamicin 
(3 µg/ml) was prepared, inoculated with 50 µl of the overnight culture, and grown to late 
exponential phase at 28°C with shaking. The assay plates contained a base of 1.5% 
ABAt agar (0.5% mannitol) with an overlay that included 500 µl of the A. 
tumefaciens NTL4(pZLR4) culture in 5.0 ml of 0.7% water agar with gentamicin (30 µg/ml) 
and 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-gal; 40 µg/ml). As above (for  
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Table 4.3. Quorum sensing assays conducted in this study.  
 
Site Name and Location No. of 
Isolates 
Examined 
Patch 
Test
CF 
Test
BBD 
Mat 
Test
Patch 
Test
CF 
Test 
BBD 
Mat 
Test
Cultured 
Isolates
Ft. Lauderdate 109 + + + + + + +
Algae Reef 27 + + + + + + +
Horseshoe Reed, Florida Keys 7 + NT NT NT NT NT NT
Water Factory 3, Curacao 39 + NT NT NT NT NT NT
Horseshoe Reed, Lee Stocking 
Island
9 + + + + + + +
BBD cyanobacteria 8 + + + + + + +
Chromobacterium 
violaceum CV026 Asssay a
Agrobacterium 
tumefaciens 
NTL4(pZLR4)  
Assay a
Vibrio harvey 
BB170 Assaya
"+" indicates that the assay was conducted; NT indicates that the assay was not conducted. Patch 
Test and CF Test refer to isolates and BBD Mat Test refers to intact, freshly collected BBD Mat Test 
refers to intact, freshly collectd BBD mat, all tested using the CV026 and the NTL4 reporter strains. 
The BB170 assay utilized actively growing cultures of isolates only (see methods section)a. 
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the C. violaceum CV026 reporter strain), assay plates were used to test both CFs and 
biomass (colonies) of the 199 bacterial isolates, as well as freshly collected BBD mat (Table 
4.3). As a positive control, A. tumefaciens NTL4(pTiC58ΔaccR), which produces C8-3-oxo-
AHL, was grown in ABAt broth at 28°C with shaking. An aliquot of the culture was centrifuged 
at 12,000 g for 10 min, and the resulting supernatant was filter sterilized. The negative  
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 control well on each plate contained either 75 µl of sterile MB for the CF assays or 75 µl of 
sterile seawater for the BBD mat assays. The assay plates were incubated for 24 h at 28°C 
and then assessed for the presence of blue coloration (X-gal cleavage) surrounding the 
wells, which would indicate a potential positive result. To detect if any of the isolates 
produced an extracellular factor that hydrolyzes X-Gal, isolates that produced a blue 
coloration in the patch test were retested on a plate containing only ABAt agar (0.5% 
mannitol) with X-Gal (40 µg/L). Isolates producing blue coloration on these plates were 
considered a false-positive result in the A. tumefaciens NTL4(pZLR4) assay and the result 
was scored as negative. AHLs were extracted from those isolates that tested positive in at 
least one AHL reporter strain assay. Extracted AHLs were then analyzed using liquid 
chromatography–tandem mass spectrometric (LC-MS/MS), which allows for the 
determination of the AHL chemical structure. The extraction and LC-MS/MS methods are 
described below. 
 
The V. harveyi BB170 reporter strain was used to screen for the presence of AI-2 (Table 
4.2) in 153 bacterial CFs (Table 4.3). The AI-2 assay used in this study follows a previously 
reported protocol developed by with slight modification 303. A modified autoinducer bioassay 
(ABVh) medium was prepared (1 L solution of 0.3 M NaCl, 0.05 M MgSO4, and 0.2% 
casamino acids) and adjusted to pH 7.5. This solution was autoclaved (121°C) and the 
following components were added to the cooled solution from sterile stocks: 0.05 M 
K2HPO4 (pH 7.0), 0.001 M L-arginine, and glycerol (to 1.0%). Fresh ABVh medium was 
inoculated with an aliquot of the V. harveyi BB170 frozen glycerol culture, which was then 
grown (30°C with aeration, shaking) until turbid and showing obvious luminescence in a 
darkroom. This culture was then diluted 1∶5,000 in fresh ABVhmedium and used to prepare 
the assay plates. The CF from the V. harveyi BB152 mutant strain served as a positive 
control in the AI-2 assay (Table 4.2). V. harveyi BB152 was cultured overnight in 
ABVh medium (30°C with aeration, shaking), centrifuged (12,000 g, 10 min), and the 
supernatant was filter sterilized and stored at −20°C. AI-2 assays were conducted in sterile 
96-well microtiter plates (BD Falcon 353219 - black plate with a clear, flat bottom and lid). 
Each assay plate contained triplicate experimental wells, control wells, and reference wells, 
all with final well volumes of 100 µl. The prepared plates were incubated at 30°C with 
shaking over the course of the 7 h assay. Optical density (OD600) and luminescence (490 
nm) readings were conducted every 15 min using a BioTek Synergy HT Multi-Mode 
Microplate Reader linked directly to a PC with Gen5 software (BioTek Instruments, Inc., 
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Winooski, VT, USA). Because some growth media components have been shown to induce 
luminescence in the V. harveyiBB170 reporter strain (e.g., borate and glucose304-306, medium 
control wells were included to monitor possible growth media effects on reporter strain 
luminescence. Media reference wells were monitored during the AI-2 assays to determine 
background luminescence output for each of the media tested. AI-2 activity was determined 
at the optimal time point (OTP) of the V. harveyi BB170 assay, defined as the time point 
immediately preceding self-induction by the V. harveyi BB170 reporter strain303. The OTP 
represents the time when the mean luminescence of the medium control wells was lowest 
during the course of the assay. The percentage of AI-2 (% AI-2) activity is expressed as a 
percentage of the positive control luminescence at the OTP307. The % AI-2 activity was 
calculated as the fold induction of the sample, i.e., the fold change between the sample 
luminescence and the corresponding reference luminescence (MB for the bacterial CFs and 
BG11 for the cyanobacterial CFs) divided by the fold induction of the positive control (the 
fold change between the positive control luminescence and the corresponding reference 
luminescence, which was ABVh medium for the positive control CF). The luminescence at 
the OTP for each sample was used to calculate the induction of luminescence, which is 
expressed as a fold induction of the sample in comparison to the luminescence of the 
positive control. The induction of luminescence was calculated by dividing the sample 
luminescence by the positive control luminescence at the OTP303, 308. 
 
AHL extraction from isolates in marine broth cultures. Fresh 25 ml aliquots of half 
strength MB in 125 ml Erlenmeyer flasks were inoculated with 500 µl of cultures grown 
overnight in the same medium. Duplicate cultures were then grown at 25°C for 24 h with 
shaking (200 rpm). At this point, 10 ml aliquots of each culture were filtered through 0.22 
µm nylon filters (GE Magna) in duplicate to generate a total of four samples per isolate. 
The filtrate was transferred to a separatory funnel, and the flask was washed with ∼1 ml 
water and added to the funnel. The filtrate was then extracted twice with 5 ml of 1.0% 
acetic acid in ethyl acetate (H+/EtOAc). The combined organic layers were then dried with 
MgSO4 and filtered. The filtrate was concentrated in vacuo and the resulting oil was then 
resuspended in 300 µl of H+/EtOAc and transferred to an autosampler vial. Samples were 
immediately analyzed via LC-MS/MS162. 
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Determination of antimicrobial production. Antimicrobial production capabilities of 
BBD, BSML and HSML isolates were tested against Roseovarius crassostreae CV919-
312 and Ferrimonas sp. EF3B-B688 using the agar overlay method. Test plates consisting 
of a basal layer of MA were overlaid with 5 ml molten MA and 100 μl of a freshly grown 
broth culture of either R. crassostreae or Ferrimonas sp. The plates were allowed to dry 
for 15 min after which bacterial isolates to be tested for activity were spotted onto the 
plates, followed by incubation at room temperature for 48 hours with visual monitoring for 
zones of inhibition. 
 
Chromobacterium violaeum CV026 AHL reporter strain assay. QS signal 
production capabilities were tested using the reporter strain Chromobacterium violaceum 
CV026 using a similar agar overlay method. This strain is used to detect the presence of 
short to medium chain AHLs, particularly C4-AHL, C6-3-oxo-AHL, C8-AHL and C8-3-oxo-
AHL300. Test isolates were freshly grown overnight on MA at room temperature. The C. 
violaceum CV026 biosensor strain was grown overnight in 5 ml Luria Bertan (LB) broth at 
30 °C at 35 rpm. Test plates consisted of a basal layer of LB medium overlaid with 5 ml of 
molten LB with 100 μl of a freshly grown overnight broth culture of C. violaceum CV026. 
For a positive control 0.01μl of 50 mM synthetic N-hexanoyl-L-homoserine lactone solution 
in ethanol was used while sterile LB broth served as negative control. All assays were 
carried out in triplicate. All results were analyzed statistically by doing the proportion t-test 
for significance (p ≤ 0.05). 
 
Subjection of AHL-positive isolates to three different temperatures. Isolates that 
tested positive for production of AHLs using the C. violaceum CV026 assay were further 
tested for the effect of temperature on AHL production by exposing isolates to three 
different temperatures (24 C̊, 27 C̊ and 30 C̊). R. crassostreae CV919-312 was also tested 
in these experiments. For each temperature, 25 ml aliquots of freshly made half strength 
marine broth (MB) in 125 ml Erlenmeyer flasks were inoculated in duplicate with 500 μl of 
culture previously grown overnight at each respective temperature (24 °C, 27 °C and 30 ̊C) 
with shaking (250 rpm). 1ml of sample was aliquoted every two hours from each flask at t 
= 0, 2, 4, 6, and 8, and 10 hours. At every time point for every sample, OD was measured 
(600 nm) and 500 μl of sample was added to a  microcentrifuge tube containing deuterated 
AHL internal standards that consisted of (D2)C4, (D2)3OHC4, (D2)C6, (D2)C3OC6, 
(D2)C7, (D2)C8, (D2)C12, (D2)3OHC12:1 and (D2)C14 that were synthesized as 
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previously described in162. This was done in duplicate to generate a total of four samples 
per isolate per time point per temperature. The eppendorf tubes were then centrifuged for 
1 min at 209 ×g to spin down bacterial cells, after which 500 μl of the supernatant were 
placed in autosampler vials and kept at -80 ̊C until further processing. 
 
AHL extraction from isolates on marine agar plates. Fresh 25 ml aliquots of half 
strength MB in 125 ml Erlenmeyer flasks were inoculated with 500 µl of cultures grown 
overnight in the same medium. Triplicate cultures were then shaken at 200 rpm at 25°C 
for 1 h. At this time, a 5.0 ml aliquot of each culture was filtered through a 0.45 µm nylon 
filter (GE Magna), which was placed cell side up on half strength MA plates and incubated 
at 25°C for 24 h, after which the filter was removed and the agar was minced and 
transferred to a 250 ml Erlenmeyer flask. A 100 ml aliquot of ethyl acetate (EtOAc) was 
added to each flask, and the suspension was stirred for 3 h. Once extraction was 
complete, the organic layer was collected. The flask was rinsed once more with 5.0 ml 
EtOAc, which was added to the previous organic layer. The combined organic fractions 
were then dried in vacuo and the resulting oils were redissolved in 300 µl of EtOAc, 
transferred to an autosampler vial, and immediately analyzed via LC-MS/MS162. 
 
LC-MS/MS analysis of AHLs. AHL analysis was performed using an LC-MS/MS method 
optimized for AHL detection162 using previously reported methods309 with slight 
modifications162. Briefly, each sample was kept in an autosampler (Thermo Electron 
Surveyor) at 4°C before injection of 10 μl of onto a reverse-phase C18 core-shell column 
((Phenomenex Kinetex, Torrance, CA, USA) (5 μm pore size, 100 Å particle size, 100 mm 
x 2 mm or 2.1 μM pore size, 100 Å particle size, 100 mm x 2 mm) via a Thermo Electron 
Surveyor autosampler (Thermo Fisher Scientific, Waltham, MA, USA). Separation was 
obtained using a gradient of 0.1% acetic acid in water and 0.1% acetic acid in acetonitrile 
at a flow rate of 200 µl/min. The eluent was introduced into a TSQ Quantum Ultra Triple 
Stage Quadrupole mass spectrometer (Thermo Scientific) using electrospray ionization, 
and multiple reaction monitoring (MRM) in positive ion mode was used for compound 
detection, annotation, and identification. This method screened for 54 unique parent m/z–
fragment m/z pairs based on neutral loss of the acyl chain giving common 102 m/z 
fragment corresponding to the common homoserine lactone of all AHLs. The method 
includes masses corresponding to chain lengths ranging from 4 to 20 carbons with the 
possibility of one hydroxyl or ketone at the 3-position as well as one double bond in the 
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chain. Note: MRM alone is unable to differentiate between compounds with the same 
parent m/z-fragment m/z pairs (e.g., 3OC6-HSL and C7-HSL). To circumvent this, further 
chemical (such as LC retention time) and biological precedence for the compound in the 
literature) information was used to annotate structures for AHLs for which standards were 
not available as previously reported309. Unique parent m/z-fragment m/z pairs were 
screened to confirm the presence of AHL molecules. An EIC extraction window of 200 
ppm was used to envision peaks, and the area for each AHL was integrated, which was 
further used to detect relative abundance and percentage of each detected AHL. Files 
collected from the instrument were converted from RAW to.mzML files using 
Proteowizard’s MSconvert algorithm310. The files were then imported into MAVEN to 
detect and report peak intensities and to generate extracted ion chromatograms (EICs) 
for each MRM311. An EIC extraction window of 200 ppm was used, and the relative 
percentage for each detected AHL was calculated from the integrated areas. 
 
LC-MS/MS analysis of DPD. Briefly, duplicate 300 µl aliquots of culture supernatants 
were transferred to 1.5 ml centrifuge tubes containing 10 µl of a 13C-labeled DPD (13C-
DPD) internal standard, prepared using a previously reported method312. Each tube was 
mixed thoroughly by vortexing for 5 s and then centrifuged for 1.5 min at 16.1 rcf to pellet 
cells. The supernatants (260 µl) were transferred to new 1.5 µl centrifuge tubes containing 
25 µl of a 5 mg/ml DPD derivatizing solution313. The contents were thoroughly mixed by 
vortexing and allowed to react for 45 to 60 min. The resulting solutions were then extracted 
twice with 130 µl of EtOAc and the combined extracts were transferred to 300 µl 
autosampler vials. Samples were placed in an autosampler tray cooled to 4°C and 10 µl 
of each was injected onto a Kinetex 5 µ C18 100 Å 100 × 2.10 mm column. Separation 
was performed with an isocratic gradient of 95% 0.1% acetic acid in HPLC grade water 
and 5% HPLC grade Acetonitrile with a flow rate of 200 µl/min for 4 min. The eluent was 
introduced into a TSQ Quantum Ultra Triple Stage Quadrupole mass spectrometer 
(Thermo Scientific) using electrospray ionization, and a positive mode selected reaction 
monitoring protocol was used for detection313. The parent m/z–fragment m/z pairings used 
for endogenous DPD and 13C-DPD were 381 m/z–202 m/z and 382 m/z–203 m/z, 
respectively. A collision energy of 43 was used for both. The peaks were automatically 
integrated with manual adjustments using the Xcalibur software (Thermo Electron 
Corporation). A correction factor was applied to account for natural isotopes313, and DPD 
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concentration was then calculated by comparing the peak areas of endogenous DPD to 
the peak areas of the 13C-DPD and multiplying by the internal standard concentration. 
 
16S rRNA gene sequencing. Genomic DNA was extracted from those isolates that 
tested positive for AHL production using at least one of the reporter strains assays either 
by placing a single colony in 100 µl of sterile phosphate buffered saline (PBS), heating to 
either 99°C in the first study or 95°C in the second study for 10 min, and centrifuging at 
5,000 g for 10 min, or alternatively by bead-beating using the FastDNA Spin Kit for Soil 
(Qbiogene, Vista, CA, USA) according to manufacturer’s protocol. DNA was then PCR-
amplified using the universal bacterial primers 27F 5′-AGA GTT TGA TCM TGG CTC AG-
3′ and 1492R 5′-TAC GGY TAC CTT GTT ACG ACT T-3′314; Integrated DNA technologies, 
Coralville, IA, USA). The final concentration for PCR reactions was 1x PCR Buffer, 2.5 
mM MgCl2, 0.25 mM of each deoxynucleotide triphosphate, 0.5 µM of each forward and 
reverse primer, 0.25 U GoTaq Flexi DNA Polymerase (Promega), 0.1% bovine serum 
albumin, DNA-grade sterile water, and 1–2 ng genomic DNA. PCR was carried out in a 
Peltier Thermal Cycler (PTC-200, MJ Research, Waltham, MA, USA) under the following 
conditions: 94°C for 3 min, followed by 28 cycles of 94°C for 1 min, 55°C for 30 s, and 
72°C for 30 s, with a final soak at 72°C for 20 min. 
 
The amplified bacterial 16S rDNA was cleaned using an ExoSAP-IT PCR cleanup kit (USB 
Corp., Cleveland, OH, USA) and sequenced with an ABI Prism 3100 genetic analyzer 
(Applied Biosystems, Foster City, CA, USA) at the DNA Core Facility at Florida International 
University using the BigDye Terminator version 3.1 (Applied Biosystems) with the 27F and 
1492R primers. The sequences were trimmed, cleaned, aligned, and assembled using DNA 
Baser Sequence Assembler (v3.2.5). The nearly full-length sequences (covering the V1–V9 
variable regions of the 16S rRNA gene) were then analyzed using the BLAST queuing 
system315 to identify their closest relatives in NCBI GenBank. Sequences analyzed in the 
first study were submitted to the GenBank database under accession numbers BBD-CUR-
3M8 (KF494427), BBD-CUR-3S11 (KF494426) and Ferrimonas sp. EF3B-B688 
(KC545309). Sequences analyzed in the second study were submitted to GenBank 
database under the accession numbers KX146440- KX146449 and KX353776-KX353778, 
and cultures. 
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Growth challenge assays. To determine whether a subset of BBD and SML isolates 
produce secondary metabolites that impact the growth of other BBD and SML bacteria, 
CFs from 19 isolates were used to challenge the growth of the other members of this group 
of isolates. The 19 isolates consisted of nine that tested positive for AHL in at least one of 
the C. violaceum CV026 and A. tumefaciens NTL4(pZLR4) reporter strain assays, and an 
additional 10 isolates that were randomly selected from the pool of isolates that tested 
negative in both assays. These isolates were also examined for synthesis of DPD. A total 
of 342 growth challenges was conducted (i.e., each of the 19 CFs were tested against the 
18 other isolate cultures). The bacterial growth challenges were conducted in sterile 96-
well microtiter plates (BD Falcon 351172). Each isolate was grown in sterile MB overnight 
at 29°C (shaking) and added to the appropriate wells. Assay plates contained triplicate 
experimental wells, control wells, and blank wells, with a single reference well for each CF 
tested to ensure that the CFs were sterile. The final volume in each well was 100 µL. 
Plates were incubated at 29°C (shaking) and OD600 readings were conducted every 30–
60 min using the Modulus Microplate Multimode Reader until the bacterial isolate culture 
control reached stationary phase. The mean growth rate constant and mean generation 
time were calculated over the linear portion of the growth curve for the untreated control 
culture and the experimental treatments. Only statistically significant effects on culture 
growth will be discussed (t-test, p<0.05). 
 
Metagenomic analysis. Samples of BBD for metagenomics analysis were collected from 
BBD infected Colpophyllia natans (Horseshoe Reef, northern Florida Keys, August 2013) 
and Pseudodiploria strigosa (Curaçao, off shore of the CARMABI research station, May 
2013). Samples were collected with sterile 10 ml syringes and placed in RNA-later, frozen 
at -80̊ C and sent for whole genome sequencing via Illumina HiSeq to Patrick Gillevet’s 
laboratory at George Mason University, Fairfax, Virginia. We obtained an average of 12 
million reads per sample with a read length of 150 base pairs. The metagenomics datasets 
were uploaded for analysis on the Metagenomics RAST (MG-RAST) server 
(http://metagenomics.anl.gov/). MG-RAST is a public resource for the automatic 
phylogenetic and functional analysis of metagenomes (Meyer et al. 2008). The presence 
of QS genes was assessed by using the subsystems with MG-RAST (Max. e-value cutoff= 
10-5, Min. % identity cutoff = 60%, Min. alignment length cutoff = 40 amino 273 acids).  
AHL and antimicrobial production detected in the second study. A total of 229 pure 
cultures of heterotrophic bacteria were isolated from four BBD infected colonies of two 
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coral species. Of these, 155 were from BBD, 38 were from apparently healthy coral 
(HSML) and 36 were from the apparently healthy part of BBD infected coral (BSML). Each 
isolate was tested for both QS signal production, using the Chromobacterium violaceum 
CV026 bioassay, and for antimicrobial activity. 
 
4.4 Results 
 
AHL production identified using reporter strains in the first study. Nine BBD mat 
(full community) samples, collected from two Caribbean coral species (Montastraea 
cavernosa and Diploria strigosa), were examined using both the C. violaceumCV026 
and A. tumefaciens NTL4(pZLR4) patch test assays. Each test was positive, revealing that 
both short-chain and medium- to long-chain AHLs are present in freshly collected, active 
BBD mat. A total of 199 bacterial isolates (BBD and SML) were examined using the C. 
violaceum CV026 assay. Of these, four (2.0%) tested positive for the patch test and none 
for the CF test (Table 4.4). A subset of isolates (N = 153) was also examined using the A. 
tumefaciens NTL4(pZLR4) assay and of these, nine (5.9%) tested positive for either the 
patch or CF test (Table 4.4). 
 
In total, 11 (5.5%) of the 199 isolates strains were positive for at least one of the two AHL 
reporter strain assays, and two of these isolates (i.e., BBD-FTL-6j and BBD-FTL-8c) tested 
positive in both assays. These two isolates were both positive in the patch test with the C. 
violaceumCV026 assay and the CF test with A. tumefaciens NTL4(pZLR4), indicating that 
they produce short-chain AHLs when grown in benthic form (on MA) and medium- to long-
chain AHLs when grown in planktonic form (in MB). The two isolates that tested positive for 
both assays were each a 99% (16S rRNA gene) sequence match in GenBank to one strain 
of Vibrio rotiferianus; however, they were obtained from BBD infections on two separate 
coral colonies and exhibited different colony morphologies when grown on agar. Five of the 
11 isolates tested positive in both the patch and CF assays with A. 
tumefaciens NTL4(pZLR4), indicating that these isolates produced medium- to long-chain 
AHLs when growing in planktonic or benthic form. Two isolates were positive only for the A. 
tumefaciens NTL4(pZLR4) patch tests. Of the 11 AHL-positive isolates, five were from BBD 
samples (collected from five separate BBD-infected coral colonies), two from BSML 
samples, and four from HSML samples. None of the eight BBD cyanobacterial strains tested 
positive in either AHL reporter stain assay. 
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  Table 4.4. Reporter assay results and sequencing data for the eleven bacterial isolates that tested 
positive for AHL production.  
 
BBD and Coral 
Isoaltes
Patch test CF Test Patch Test CF Assay GenBank 
Accession 
No.
Sequence 
Length (bp)
Closest Relative in GenBank (% 
Similarity), Accession No. 
BBD-FTL-6j + - - + KF148598 1393 bVibrio rotiferianus strain : LMG 
21460 (99%), NR042081
BBD-FTL-8c + - - + KF148599 1415 bVibrio rotiferianus strain : LMG 
21460 (99%), NR042081
BBD-FTL-1d - - + + KF148596 1326 Nautella italica Istrain : LMG 24365 
(99%), NR042673
BBD-FTL-3MB + NTc NTd NTd KF494427 1391 Vibrio harveyi strain : NB0903 
(99%), HM008704
BBD-FTL-3S11 + NTc NTd NTd KF494426 1396 Vibrio harveyi strain : BD1 (99%), 
KC756840
BSML-FTL-6w - - + - KF48595 1326 Ruegeria scottomollicae : LMG 
24367 (96%), KC756840
BSML-FTL-7l NDe - + - KF148600 1385 Pseudoalteromonas phenolica 
strain O-BC30 (98%), NR028809
HSML-FTL-9c - - + + KF148601 1414 Vibrio harveyi strain NCIMB 1280 
(99%), NR043165
HSML-FTL-9e - - + + KF148602 1398 Aliagarivorans marinus strain 
AAM1 (95%), NR044585
HSML-FTL-9i - - + + KF148603 1345 Pseudoruegeria aquimaris strain 
SW-255 (96%), NR043932
HSML-FTL-10a NDe - + + KF148597 1387 Pseudoalteromonas luteoviolacea 
strain NCIMB 1893 (99%), 
NR026221
Chromobacterium 
violaceum CV026 Assay a
Agrobacterium tumefaciens 
NTl4(PZLR4) Assaya
"+" indicates a positive assay result and a "-" indicates a negative resulta. Although BBD-FTL-6j and 
BBD-FTL-8c shared the same closest relative in GenBank, these isolates showed differing colony 
morphologies and were isolated form two different BBD samples on three separate coral coloniesb. 
Culture fluids of isolates not tested with the C. violaceum CV026 reporter strainc. Isolates not tested 
with the A. tumefaciens NTL4(pZLR4) reporter straind. Not detectable. These isolates inhibited 
growth of the C. violaceum CV026 reporter strain in the patch tests, eliciting an area of clear, cell-
free agar in the assay plate surrounding the bacterial patch. Additionally, isolate HSML-FTL-10a 
produced a dark purple pigmente.  
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AI-2 Production identified using reporter strains from the first study. More than 
half (84, or 55%) of the 153 CFs tested positive in the AI-2 reporter strain assay (Table 
4.5). Figure 4.2 shows results of a representative experiment using the CFs of four 
isolates, including two that tested positive (BSML-FTL-7m and BSML-FTL-7q) and two 
that tested negative (BSML-FTL-7h and BSML-FTL-7k). The positive results indicate that 
isolates produced DPD-like molecules (or a CAI-1 signal specific to certain Vibrio spp.) 
that can be detected by the V. harveyi BB170 reporter strain used in this study. 
  
 
The AI-2 activity induced by CFs from the positive isolates ranged widely, from 
approximately 28% to 346% of the positive control luminescence (Table 4.6) with the 
triplicate readings within 30% of the mean luminescence values, expressed in relative light 
units (rlu). The induction of luminescence over the positive control was calculated for each 
CF tested and ranged from 0.22–2.8 fold. 70% of the BBD CFs, 68% of the BSML CFs and 
33% of the HSML CFs tested positive for AI-2 production (Table 4.5). None of the 
cyanobacterial CFs tested positive in the AI-2 assay.  
 
The media used in this study did not in any case stimulate light production in the AI-2 assay 
prior to self-induction by the V. harveyi BB170 reporter strain (Figure 4.3). The slight rise in 
luminescence near the end of the experiment is likely the result of light contamination from 
adjacent wells (Figure 4.3). The medium control curves indicate that the three growth media 
used in this study did not stimulate light production prior to self-induction by the Vibrio 
harveyi BB170 reporter strain. The luminescence of the medium reference wells, which 
contained sterile growth media, remained minimal over the course of the AI-2 reporter assay, 
although some minor increases in light were measured in these wells at the end of the assay 
due to light contamination from adjacent wells. Arrow indicates time of self-induction by the 
reporter strain, after which the luminescence of the reporter strain increases rapidly. 
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Figure 4.2. Representative experiment showing light production over time in the AI-2 reporter 
strain assay. The curves generated by the cell-free culture filtrates (CFs) from BSML-FTL-7m and 
BSML-FTL-7q (both positive in the assay) follow the positive control curve. The curves generated by 
the CFs from BSML-FTL-7h and BSML-FTL-7k (both negative in the assay) follow the Marine Broth 
(MB) medium control curve. Dashed vertical line indicates the optimal time point (OTP) of the assay, 
which is the time point immediately preceding self-induction by the V. harveyi BB170 reporter strain 
and the time when the mean luminescence of the medium control wells was lowest during the course 
of the assay. Data at the OTP is used to calculate the percentage of AI-2 (% AI-2) activity and the 
induction of luminescence over the positive control. 
Table 4.5. Autoinducer-2 activity detected using the Vibrio harveyi BB170 reporter strain presented 
according to isolate type.  
 
Isolate Type No. CFs Tested No. and % Positive CFs Percentage of Total Positive Results
BBD 63 44 (70%) 52%
BSML 37 25 (68%) 30%
HLML 45 15 (33%) 18%
Cyanobacteria 8 0 0%
Totals 153 84 (55%) 100%
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  Table 4.6. Percentage of AI-2 activity (± standard deviation) and induction of luminescence values for 
the 84 CFs that tested positive in the AI-2 assay. 
Isolate CF % AI-2 Activity 
( ± SD)
Induction of 
Luminescence
Isolate CF % AI-2 Activity 
( ± SD)
Induction of 
Luminescence
Isolate CF % AI-2 Activity 
( ± SD)
Induction of 
Luminescence
BBD-216-1b 345.84 ± 21.6 2.7 BBD-FTL-6c 120.89 ± 21.4 0.94 BSML-FLK-1h 65.307 ± 6.42 0.65
BBD-FTL-6j 275.70 ± 50.3 2.15 BSML-FLK-1i 117.61 ± 11.8 1.17 BSML-FLK-1a 65.153 ± 2.62 0.65
HSML-FTL-11b 275.28 ± 8.36 2.81 BBD-FTL-1g 116.64 ± 4.84 1.4 BSML-FLK-1l 63.282 ± 2.79 0.63
BBD-FLK-1h 271.58 ± 53.2 2.12 BSML-FTL-7m 115.50 ± 20.8 1.15 BSML-FTL-8b 60.889 ± 10.0 0.61
BBD-FLK-1k 260.04 ± 31.1 2.03 BSML-FLK-1k 115.34 ± 11.2 1.15 BBD-FTL-5f 60.073 ± 11.6 0.58
HSML-FTL-10bb 256.29 ± 14.8 2.62 BBD-FTL-6m 111.42 ± 11.3 1.07 BSML-FLK-1m 59.759 ± 9.66 0.6
BSML-FTL-7q 232.11 ± 12.8 2.32 BBD-FTL-6b 111.03 ± 27.9 0.87 BBD-FTL-8c 57.091 ± 3.90 0.68
BSML-FLK-1c 226.54 ± 12.2 2.26 BBD-216-2d 110.58 ± 7.23 1.07 BBD-FTL-7a 55.744 ± 4.52 0.54
HSML-FTL-9f 213.76 ± 16.1 1.7 BBD-FLK-1n 109.27 ± 15.5 0.85 BBD-FTL-4b 54.912 ± 5.43 0.43
HSML-FTL-9d 200.67 ± 11.9 1.6 BSML-FTL-7d 108.65 ± 19.7 1.3 BBD-FTL-6k 51.745 ± 2.51 0.5
HSML-FTL-11i 191.23 ± 10.6 1.96 BBD-FLK-1l 108.07 ± 13.1 0.84 BBD-FLK-1j 49.431 ± 9.76 0.39
HSML-FTL-10z 188.15 ± 5.13 1.92 BBD-FLK-1c 101.00 ± 6.31 0.79 BSML-FTL-6w 48.672 ± 6.20 0.47
HSML-FTL-10aa 173.52 ± 12.7 1.77 BBD-216-4e 99.694 ± 8.49 0.96 BBD-217-2d 47.873 ± 6.88 0.46
BBD-FLK-1b 173.11 ± 26.4 1.35 BSML-FTL-7o 97.875 ± 5.70 0.98 BBD-FLK-1e 45.179 ± 1.91 0.44
BBD-FTL-6g 167.57 ± 16.5 1.31 BBD-FTL-6p 95.795 ± 8.34 0.92 BBD-216-4a 42.636 ± 4.45 0.51
HSML-FTL-9m 156.74 ± 7.91 1.25 BSML-FTL-6u 95.241 ± 7.32 1.14 BBD-FTL-1m 42.118 ± 0.30 0.5
BBD-FLK-1m 148.82 ± 22.8 1.16 BBD-FTL-6n 90.130 ± 11.8 0.87 HSML-FTL-10r 39.907 ± 4.77 0.32
HSML-FTL-9a 146.16 ± 11.0 1.16 BSML-FLK-1o 86.974 ± 6.15 0.87 BBD-FTL-7b 39.287 ± 1.19 0.38
HSML-FTL-9b 144.32 ± 14.4 1.15 BSML-FLK-1n 83.783 ± 5.23 0.84 BBD-FTL-3h 37.647 ± 2.27 0.36
BSML-FTL-7e 143.00 ± 17.9 1.71 BBD-216-3d 83.109 ± 1.18 0.8 BBD-FTL-1h 37.159 ± 6.77 0.44
BBD-FTL-3b 140.38 ± 4.35 1.1 BSML-FLK-1b 82.627 ± 13.8 0.82 HSML-FTL-11l 36.328 ± 5.64 0.37
BSML-FLK-1e 132.75 ± 7.79 1.32 BBD-FTL-1f 79.148 ± 19.5 0.95 BBD-FTL-1e 35.451 ± 2.36 0.42
BBD-FTL-8b 127.81 ± 9.08 1.53 BBD-217-2b 74.398 ± 19.0 0.89 BSML-FLK-1f 35.182 ± 8.99 0.35
HSML-FTL-9j 127.21 ± 8.97 1.01 BSML-FTL-6r 74.102 ± 6.47 0.89 HSML-FTL-9i 33.598 ± 3.87 0.27
BBD-FTL-3j 122.89 ± 5.15 1.18 BSML-FLK-1d 73.342 ± 3.42 0.73 BBD-FTL-6q 32.479 ± 1.54 0.31
BBD-FTL-1j 122.04 ± 3.40 1.46 BSML-FTL-7n 71.458 ± 14.4 0.71 HSML-FTL-9c 31.191 ± 5.50 0.25
BSML-FTL-8c 121.85 ± 6.18 1.22 BBD-FTL-6o 66.858 ± 5.12 0.64 BBD-FTL-6l 30.549 ± 2.75 0.29
BSML-FTL-8a 121.47 ± 4.81 1.21 BBD-FTL-1b 65.542 ± 2.36 0.63 BBD-FTL-6h 28.236 ± 3.21 0.22
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Figure 4.3. Light production of the media control wells and media reference wells in the AI-2 reporter 
assay. 
 
 
Figure 4.3. Light production of the media control wells and media reference wells in the AI-2 reporter 
assay. 
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Among the 229 isolates, 27 tested positive in the QS assay, consisting of 23 BBD isolates 
and two each from HSML and BSML. HSML and BSML isolates had similar percentages of 
isolates that tested positive for QS in the CV026 assay, 5.3% (2 out of 38) and 5.6% (2 out 
of 36) respectively. The percentage of QS positive isolates from BBD in comparison was 
approximately three times higher at 14.8% (24 of 155). When comparing QS producing 
isolates between BBD vs. HSML and BBD vs. BSML, a significant (p ≤ 0.05) difference in 
proportions was detected. The isolates from the different health states were also tested for 
antimicrobial activity against two ecologically relevant test strains, Roseovarius 
crassostreae CV919-312 and Ferrimonas sp. EF3B-B688 (Tables 4.7 and 4.8). In the case 
of R. crassostreae CV919-312, a higher percentage of BSML (13.9%) isolates caused 
inhibition in comparison to the HSML (10.5%) and BBD (9.0%) isolates. In contrast, the 
HSML isolates had the highest percentage that inhibited Ferrimonas sp. EF3B-B688 
(23.7%), followed by 293 5.6% of BSML isolates and 2.6% of BBD isolates. 23.7% isolates 
from HSML and 19.4% isolates from BSML also inhibited C. violaceum CV026. When 
viewing the isolates as a whole, of the 229 that were tested 23 (14.8%) inhibited R. 
crassostreae CV919-312, 15 (6.6%) inhibited the growth of Ferrimonas sp. EF3B-B688, and 
16 (6.9%) inhibited the QS reporter strain. 
 
Varieties and relative abundance of AHLs in the first study. With one exception 
(BSML-FTL-7l), each of the 11 isolates that were examined for identification of AHLs by 
LC-MS/MS produced AHLs under both planktonic (MB) and benthic (MA) conditions 
(Table 4.9), a result that is in contrast to the variable results obtained using the reporter 
strains. Note that of these 11 strains, 10 were discussed previously in terms of reporter 
strain results (Table 4.4).  
 
One strain (HSML-FTL-10a) was not analyzed by LC-MS/MS because this strain failed to 
grow at the time of the LC-MS/MS analysis. Also, note the inclusion of an additional isolate 
(BBD-FLK-1M2) not previously discussed (Table 4.9). Though this isolate tested negative 
for AHL production using the reporter assays, it is the subject of current physiological studies 
of BBD bacteria (data not included here), and thus was included in the LC-MS/MS analysis. 
The most common AHL variant produced among the 11 isolates was C6-HSL, produced by 
five (45%) of the strains in liquid culture and seven (64%) of the strains grown on plates 
(Table 4.9). This signal accounted for 50–92% of the AHLs produced (per strain) and was 
produced by all of the AHL-positive strains isolated from BBD and two strains from the SML  
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Table 4.8. Isolates from the three coral health states that were positive for QS signal production tested 
with the C. violaceum CV026 biosensor strain, and antimicrobial activity against R. crassostreae 
CV919-312, Ferrimonas sp. EF3B-B688, and C. violaceum CV026. 
 
Table 4.8. Isolates from the three coral health states that were positive for QS signal production 
tested with the C. violaceum CV026 biosensor strain, and antimicrobial activity against R. 
crassostreae CV919-312, Ferrimonas sp. EF3B-B688, and C. violaceum CV026. 
Table 4.7. Sampling dates and locations and bacterial isolates used in this study.  
Isoaltes AHLs Detected in Liquid Culturea,c,d AHLs Detected on Agarb,c,d DPD Conc (µM)1,5
BBD-FTL-6j C6 (78%), 3OC4 (13%), 3 others (9%) C6 (74%), 3OC4 (11%), 3 
others
0.99±0.32
BBD-FTL-8c C6 (70%), 3OC4 (11%), 6 others (9%) C6 (50%), 3OC6 (21%), C4 
(13%), 4 others (16%)
0.94±0.09
BBD-FTL-1d C6 (69%), 3OHC10 (9%), 9 others (22%) C6 (61%), 7 others (39%) 1.08±0.28
BBD-FTL-3MB C6 (92%), 3 others (8%) C6 (69%), COC4 (31%) 1.10±0.49
BBD-FTL-3S11 C6 (86%), 3 others (14%) C6 (80%), 3 others (20%) 1.38±0.19
BSML-FTL-6w C14 (45%), C10 (26%), 3OHC4 (23%), 3OC20 
(5%)
C10 (39%), 3OHC8 (23%), 
3OC4 (18%), 3others 
(20%)
0.32±0.13
BSML-FTL-7l 26 AHLs measured (ranging from 0.6-14%) NDf 0.48±0.09
HSML-FTL-9c 3OC4 (52%), C14(31%), 3OC18:1 (12%), 
3OC20 (5%)
3OHC9:1 (79%), 3OHC4 
(21%)
1.41±0.16
HSML-FTL-9e 3OHC10 (75%), 7 others (15%) C6 (65%), 3OHC10 (22%), 4 
others (13%)
0.37±0.02
HSML-FTL-9i 3OHC10 (70%), 3OHC18 (14%), 2 others 
(16%)
C6 (51%), 3OHC10 (36%), 
3OC4:1 (14%)
0.31±0.08
HSML-FTL-1M2g 3OC6 (29%), 3OC18:1 (19%), C14 (19%), 
3OHC10 (12%), 7 others (21%)
3OHC10 (100%) 1.19±0.12
Isolate 
Source 
No. of isolates positive 
in CV026 QS assay
No. of isolates inhibiting R. 
crassostreae CV919-312
No. of isolates inhibiting 
Ferrimonas sp. EF3B-B688
No. of isolates inhibiting 
C. violaceum CV026
Total no. of 
isolates tested
HSML 2 (5.3%) 4 (10.5%) 9 (23.7%) 9 (23.7%) 38
BSML 2 (5.6%) 5 (13.9%) 2 (5.6%) 7 (19.4%) 36
BBD 23 (14.8%) 14 (9.0%) 4 (2.6%) 0 (0%) 155
Total 27 (11.8%) 23 (14.8%) 15 (6.6%) 16.9 (6.9%) 229
BBD = black band disease mat sample, HSML= sample taken from apparently healthy coral of the 
same host species, BSML= sample taken from the apparently healthy part of the BBD infected coral. 
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Table 4.9. AHLs detected via LC-MS/MS after 24 hour incubation.  
 
Location Date of sample collection Coral host Sample 
type
No. of 
isolates
Horseshoe Reef, 
Florida Keys, Fl, 
USA (N 25° 08.362' 
W 80° 17.641')
9/30/2012 Pseudodiploria strigosa BBD 8
Water Factory, 
Curacao, 
Netherlands Antilles 
(N 12° 06.779' W 
68° 57.662')
2/23/2013 P. strigosa BBD 44
Water Factory, 
Curacao, 
Netherlands Antilles 
(N 12° 06.779' W 
68° 57.662')
5/25/2013 P. strigosa BBD 67
Algae Reef, Florida 
Keys, Fl, USA (N 
25° 08.799' W 80° 
17.579')
8/19/2013 Montastraea cavernosa BBD, 
HSML, 
BSML
36, 38, 36
Total number of isolates isolated and tested 229
Results are an average of four samples (two cultures sampled twice)a. Results are an average of six 
samples (two cultures injected twice)b. Percentages represent relative abundance within the culturec. 
AHLs are comprised of a homoserine lactone ring attached to an acyl side chain (generally between 
4-20 carbons in length) and may have a keto or hydroxy substituent ant the C3-position. 
Abbreviations: CX - AHL contains "X" carbon molecules in the acyl chain; 3OCX-AHL has a keto 
substituent at the C3-position; 3OHCX-AHL has a hydroxyl substituent at the C3-positiond. Error is 
reported substituent at the C3-positione. Not detectedf. Isolate BBD-FLK-1M2 was identified through 
16S rRNA gene sequencing as a 100% match to Ferrimonas sp. EF3B-B688 (Accession No. 
KC54309.1). This isolate tested negative in the Chromobacterium violaceum CV026 parch test and 
was not tested using the Agrobacterium tumefaciens NTL4(pZLR4) assayg. 
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of (two) apparently healthy corals (HSML samples). The second most common AHL was 
3OC4-HSL, detected in five (45%) of the strains (isolated from 3 BBD, 1 BSML, and 1 HSML 
sample). This variant accounted for a maximum of 52% of AHL detected for strain HSML-
FTL-9c (range of 11–52%). Additional AHLs were produced by fewer strains, but in some 
cases were the majority of the variant detected (e.g., for strains HSML-FTL-9e and HSML-
FTL-9i grown in broth culture, 3OHC10-HSL accounted for 75% and 70% of AHLs produced, 
respectively). Other AHLs were produced in smaller amounts (see Table 4.9), including 
3OC20-HSL which constituted 5% of AHLs produced by two isolates. To our knowledge, this 
AHL has not been reported in the literature. 
 
DPD Quantitation from the first study. LC-MS/MS was also used to assess the 
presence and concentration of DPD produced by the 11 isolates discussed above. All of 
the isolates produced DPD at concentrations that ranged from 0.31 to 1.41 µM (Table 
4.9). All six of the BBD isolates produced high amounts of DPD (average of 1.11 µM) 
while, with one exception, the SML isolates (both HSML and BSML) produced much less 
(approximately one third to one half of the amount produced by BBD isolates). The 
anomalous isolate (HSML-FTL-9c), which produced the highest concentration of DPD 
detected for any strain independent of source, was a 99% match to Vibrio harveyi, a well-
known AI-2 signaling species. The other five isolates produced an average of 0.37 µM 
DPD. 
 
Variety and relative abundance of AHLs across different temperatures from the 
second study. A subset of isolates (23 of the 27 that tested positive for AHL signal 
production), 298 plus the 299 ATCC culture of R. crassostreae, were investigated further 
(Tables 4.10 and 4.11). Data are reported for only one of the two BSML isolates that 
tested positive in the C. violaceum assay since the second did not grow during the 
additional experiments. The isolates tested were identified by 16S rRNA gene sequencing 
(Table 4.10) and analyzed using LC-MS/MS to determine the identity and relative 
abundance of specific AHLs (Table 4.11). Nearly all the isolates were found to be Vibrio 
species. It should also be noted that several Vibrio harveyi and Vibrio spp. are different 
strains (Table 4.11). One isolate, Pseudoalteromonas ruthenica strain D2-5M, did not 
yield any identifiable AHLs although this strain was positive in the QS reporter assay. The 
identity and relative abundance of AHLs produced by the subset of isolates were across 
three temperatures (24 C̊, 27 C̊ and 30 ̊C) across six time points (t = 0, 2, 4, 6, 8, and 10  
164 
 
  
Table 4.10. Identification of AHL producing isolates used in this study based on 16S rRNA gene 
sequencing.  
Strain no. Isolate Source Genbank 
Accession 
Number
Closest relative in 
Genbank
Percentage 
Similarity of 
relative
Accession number 
of closest relative 
in GenBank
1 BBD-CUR-
3M8
BBD KF494427 Vibrio harveyi   strain 
NB0903
99% HM008704
2 BBD-CUR-
3S11
BBD KF494426 Vibrio rotiferianus strain 
DBI
99% KC756840
3 3-BBD-S26 BBD KX353778 Uncultured 
proteobacterium clone 
ATIntfc2_RS175
99% KM018571
4 4-BBD-S11 BBD KX353777 Vibrio  sp. PaD3.29b 100% GQ406662
5 5-BBD-S1 BBD KX353776 Vibrio harveyi   strain 
QH141026D
99% KU245732
6 5-BBD-S5 BBD NA NA NA NA
7 5-BBD-S8 BBD KX146443 Vibrio harveyi  strain 
X11XC19
99% KM881533
8 5-BBD-S11 BBD KX146444 Vibrio  sp. PMS13 99% EU372931
9 5-BBD-S21 BBD NA NA NA NA
10 5-BBD-S22 BBD KX146442 Vibrio harveyi   strain 
QH141026D
99% KU245732
11 5-BBD-S24 BBD NA NA NA NA
12 5-BBD-M2 BBD KX146440 Vibrio harveyi   strain 
QH141026D
99%
13 5-BBD-M5 BBD NA NA NA NA
14 5-BBD-M6 BBD KX146441 Vibrio harveyi   strain 
QH141026D
99% KU245732
15 5-BBD-M10 BBD KX146445 Vibrio harveyi  strain 
bb4
99% KC455398
16 5-BBD-M12 BBD KX146446 Vibrio sp. sw0106-05 100% KT276382
17 4-BBD-M29 BBD KX146447 Pseudoalteromonas 
ruthenica  strain D2-5M
99% AB617562
18 Roseovarius 
crassostreae 
CV919-312
ATCC NA NA NA NA
19 Ferrimonas 
sp. EF3B-
B688
BBD KC545309 NA NA NA
20 4-BBD-M13 BBD NA NA NA NA
21 5-BBD-M4 BBD KX146448 Vibrio tubiashii  strain 
T33
99% KP329558
22 5-BBD-S17 BSML KX146449 Vibrio  sp. PaH2.06c 99% GQ406738
23 5-BBD-S16 HSML NA NA NA NA
24 5-BBD-S1 HSML NA NA NA NA
ATCC = American Type Culture Collection. ‘M’ in isolate designation refers to culture isolated using 
marine agar medium; ‘S’ in isolate designation refers to culture isolated using sea water tryptone 
agar medium. NA = not applicable, “-“= cultures that failed to grow for 16S rRNA gene identification. 
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Table 4.11. Percentages of AHLs produced by each isolate across three temperatures and six time 
points (pooled and averaging replicate sample values) as analyzed by LC-MS/MS. 
 
Table 4.11. Percentages of AHLs produced by each isolate across three temperatures and six time 
points (pooled and averaging replicate sample values) as analyzed by LC-MS/MS. 
Strain no. Designation of 
isolate
Source of 
isolate
3OHC4 C5 3OHC5 3OC5:1 C6 3OHC6 3OHC8 3OC12
1 BBD-CUR-3M8 BBD 5.10% 3.40% - - 91.50% - - -
2 BBD-CUR-3S11 BBD - - - - 100% - - -
3 3-S26 BBD - 1.90% 10.20% - 87.90% - - -
4 4-S11 BBD - - - - 100% - - -
5 5-BBD-S1 BBD 2.60% - - - 97.40% - - -
6 5-BBD-S5 BBD - 1.50% - 2.70% 95.80% - - -
7 5-BBD-S8 BBD - - - - 100% - - -
8 5-BBD-S11 BBD 98.70% - 1.30% - - - - -
9 5-BBD-S21 BBD 6.50% - - - 93.50% - - -
10 5-BBD-S22 BBD 96.40% - 3.60% - - - - -
11 5-BBD-S24 BBD 98.30% - 1.70% - - - - -
12 5-BBD-M2 BBD 45.40% - - - 54.60% - - -
13 5-BBD-M5 BBD 37.90% - - - 62.10% - - -
14 5-BBD-M6 BBD 98.60% - 1.40% - - - - -
15 5-BBD-M10 BBD 98.60% - 1.40% - - - - -
16 5-BBD-M12 BBD 31.20% - - - - 68.80% - -
17 4-BBD-M29 BBD No AHL 
detected
18 Roseovarius 
crassostreae 
CV919-312
ATCC - - - - 100% - - -
19 Ferrimonas sp. 
EF3B-B688
BBD 87.60% - - - 12.40% - - -
20 4-BBD-M13 BBD 94.50% - 2.70% - 2.80% - - -
21 5-BBD-M4 BBD 66.70% - - - - 32.00% 1.30% -
22 5-BSML-S17 BSML 99.20% - - - - 0.80% - -
23 5-HSML-S16 HSML 12.90% - - - - 78.90% - 8.20%
24 5-HSML-S1 HSML 75.70% - - - - 3.80% - 20.50%
Number of times 
the corresponding 
AHL is present (out 
of 24)
17 3 7 1 13 5 1 2
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hours). Data  are reported in amounts of relative abundance of AHLs per isolate (Table 
4.11). 3OHC4 was found to be produced by the highest number of isolates (17 out of 24), 
followed by C6 (13 out of 24), 3OHC5 (6 out of 24) and 3OHC6 (5 out of 24). Comparing 
relative quantities (per isolate), the production of 3OHC4 was approximately 10-fold that 
of the next most abundantly produced AHL, C6 (data not shown), followed by 3OHC5 and 
3OHC6 (produced by seven and five isolates respectively). C5 was produced by three 
isolates. The longest chain AHL (3OC12) detected in this study was produced by two 
isolates, both from HSML. 3OC5:1 and 3OHC8 were the rarest, each with one isolate 
producing it in combination with other AHLs. Of the 24 isolates, four isolates produced 
only one AHL, identified as C6 in all cases (Table 4.11). Twelve isolates produced two 
AHLs and seven isolates produced three AHLs. The two HSML isolates produced the 
same three AHLs (3OHC4, 3OHC6 and 3OC12) but in varying percentages. Most of the 
AHL production by the sole BSML isolate tested was contributed by 3OHC4 (99.2%). At 
each sampling, the OD for each isolate was measured to assess any correlation 321 
between AHL production and the stage of growth of that isolate. The growth curves were 
found to be standard across all isolates and there was no correlation between AHL 
production and growth (data not shown). 
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Table 4.12 compiles statistically significant results from an ANOVA multivariate analysis of 
all isolates that produced a particular AHL together with results of ANOVA repeated measure 
analyzing all isolates individually for each AHL at three different temperatures. For both of 
these statistical tests, AHL production values across all time-points were taken together 
across all replicates (p ≤ 0.05). Twelve of the 24 isolates tested exhibited significant 
differences in AHL production in terms of temperature, and of these 12, ten were isolated 
from BBD and were vibrios. Isolates with non-significant differences in AHL production 
across temperature, and temperature comparisons that were non-significant for a particular 
AHL, are not shown (Table 4.12). AHLs 3OHC4, 3OHC5 and 3OHC6 had significant 
differences across all three temperature comparisons for some of the isolates, while 3OC5:1 
had a significant difference only when comparing temperatures 24 ̊C vs. 27 ̊C (Table 4.12). 
However, it is noteworthy that these results pertained to only one isolate that produced this 
AHL (isolate no. 6). 
 
Table 4.13 shows relative AHL production among isolates (all time-points pooled) when 
comparing production at 24 ̊C vs 30 ̊C (below and above the temperature threshold of BBD 
on the reef). Only data that were significant (p ≤ 0.05) are shown, representing seven of the 
24 tested. Of these seven, six were from BBD (all vibrios) and one from HSML (isolate no. 
23). In each case AHL production was relatively higher at 30 ̊C when compared to 24 ̊C. 
This elevated production above the BBD temperature threshold was seen for four AHLs, 
with 3OHC5 by far the most common. 
Table 4.12. Results of ANOVA repeated measures analysis of all isolates individually for AHL 
production, and ANOVA multivariate analysis comparing each AHL individually across all isolates.  
1 6 8 10 11 14 15 16 20 21 23 24
3OHC4 24 ̊C vs. 27  ̊C 0.05 - NS NS NS NS NS 0.001 NS NS NS 0.014 0.017
27 ̊C vs. 30  ̊C NS - NS NS NS NS NS 0 NS 0.045 0.001 0 0.017
24 ̊C vs. 30  ̊C NS - NS NS NS NS NS NS NS NS 0.001 NS 0
3OHC5 24 ̊C vs. 27  ̊C - - NS NS NS 0.012 0.036 - 0 - - - 0
27 ̊C vs. 30  ̊C - - NS NS NS 0.002 0.008 - NS - - - 0
24 ̊C vs. 30  ̊C - - 0.001 0.002 0 0 0 - 0 - - - 0
C6 24 ̊C vs. 27  ̊C NS NS - - - - - - 0 - - - NS
27 ̊C vs. 30  ̊C NS NS - - - - - - 0 - - - NS
3OHC6 24 ̊C vs. 27  ̊C - - - - - - - 0.01 - 0.001 0 NS 0
27 ̊C vs. 30  ̊C - - - - - - - NS - 0.004 0.02 NS 0.011
24 ̊C vs. 30  ̊C - - - - - - - NS - NS 0 NS 0.006
3OC5:1 24 ̊C vs. 27  ̊C - 0.011 - - - - - - - - - - 0.011
AHL Temperatures 
compared
Isolate ID Overall 
significance 
across isolates
All time-points were pooled across all replicates (p ≤ 0.05). Comparisons of AHL quantitation were 
done in pairs (24 ̊C vs. 27 ̊C, 27 ̊C vs. 30 ̊C, 24 ̊C vs. 30 C̊). “-” = absence of AHL production, NS = 
non-significant AHL production, *0.000 indicates that the p values were very small or very significant. 
Only data for AHLs that yielded a significant difference per temperature comparison are shown. 
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Table 4.13. Comparison of AHL production by isolates at 24 ̊C vs 30 ̊C.  
 
 
Table 4.13. Comparison of AHL production by isolates at 24 C̊ vs 30 ̊C. Only results that were 
statistically significant (p < 0.05) are presented. “-” = absence of AHL production, NS = non-significant 
AHL production. 
 
24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C 24  ̊C 30  ̊C
NS NS - - Lower Higher - - - - - - - - - -
NS NS - - Lower Higher - - - - - - - - - -
NS NS - - Lower Higher - - - - - - - - - -
NS NS - - Lower Higher - - - - - - - - - -
NS NS - - Lower High r - - - - - - - - -
NS NS - - Lower Higher - - Lower Higher - - - - - -
Lower Higher - - - - - - - - Lower Higher - - NS NS
3OHC8 3OC123OHC4 C5 3OHC5 3OC5:1 C6 3OHC6
Only results that were statistically significant (p < 0.05) are presented. “-” = absence of AHL 
production, NS = non-significant AHL production. 
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Comparison of AHLs across three coral health states from the second study. 
BBD isolates, in addition to constituting the sample group with the highest number of QS 
producing isolates (Table 4.8), produced the largest variety of AHLs when compared to 
isolates from the other two coral health states (Table 4.14). AHLs 3OHC4 and 3OHC6 
were produced by isolates from all three health states. These AHLs were also two of the 
four that varied significantly in terms of temperature (Table 4.9) and, as noted above, 
3OHC4 was the most commonly produced AHL among all isolates (Table 4.14). 
 
 
Growth Challenge Assays. Of the 342 growth challenges, 92 (27%) resulted in 
significant (see methods) inhibition and eight (2.3%) resulted in significant stimulation of 
isolate growth (Table 4.15). When considered by isolate source and the number of isolates 
tested per source, the CFs of HSML isolates inhibited the most growth at 32% of 
challenges (29 of 90 tests), followed by the CFs of BSML isolates (26%, or 28 of 108), and 
CFs of BBD isolates (24%, or 35 of 144). Growth stimulation by CFs occurred for 
approximately 4% of challenges with BSML isolates, 2% of BBD isolates, and 1% of HSML 
isolates (Table 4.15). Independent group t-tests revealed that there was no significant 
difference (p>0.05) between the numbers of cultures inhibited or stimulated by CFs from 
any combination of the three isolate types. The 19 isolates examined in the growth 
challenges included nine AHL-positive isolates (Table 4.15). Five of these nine also tested 
positive for AI-2 activity using the V. harveyi BB170 reporter strain assay, and eight produced 
DPD detected by LC-MS/MS (Table 4.9). Of the 10 AHL-negative isolates, nine tested 
positive for AI-2 activity. Table 4.16 examines the correlation between the 
presence/absence of AHL, AI-2 activity, and DPD among isolates that caused inhibition of 
growth. Strain HSML-FTL-10a (which inhibited seven strains and stimulated one; Table 
4.15) was not included in this data set because it did not grow during the LC-MS/MS  
Table 4.14. Comparison of AHLs produced by isolates in terms of isolate origin across three coral 
health states.  
 
 
Table 4.14. Comparison of AHLs produced by isolates in terms of isolate origin across three coral 
health states.  
 
BBD infected coral 
(BBD) (n=20)
SML of healthy coral 
(HSML) (n=2)
SML from healthy part of BBD infected 
coral (BSML) (n=1)
3OHC4 3OHC4 3OHC4
3OHC6 3OHC6 3OHC6
C5 3OC12
3OHC5
3OC5:1
C6
3OHC8
Isolate Source
170 
 
  
Table 4.15. Isolates that elicited inhibition and stimulation of growth according to isolate source and 
production of AHLs or AI-2 activity based on reporter strain data and DPD (LC-MS/MS).  
 
Isolate Source CF Tested AHL AI-2 DPD No. 
Cultures 
Inhibited
No. 
Cultures 
Stimulated 
BBD (144 challenges) BBD-FTL-6j + + + 6 0
BBD-FTL-8c + + + 3 0
BBD-FTK-1d + - + 3 0
BBD-FTL-1ha - + NT 4 0
BBD-FTL-6da - - NT 6 1
BBD-FTL-6na - + NT 5 0
BBD-FTL-6pa - + NT 6 1
BBD-FTK-1ea - + NT 2 1
N and % of 
Challengesb
35 (24%) 3 (2.1%)
BSML (108 challenges) BSML-FTL-6w + + + 9 1
BSML-FTL-7l + - + 3 0
BSML-FTL-6ua - + NT 5 1
BSML-FTL-7da - + NT 4 2
BSML-FTL-7qa - + NT 4 0
BSML-FTL-1da - + NT 28 (26%) 0
N and % of 
Challengesb
4 (3.7%)
HSML (90 challenges) HSML-FTL-9c + + + 3 0
HSML-FTL-9e + + + 4 0
HSML-FTL-9i + + + 4 0
HSML-FTL-10aa + + NT 11 0
HSML-FTL-10ra - - NT 7 1
N and % of 
Challengesb
29 (32%) 1 (1.1%)
Total Challenges (342) 92 (27%)
These strains denoted were not analyzed for DPD production using LC-MS/MS (refer to Table 6)a. 
The percent values denoted represent the percent of the total challenges (144 BBD strains, 108 
BSML strains, and 90 HSML strains) that resulted in inhibition or stimulation of growth in each isolate 
source category. 
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Table 4.16. Percent of 81 assays that resulted in growth inhibition.  
 
 
Table 4.16. Table 4.16. Correlations between autoinducer production and inhibition of growth. 
Percent of 81 assays that resulted in growth inhibition. Isolate HSML-FTL-10a not included (see text). 
Percent of 81 assays that resulted in growth inhibition. Isolate HSML-FTL-10a not included (see 
text)a. 
 
Source of Isolate and 
Autoinducer Produced
No. Isolates that Elicited Inhibition (No. Test Strains Inhibited) % of Inhibitiona
Source of Isolate BBD BSML HSML 49.4
AI-2/DPD 4 (17) 4 (16) 1 (7) 13.2
AHL and AI-2/DPD 3 (12) 2 (12) 3 (11) 7.4
Neither 1 (6) 0 0 100%
Total 8 (35) 6(28) 4 (18)
Isolate HSML-FTL-10a not included (see text)a. 
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experiments. Although HSML-FTL-10a was negative for AI-2 activity using the reporter 
strain, three additional strains that also tested negative for the reporter strain assay 
produced detectable DPD (Table 4.9), thus we cannot rule out that HSML-FTL-10a also 
produces DPD. The resulting data set therefore consists of 81 challenges (using 18 
isolates) that resulted in inhibition of growth. Of these, nine strains produced AI-2/DPD 
(positive for at least one of these assays) but no AHL, and were responsible for 49% of 
the 81 cases of growth inhibition. Eight strains produced both AI-2/DPD and AHL, and 
inhibited 43% of the 81 cases. One strain (BBD-FTL-6d) did not produce AI-2/DPD or AHL 
and inhibited six isolates. There was no statistically significant difference (independent 
group t-tests, p>0.05) between the number of cultures inhibited by isolates producing AI-
2/DPD only and those that produced both AHL and AI-2-DPD. 
 
Metagenomics analysis. Table 8 presents all proteins and their ascribed functions 
associated with QS genes that were identified in BBD metagenomes from the Florida Keys 
and Curacao samples under the subsystem category of regulation and cell signaling within 
MG-RAST. The light grey colored cells in the first column represent the Florida Keys 
sample, and the Curacao sample is represented by the dark grey cells. Rows that are 
shaded throughout represent protein products from QS genes that are unique in that 
particular sample. As is evident, more than 50% of the identified QS genes were found to 
be those associated with vibrios. The luxI, rhlL and luxR genes identified under the subset 
of ‘AHL autoinducer QS’ are not associated with any particular bacterial genus. QS 
associated functional sequences were differentially found within the two BBD 
metagenomes. Both luxI and luxR genes associated with AHL synthesis were found in 
both samples, while rhlL, another AHL synthase, was found to be present only in the 
Florida Keys BBD metagenome. Four Vibrio-associated QS genes were found exclusively 
in the Florida Keys metagenome, specifically cqsA, luxP, luxM and hapR. Other QS genes 
(luxI, luxR, luxO, luxS and uvrY) were found in both metagenomes. A particular N-
homoserine lactone hydrolase (associated with QS in Yersinia) was uniquely present in 
the Curacao metagenome. One Pseudomonas associated QS gene was exclusively 
present in either of the two metagenomes (vfr in Curacao metagenome and rhlR in Florida 
Keys metagenome). The results of the QS genes in the BBD metagenomes correlated 
with the identification of the AHL-producing isolates used in this study (mainly vibrios) in 
that a high number of Vibrio-associated QS genes were present in the metagenomes. 
 
173 
 
4.5 Discussion for the first study 
 
Quorum Sensing Signals in BBD and Coral-Associated Bacteria. This study 
revealed the presence of AHLs in nine freshly collected BBD microbial mat samples from 
two Caribbean coral species. In each case, the full BBD community was present. The 
immediate questions that rise from these results are: 1) what microbial constituents within 
this pathogenic polymicrobial community are synthesizing AHLs?; 2) are the AHL 
producers in BBD also present in the coral microbiome?; 3) what are the structures of the 
AHLs produced?; and 4) do BBD and SML bacteria also produce AI-2? We addressed 
each of these questions in the present study. 
 
The observation that all (full community) BBD samples examined using the AHL reporter 
strains were positive for the presence of AHLs is in agreement with previous studies on QS 
signal production in cyanobacterial-dominated communities in other environments. These 
include Trichodesmium colonies in the North Atlantic316, marine stromatolites in the 
Bahamas283, and cyanobacterial mats in Swiss alpine wetland ponds317. On the other hand, 
although cyanobacterial isolates have been reported to produce AHLs in the laboratory318, 
none of the eight BBD cyanobacterial isolates examined in this study tested positive in either 
AHL reporter strain assay. We note that our cyanobacterial culture medium had a pH of ∼8 
(or higher during photosynthesis), and that alkaline pH has been demonstrated to degrade 
AHL signals282, 298 . Furthermore, it is possible that the AHL reporter strain assays yielded 
false-negative results for a variety of other reasons (e.g., the AHL produced was 
undetectable by the reporter strains, AHL concentrations were below the detectable levels 
of the reporter strains, AHL production was inhibited by the laboratory conditions used in this 
study, the isolate was also producing quorum quenching molecules that inhibited detection 
of AHLs, and/or other abiotic factors besides pH degraded the AHL signal). These same 
scenarios could explain false negative results in any of the reporter strain assays used to 
detect QS signals in this study. 
 
To investigate the identity of culturable BBD bacteria that are capable of producing AHLs (as 
well as DPD), we tested bacterial isolates from the complex microbial communities that 
constitute BBD, the apparently healthy SML of BBD-diseased colonies, and the SML of 
healthy colonies. We found that 11 of 199 (5.5%) isolates, all bacterial, from BBD, BSML, 
and HSML can produce QS signals under laboratory conditions. This result is similar to the 
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4% observed in a study240 in which more than 300 bacterial cultures isolated from marine 
invertebrates (i.e., coral SML, other marine invertebrates, and dinoflagellate symbionts) 
were screened using a variety of reporter strains that detect AHLs of varied chain lengths. 
We also showed that 55% of CFs tested positive for AI-2 activity (or the CAI-1 signal specific 
to some Vibrio spp.), as detected by the V. harveyi BB170 reporter strain. The high 
percentage of isolates capable of AI-2 activity is not unexpected, as this molecule is 
considered to be an interspecies signal molecule279, 319. It should be noted that AHL and AI-
2 production in some bacteria may be specific to a certain portion of the bacterial growth 
phase320-321. For the bacterial isolates investigated in this study, all CFs were collected during 
early stationary phase. Thus, an isolate producing QS signals during a different growth 
phase may have produced a negative result in the reporter strain assays. Based on 
subsequent 16S rRNA gene sequencing, all 11 AHL-producing isolates most closely aligned 
with members of the Alpha-and Gamma-proteobacteria (Table 4.4). Five of these were 
closely related to Vibrio spp. Vibrio fischeri and V. harveyi represent the archetypal system 
for AHL- and AI-2-regulated gene expression257, 322, and a variety of Vibrio spp. have been 
documented to produce AHLs323-325. Vibrios have been routinely detected in BBD228, 247, 326, 
and it has been suggested that proteolytic activity by Vibrio spp. might play a role in BBD 
pathology247.Vibrio strains isolated from both healthy and diseased corals have also been 
shown to produce AHLs291. 
 
Two AHL-producing isolates (BBD-FLK-1d and BSML-FTL-6w) were most closely related to 
strains belonging to the Rhodobacteraceae, also commonly detected in BBD and coral SML 
communities203, 228. AHL production by members of the Roseobacter-Ruegeria subgroup of 
the Alpha-proteobacteria has been previously demonstrated3, 327-328. Isolates BSML-FTL-7l 
and HSML-FTL-10a were most closely related to the genus Pseudoalteromonas, also 
previously documented to produce AHLs329. Isolate HSML-FTL-10a was most closely 
related to P. luteoviolacea strain NCIMB 1893 (99% similarity) and, consistent with the 
description of this strain as a producer of violacein330, isolate HSML-FTL-10a produced a 
dark purple pigment. P. luteoviolacea has been documented to have antibacterial activity330, 
and antibiotic activity has also been demonstrated for violacein331. 
 
QS Signals in the BBD Mat and Coral SML. Within the BBD mat, an exopolysaccharide 
(EPS) matrix surrounds the diverse members of the BBD microbial community. High 
concentrations (>600 µM) of AHLs have been measured within Pseudomonas 
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aeruginosa biofilms332, suggesting that bacterial EPS may effectively sequester QS 
signals. Because the surface of the BBD mat is exposed to seawater, and thus diffusion, 
advection, and dilution333, accumulation of QS signals would likely be greater in the depths 
of the BBD mat than on the mat surface. In a similar manner, coral mucus forms a 
protective coating over the coral surface and is present as a thin layer that can be 
considered as a biofilm. While the chemical composition of coral mucus varies between 
species, the basic structure of the SML consists of an insoluble, hydrated glycoprotein226, 
334. The gel-like nature of coral mucus would likely concentrate particularly hydrophobic 
signal molecules similar to EPS. 
 
Within BBD, the persistence of QS signals may be impacted by the local chemical and 
physical microenvironment to a greater extent than within non-cyanobacterial associated 
biofilms. Alkaline conditions may result in hydrolysis of the AHL lactone ring282, 298 with short-
chain (< C10) AHLs appearing to be more susceptible282-283. The BBD mat contains 
pronounced biogeochemical microgradients of oxygen, pH, and sulfide245-246 which fluctuate 
based on changes in the predominant metabolic pathways occurring within the BBD mat. 
During daylight, when oxygenic photosynthesis dominates, the pH in the BBD mat ranges 
from 7.58–8.13246, while in darkness, when predominant metabolic pathways shift to 
respiration and fermentation, pH values drop to 7.33–7.49246. Based on the relative stability 
of AHLs in terms of pH283-284, microbial mats in general could use both short- and longer-
chain AHL signaling during the night and longer-chain AHL signaling during the day. Coral 
mucus itself is acidic (pH of 5.5 to 7.7) in comparison to surrounding seawater335; thus, AHL 
signals within the coral SML would likely remain stable enough for signaling to occur both 
night and day. We found both short- and long-chain AHLs in this study, including variant 
3OC20-HSL produced by two isolates. To our knowledge this AHL has not been reported in 
the literature. 
 
The implications of abiotic and biotic influences on AI-2 signaling and the impact of the 
natural environment are not well understood at this time. Like AHLs, production of DPD may 
be dependent on the particular strain, the growth phase, or the culture medium303, 336. DPD 
appears to be relatively stable in comparison to the AHLs337. We found that 70% of the CFs 
from BBD isolates and 68% of the CFs from BSML isolates tested positive for AI-2 activity, 
compared to only 33% of the CFs from HSML isolates. All of the 11 isolates we examined 
for DPD production produced detectable amounts of this precursor to AI-2, with BBD isolates 
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producing two to three times as much as the SML isolates (Table 4.9). It is possible that AI-
2 signaling may be occurring more frequently within the BBD microbial consortium as 
compared to the coral SML, if AI-2 signaling is indeed occurring within these environments. 
 
Interactions among Isolates from BBD and SML. Results of the growth challenges 
revealed that 27% of 342 challenges resulted in significant inhibition of bacterial growth. 
While others have detected increased antimicrobial activity by the mucus of healthy corals, 
as opposed to diseased corals241-242, this study found no significant difference in 
antimicrobial production based on isolate source (BBD, BSML, or HSML). Toxins have 
been documented previously to be produced by BBD cyanobacteria232-234,235 and 
antimicrobials by coral-associated bacteria242-243, 338-339, and it is likely that antimicrobial 
production contributes to the temporal and spatial dynamics occurring in BBD340. 
Interestingly, only 2% of the 342 growth challenges exhibited significant growth stimulation 
by the culture filtrates. The vast majority (∼88%) of these stimulatory CFs were from BBD 
isolates. Thus, cooperation between microbes may be more common in interactions 
among members of the BBD than among SML bacteria. 
 
Almost all (∼93% of cases) of the growth inhibition documented in the challenge study was 
caused by the CFs of isolates that were positive for AI-2 activity and/or production of DPD. 
AI-2 is widely recognized for its involvement in interspecies signaling and has been linked 
to the upregulation of antibiotic biosynthesis288, 341. Regulation of bacterial relationships 
within complex microbial communities is another proposed role of DPD in the natural 
environment277. Our findings are in complete agreement with this proposal. For example, 
isolates that produced AI-2/DPD (with some also producing AHLs) were cultured from BBD, 
BSML, and HSML, and were shown to inhibit growth of isolates from all three of these 
sources. Thus, if present and active within these natural environments, it is possible that AI-
2 could regulate both pathogenic and probiotic microbial populations with communication 
between such populations. Only one strain that caused growth inhibition produced neither 
AI-2/DPD nor AHL. Further research is needed to determine if this is a pattern that holds 
true for bacterial members of complex communities in general. 
 
Potential Roles of QS Signal Production in Coral Health and Disease. This is the 
first report of the presence of AHLs in samples freshly collected from in situ coral disease. 
Only one previous study291 has directly and empirically addressed the potential role of QS 
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in coral health and disease. Similar to our study, Tait et al.291 used reporter strains (as well 
as thin layer chromatography) to detect AHLs and AI-2 production by bacteria (Vibrio spp. 
and Photobacterium rosenbergii strains) isolated from or near corals. Twenty-nine isolates 
were tested, of which 17 produced AHLs and 29 (100%) produced AI-2. Six of the 29 
strains were isolated from the tissue of “diseased” corals, although the disease was not 
identified; of these, three were positive for AHL production. Three strains were isolated 
from bleached corals (two from tissue, one from mucus), with both tissue samples positive 
for AHL production and the mucus sample negative. An additional 11 samples are 
identified as from the water in association with specific coral species; however, the 
distance of the sample from the coral surface is not provided; of these, six were positive 
for AHLs. Finally, of nine isolates from tissue or mucus samples associated with 
presumably healthy corals (only one identified as such), five (two tissue and three mucus) 
produced AHLs. These results suggest that QS may be a process in the coral microbiome 
(and coral environment), and our findings support their conclusion291. 
 
Despite nearly 40 years of research, the etiology, pathogenesis, and pathobiology of BBD 
remain unresolved. Mechanisms of BBD mat formation and organization, the mode of 
microbial recruitment to the BBD community, and the factors leading to initiation of the 
pathogenic, migrating band are not understood. It is, however, well known that AHLs 
produce and control similar virulence factors in other systems, including in laboratory 
experiments using the coral pathogen Serratia marcescens342. Although there has been little 
work on DPD production by coral-associated bacteria, AI-2 signaling is also known to be 
associated with disease function in pathogenic bacteria in general (reviewed in277, 279. 
 
If QS is indeed occurring within BBD, the potential roles of AHL and/or AI-2 signals with 
regard to virulence, biofilm structure, and community composition makes QS an important 
aspect of future study for BBD as well as other coral diseases. QS between potential 
pathogens and the healthy coral microbiota may contribute to disease processes as well. 
Future research to elucidate the roles that QS signaling molecules play in coral health and 
disease will require thorough investigations targeting specific effects of QS signals on 
regulatory and physiological systems, as well as gene expression. 
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4.6 Discussion for the second study 
 
One of the most interesting findings of this study was the fact that, by far, isolates from BBD 
had a significantly higher proportion of members that produced AHLs when compared to 
isolates from the SML of apparently healthy and BB-diseased corals. Only four of 74 (5.4%) 
isolates from BSML and HSML combined tested positive using the reporter strain whereas 
23 of 155 (14.8%) BBD isolates did so. This suggests that quorum sensing is more active, 
and presumably more important, in BBD bacterial communities as compared to SML 
bacterial communities. Overall BBD is a pathogenic polymicrobial consortium and the coral 
SML is believed to have probiotic characteristics. Both of these types of microbial 
communities (pathogenic and probiotic) have been proposed to involve QS on a functional 
basis. A second very interesting result of this study was that 12 of the 24 AHL producing 
isolates exhibited a significant difference in AHL production in terms of temperature. In 
particular, seven of the twelve isolates were significant when comparing AHL production 
above and below the threshold temperature of BBD (27.5 ̊C). In each case, there was 
increased AHL production at the higher temperature (30 ̊C) compared to the lower 
temperature (24 ̊C). Four of the eight AHLs detected in this study showed this pattern, and 
six of the seven isolates that exhibited the temperature threshold response were from BBD, 
which further suggests that quorum sensing is potentially important in BBD etiology. 
Previous studies of AHL production in terms of temperature and disease revealed varying 
effects for different AHLs. For example, AHL production by some sub-species of Erwinia, 
which causes soft rot in plants above a threshold temperature of 20 ºC, was increased at 
34.5 ºC compared to 28 ºC, whereas production decreased at the elevated temperature for 
other, non-pathogenic sub-species of the same genus343. Pecobacterium atrosepticum, 
which causes soft rot in potatoes at and above 20 ºC, produces four AHLs which all increase 
from 4 ºC to 24 ºC, but then decrease at 28 ºC344. These findings, along with the results of 
this study, implicate temperature as an environmental factor that influences the role of QS 
in disease. AHLs are affected by other environmental factors in addition to temperature. 
These include pH, redox state and oxygen concentration170, 333. Alkaline pH causes 
degradation of AHLs rendering the molecule incapable of signaling282. In general, it has been 
shown that the longer the AHL chain length, the more stable the molecule is to external 
factors and the lower the turnover rate282, 316. The pH of sea water is around 8.2, hence one 
can argue that marine AHL producing bacteria must have long chain AHLs to be capable of 
signaling in an alkaline pH329. However, several studies have found that both short and long 
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chain AHLs are produced by bacteria in marine environments154, 157, 240, 289-290, 309, 328, 345-347. It 
may be that the small chain AHLs are produced at high quantities to counteract breakdown 
due to external factors. Decho et al. (2009) proposed that differential degradation of AHLs 
likely affects signal reception by bacteria, and that this could result in variation of 
chronological windows in which signaling can occur283. A greater abundance of AHLs has 
been observed in buffered media as compared to unbuffered media, which could be the 
result of increased pH as a growing culture becomes more alkaline282. Although buffered 
media were not utilized in the present study, growth periods were short (on the order of 
hours) and samples were extracted and immediately frozen at - 20 ºC to minimize any 
breakdown and/or degradation of AHL molecules.  In terms of BBD, the results of this study 
showed that temperature influenced the relative abundance of AHLs produced by BBD 
isolates with more AHL produced above the BBD temperature threshold. Considering the 
polymicrobial nature of BBD, the observed variable effect of temperature on specific AHLs 
would likely affect the interactions within the BB-disease microbial community, which may 
lead to maintenance of the disease process either during initiation or progression. In addition 
to temperature, pH is an important environmental factor in BBD in that it fluctuates widely 
over each 24-hour period. The pH in the band is 7.6 during the night due to release of CO2 
during respiration and 8.2 during the day due to CO2 uptake during photosynthesis245-246, 
283. This may indicate that only long chain AHLs are available during the day and both short 
and long chain AHLs at night, which would in turn affect gene transcription and regulation 
over the 24-hour period283. In the current experiment pH was not manipulated, but it would 
be interesting in future studies to assess the role of pH on AHL production among the BBD 
(and SML) isolates. Nearly all isolates that produced AHLs in this study were identified to be 
Vibrio species, which is interesting in that many vibrios exhibit QS. Vibrio species are also 
known pathogens in several coral diseases. For example, Vibrio coralliilyticus and Vibrio 
shiloi both cause coral bleaching348-350, Vibrio harveyi and other vibrio species have been 
implicated in white syndrome disease351-352 and V. alginolyticus is a proposed pathogen of 
yellow blotch/band disease353. Several studies have found Vibrio species to be present in 
higher abundance in diseased corals as compared to healthy corals291, 354-355 and vibrios 
have been proposed to be, in general, opportunistic pathogens of corals356, including 
BBD247. To date, all of the vibrios that have caused disease in corals have done so at a 
temperature of above 26 ºC, close to the temperature threshold of BBD. In our study all six 
of the BBD isolates 435 that produced significantly more ALHs at 30°C compared to 24°C 
were vibrios. The presence of many well-known and common QS genes in the BBD 
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metagenome dataset indicates a very high potential for active quorum sensing within the 
black band mat. Both AHL and AI-2 genes were found to be present in the BBD 
metagenome, many of which are vibrio associated, which agrees with the high proportion 
of vibrios among the BBD isolates tested. Overall, a greater variety of QS genes were 
exclusively present in the Florida Keys metagenome. The antimicrobial assays conducted 
in this study revealed that, when comparing bacterial isolates from the three coral health 
states, BBD isolates had the fewest number of isolates that exhibited growth inhibition of the 
potentially important BBD bacteria Roseovarius and Ferrimonas. This result, although 
based on tests using only two strains, does suggest that isolates from BBD in general are 
less competitive than bacterial members within the SML. It may be that interactions within 
polymicrobial pathogenic communities minimize antagonism among the individual 
community members, in contrast to enhanced competition that would be expected in a 
nutrient and carbon rich environment (such as the coral SML on coral reefs). In summary, 
our findings reveal that temperature has a significant effect on the production of specific 
quorum sensing signal molecules (AHLs) produced by isolates of BBD bacteria and that 
production of half of these (four of eight detected) is increased above the BBD temperature 
threshold. Furthermore, we found that when comparing QS signal production by BBD 
bacteria vs. bacteria isolated from coral SML, the proportion of QS sensing by BBD bacteria 
was significantly higher. Our results further imply a particular importance of BBD vibrios in 
the functioning of BBD community quorum sensing, both in the laboratory experiments using 
bacterial isolates and in our investigation into the BBD metagenome. Whether vibrios and 
specific quorum sensing signal production capabilities are directly involved in BBD disease 
etiology necessitates further investigation targeting specific 458 mechanisms of BBD 
pathobiology that are linked to QS.  
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CONCLUSION  
This dissertation consisted of six studies spread over three chapters, each describing the 
activities of three different biological signaling molecules in terms of therapeutic potential on 
an in vivo system, environmental degradation, and transcription-level control of phenotype 
of a species and consortium of bacteria. Each of these studies was in the realm of chemical 
biology and relied on the powerful tools of synthetic and analytical chemistry in application 
to identification, synthesis, and characterization of each biological signaling molecules in 
each study. The primary chemist contribution of CWP in each study was significant in terms 
of the generation and analysis of data and discussion thereof. Through contribution and 
experience in these inherently collaborative projects, mastery of a type of scientific method 
was accomplished. First, the hypothesis is generated from the presumption that a single, 
group, or class of signaling molecules are responsible for an activity of interest. If the 
molecule is unknown or poorly defined, the tools of biology and chemistry, such as NMR 
and MS can be applied to this end. From this, organic synthesis can generate a synthetic 
version or analogue of the signaling molecule(s) to modulate the activity of interest in order 
to understand the activity or alter the activity in a desired fashion. Finally, evaluation of the 
activities through biological methods such as quantitating gene transcripts of products 
associated with the activity of interest, such as a luciferase reporter gene assay or qPCR 
assay, and chemistry methods capable of quantitating the amount of molecules of interest, 
such as ID-HPLC-MS/MS, provide data to be analyzed to test and refine the hypothesis. 
Mastery of this method may allow a chemist working in the field of chemical biology to 
contribute to the conception of a study similar to those discussed herein, which studies the 
activities or degradation of a biological signaling molecule or signal disruptor.  
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